data_1m3b_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m3b _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.477 0.179 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.445 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.433 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.41 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.56 0.219 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.463 HD13 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CE3' HG23 ' A' ' 184' ' ' VAL . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 176' ' ' GLU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.522 0.201 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.513 ' CG ' HD13 ' A' ' 158' ' ' ILE . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.41 ' CD2' ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.575 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.516 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.516 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.57 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.546 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.595 ' CE3' HG22 ' A' ' 184' ' ' VAL . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.504 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.406 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 3.1 t80 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.497 0.189 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.588 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HD2' ' CD2' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.484 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.402 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 28.4 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.644 ' CZ3' ' CG2' ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.512 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.497 ' CG2' HG11 ' A' ' 187' ' ' VAL . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 190' ' ' TYR . 74.3 t80 . . . . . 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.514 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.533 0.206 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.581 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 10.3 tp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.483 HD22 ' CG2' ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.491 ' CG2' ' HD2' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.587 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.428 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 . . . . . 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.504 0.192 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CB ' ' HA3' ' A' ' 180' ' ' GLY . 3.7 tp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.535 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.47 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.559 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.51 ' HB3' ' H ' ' A' ' 171' ' ' ASN . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.503 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.521 ' CE2' ' HB3' ' A' ' 183' ' ' PRO . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.51 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.559 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.426 ' CG ' HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 151' ' ' LEU . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.795 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.487 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.506 0.193 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' CG2' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.713 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.654 ' CE3' HG21 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.41 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.524 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.555 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.535 0.207 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.455 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.504 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.582 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.552 ' O ' ' CG1' ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.575 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 153' ' ' PHE . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.43 ' O ' HG11 ' A' ' 187' ' ' VAL . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.53 0.205 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.572 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.606 ' N ' ' OE2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.613 ' CE3' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.46 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 176' ' ' GLU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.46 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.459 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.627 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 184' ' ' VAL . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.467 0.175 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.578 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.454 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.423 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.465 HD22 ' CB ' ' A' ' 174' ' ' ASP . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.425 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.406 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.465 ' CB ' HD22 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.542 ' CG2' HG11 ' A' ' 187' ' ' VAL . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.58 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.58 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.554 0.216 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.631 ' CG1' ' HB ' ' A' ' 187' ' ' VAL . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.497 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.485 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.582 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 9.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.418 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.454 HD12 ' CG2' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.598 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.814 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.631 ' HB ' ' CG1' ' A' ' 137' ' ' VAL . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.488 0.185 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.51 ' CB ' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.407 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.416 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.51 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.451 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 ' CA ' ' A' ' 174' ' ' ASP . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.55 ' CG ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.511 ' CA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.423 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.421 0.153 . . . . 0.0 111.02 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.435 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.454 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.534 ' CE1' ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 138' ' ' ARG . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.538 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.531 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.531 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 176' ' ' GLU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.48 ' CD1' HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.467 0.175 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.599 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.429 ' CD1' HG12 ' A' ' 187' ' ' VAL . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.533 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.577 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.533 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.412 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.579 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.516 ' O ' ' CD2' ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.516 ' CD2' ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.453 ' CG2' ' HE2' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.569 ' CE3' HG23 ' A' ' 184' ' ' VAL . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 176' ' ' GLU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.401 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.457 ' CD1' ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 183' ' ' PRO . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.557 0.218 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.532 ' CB ' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.478 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.478 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.604 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 176' ' ' GLU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.486 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 169' ' ' TRP . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.668 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.668 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.514 0.197 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 152' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.402 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.547 ' O ' ' CG1' ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 176' ' ' GLU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.427 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.402 HG12 ' CB ' ' A' ' 172' ' ' ALA . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.607 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.859 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.479 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 12.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.474 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.567 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.575 ' CE3' HG22 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.427 ' CG ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.432 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.644 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.48 HG11 ' CA ' ' A' ' 139' ' ' ALA . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.487 0.184 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 153' ' ' PHE . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.576 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 . . . . . 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.566 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.502 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.508 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.502 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.402 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 160' ' ' ARG . 33.7 p90 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.523 0.201 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.2 t80 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' PRO . . . . . 0.407 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLU . . . . . 0.437 ' CG ' ' HE2' ' A' ' 181' ' ' MET . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLN . . . . . 0.601 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLU . . . . . 0.423 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' MET . . . . . 0.437 ' HE2' ' CG ' ' A' ' 166' ' ' GLU . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 172' ' ' ALA . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' VAL . . . . . 0.85 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' VAL . . . . . 0.477 HG23 ' HA ' ' A' ' 184' ' ' VAL . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLU . . . . . 0.592 ' OE2' ' CD1' ' A' ' 190' ' ' TYR . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 38.13 2.8 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.512 1.132 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -147.93 141.5 25.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 0.738 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.547 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.579 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 13.9 t80 -93.44 157.29 16.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -95.75 -51.51 4.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.463 1.102 . . . . 0.0 109.265 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.579 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -36.54 154.46 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.501 1.125 . . . . 0.0 110.995 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -159.47 60.66 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 0.744 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 147' ' ' ASP . 1.3 p30 -68.67 152.46 45.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.142 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -86.63 39.16 0.82 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 110.33 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -144.49 -39.73 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 0.0 110.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.74 147.25 27.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.285 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.445 ' CD1' ' OD2' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -77.7 139.18 62.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.474 1.109 . . . . 0.0 109.288 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.408 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.433 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.593 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.468 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.554 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.41 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.554 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.593 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' OD2' ' CD1' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.407 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.575 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 139' ' ' ALA . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -95.66 -42.26 8.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 O-C-N 124.462 1.101 . . . . 0.0 110.993 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.24 -66.38 0.48 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.513 1.133 . . . . 0.0 111.064 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 -88.75 153.11 21.34 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.556 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.501 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 -117.88 163.31 16.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 5.5 t30 -150.1 118.17 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.518 1.136 . . . . 0.0 109.328 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' ASN . . . -157.0 -139.96 2.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.444 1.09 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' GLY . 11.4 t30 176.38 48.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.29 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.29 129.87 34.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 0.0 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -81.64 45.87 0.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.544 1.153 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.41 -37.63 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.564 1.165 . . . . 0.0 110.313 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -103.4 161.89 13.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 0.0 109.28 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.91 139.8 23.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.575 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.463 HD13 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.473 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.473 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CE3' HG23 ' A' ' 184' ' ' VAL . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.575 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.491 ' C ' ' H ' ' A' ' 176' ' ' GLU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.427 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.586 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.556 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.28 -26.21 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.468 1.105 . . . . 0.0 110.955 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 63.0 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 53.41 69.2 1.29 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.466 1.104 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 52.0 m-85 -150.53 155.83 40.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 0.753 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.513 ' CG ' HD13 ' A' ' 158' ' ' ILE . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.545 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.41 ' CD2' ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -134.76 125.44 26.94 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -135.54 117.03 14.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.322 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.99 111.71 3.19 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.386 1.054 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -173.7 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.455 0.739 . . . . 0.0 109.301 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 166.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.403 1.065 . . . . 0.0 109.29 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -38.31 -42.53 0.72 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 1.103 . . . . 0.0 110.302 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -37.13 -50.08 0.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 0.0 110.278 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.452 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -87.47 113.0 22.78 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.425 1.078 . . . . 0.0 109.222 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.575 ' O ' ' CE2' ' A' ' 153' ' ' PHE . 0.6 OUTLIER -52.86 149.51 11.5 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 0.0 109.248 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.436 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.516 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.516 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.475 ' CD1' ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.439 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.57 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.546 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.546 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.595 ' CE3' HG22 ' A' ' 184' ' ' VAL . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.423 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.504 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.426 ' O ' ' CG ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 3.1 t80 -88.8 -44.2 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.447 1.092 . . . . 0.0 111.025 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -56.43 -109.28 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.458 1.099 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -99.4 -176.52 3.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.556 0.798 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.432 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.485 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -142.79 164.35 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -102.67 166.71 10.35 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.543 1.152 . . . . 0.0 109.385 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.81 -131.5 7.39 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.464 1.102 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 178.03 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 0.776 . . . . 0.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.64 -170.67 3.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 0.0 109.288 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.06 31.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.546 1.154 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -37.16 4.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.528 1.143 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 165.49 12.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 0.0 109.253 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.588 ' C ' ' CD1' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -107.13 125.39 32.61 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.438 ' HD2' ' CD2' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.587 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.419 ' O ' ' OD1' ' A' ' 174' ' ' ASP . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.477 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.518 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.484 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.402 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.531 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.402 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 28.4 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.644 ' CZ3' ' CG2' ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.456 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.518 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.512 ' HB2' ' CD2' ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.497 ' CG2' HG11 ' A' ' 187' ' ' VAL . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.587 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.534 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 190' ' ' TYR . 74.3 t80 -111.18 75.34 0.91 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 O-C-N 124.605 1.191 . . . . 0.0 111.04 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' TYR . 5.2 p . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 119.62 -111.63 2.08 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.514 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 -144.45 -144.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 0.732 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.581 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -97.04 108.7 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -68.12 142.38 55.79 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.517 1.136 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 127.55 -165.79 20.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.428 1.08 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -179.05 74.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 0.768 . . . . 0.0 109.318 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.39 144.71 54.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 0.0 109.27 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -86.14 43.18 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.495 1.122 . . . . 0.0 110.3 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -154.83 -41.0 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.58 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 14.1 m-20 -101.29 170.43 8.24 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.395 1.06 . . . . 0.0 109.282 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 ' HB3' ' CG2' ' A' ' 182' ' ' ILE . 10.3 tp -103.94 120.73 50.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 109.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.483 HD22 ' CG2' ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.553 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.491 ' CG2' ' HD2' ' A' ' 164' ' ' LYS . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.587 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.58 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.587 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.553 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.428 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.456 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.428 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.412 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.53 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.488 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.479 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 -70.8 132.31 45.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.446 1.091 . . . . 0.0 110.985 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.45 -59.82 0.19 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.542 1.151 . . . . 0.0 111.005 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.82 161.41 16.01 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.526 0.78 . . . . 0.0 111.001 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.429 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.545 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 -100.48 156.91 17.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 1.1 t-20 -110.99 153.35 25.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.62 173.79 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.591 1.182 . . . . 0.0 110.985 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.494 0.761 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.54 153.67 19.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.128 . . . . 0.0 109.273 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.02 39.34 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -45.04 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 0.0 110.282 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.593 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -94.36 169.03 10.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.272 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.439 ' CB ' ' HA3' ' A' ' 180' ' ' GLY . 3.7 tp -110.57 120.73 43.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.545 ' CZ ' ' HB2' ' A' ' 143' ' ' PHE . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.535 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.535 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.47 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.559 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.51 ' HB3' ' H ' ' A' ' 171' ' ' ASN . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.503 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.51 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.559 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.426 ' CG ' HD22 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.439 ' HA3' ' CB ' ' A' ' 151' ' ' LEU . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.478 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.795 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.487 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.526 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -119.18 100.85 7.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.568 1.168 . . . . 0.0 111.006 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.49 0.5 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.508 1.13 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.471 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -86.5 145.1 26.93 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.495 0.762 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.494 HG11 ' CG2' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.47 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -153.22 135.09 14.62 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.1 174.92 7.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 0.0 109.25 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -173.28 -139.13 2.79 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.439 1.087 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' ND2' ' OE2' ' A' ' 149' ' ' GLU . 6.2 p30 178.57 43.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 109.363 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.72 174.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.42 1.075 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 4.1 tt0 52.12 44.08 29.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 110.21 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 17.4 pt-20 178.6 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 0.0 110.288 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER 167.81 124.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.582 1.177 . . . . 0.0 109.269 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -56.68 152.62 25.26 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 109.338 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 158' ' ' ILE . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.421 ' O ' ' CB ' ' A' ' 137' ' ' VAL . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.429 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.713 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.713 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.654 ' CE3' HG21 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.47 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.605 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.47 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.425 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.524 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.555 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.555 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.434 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -48.35 18.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 O-C-N 124.532 1.145 . . . . 0.0 111.017 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -78.35 1.17 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.494 1.121 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 -87.64 151.3 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 0.82 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.504 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.403 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.78 147.25 10.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -139.93 156.35 46.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.464 1.103 . . . . 0.0 109.313 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.88 -108.63 0.86 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.436 1.085 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 177.34 38.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.547 0.792 . . . . 0.0 109.342 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 74.7 42.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.315 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.36 46.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.456 1.098 . . . . 0.0 110.308 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 73.65 27.29 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.135 . . . . 0.0 110.323 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.38 132.32 3.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 0.0 109.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.86 147.3 48.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 0.0 109.256 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.455 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.504 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.582 ' HB3' ' CD2' ' A' ' 136' ' ' TYR . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.552 ' O ' ' CG1' ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.526 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.575 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.488 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.553 HG13 ' CZ ' ' A' ' 153' ' ' PHE . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.43 ' O ' HG11 ' A' ' 187' ' ' VAL . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.528 HG23 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.474 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -69.04 -46.19 68.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.54 1.15 . . . . 0.0 110.998 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 134' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.14 -59.22 0.34 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.557 1.161 . . . . 0.0 110.989 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 -88.15 145.71 25.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 0.742 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.532 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.578 ' CE2' ' HB2' ' A' ' 146' ' ' ASN . 0.8 OUTLIER -94.7 136.82 34.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.411 ' O ' ' O ' ' A' ' 145' ' ' GLY . 37.2 p-10 -131.21 92.58 3.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.611 1.195 . . . . 0.0 109.3 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.45 ' N ' ' CE1' ' A' ' 143' ' ' PHE . . . 54.78 164.47 0.02 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.577 1.173 . . . . 0.0 111.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.578 ' HB2' ' CE2' ' A' ' 143' ' ' PHE . 0.4 OUTLIER 169.69 -54.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.532 0.783 . . . . 0.0 109.334 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -166.79 150.07 6.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.452 1.095 . . . . 0.0 109.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -85.97 36.55 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.518 1.136 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.61 -11.39 9.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 0.0 110.358 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.9 OUTLIER -131.39 143.03 50.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 0.0 109.307 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -75.03 144.12 78.75 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.481 1.113 . . . . 0.0 109.224 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.572 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.572 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.6 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.606 ' N ' ' OE2' ' A' ' 166' ' ' GLU . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.613 ' CE3' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.46 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.6 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.46 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.415 ' C ' ' H ' ' A' ' 176' ' ' GLU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.415 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.46 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.451 ' CD1' ' HB2' ' A' ' 172' ' ' ALA . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.627 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.627 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.429 ' CG2' ' HA ' ' A' ' 184' ' ' VAL . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.532 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -111.58 82.43 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 124.529 1.143 . . . . 0.0 111.026 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.02 51.07 0.18 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.474 1.109 . . . . 0.0 110.983 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.45 171.64 8.64 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.562 0.801 . . . . 0.0 111.011 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.57 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.498 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.531 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.578 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 -111.49 141.28 45.26 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.545 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 1.7 t30 -98.76 155.37 17.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 0.0 109.327 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -40.23 158.26 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.442 1.088 . . . . 0.0 110.978 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -170.0 -42.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 0.752 . . . . 0.0 109.29 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -161.46 120.44 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.2 pt-20 -49.6 -47.61 49.39 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 1.133 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 150' ' ' ASP . 17.2 pt-20 -45.74 -36.82 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.245 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 149' ' ' GLU . 7.9 m-20 -92.95 112.08 23.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.561 1.163 . . . . 0.0 109.303 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.454 ' CD1' ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp -63.8 131.77 95.02 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 0.0 109.37 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.423 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.465 HD22 ' CB ' ' A' ' 174' ' ' ASP . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.555 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.425 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.406 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.483 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.406 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.472 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.465 ' CB ' HD22 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.542 ' CG2' HG11 ' A' ' 187' ' ' VAL . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.58 ' O ' ' CG2' ' A' ' 187' ' ' VAL . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.502 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.58 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.57 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.15 139.53 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.911 0 O-C-N 124.554 1.159 . . . . 0.0 111.066 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.27 -45.34 0.22 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.531 1.144 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -87.8 170.56 11.1 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 0.792 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.631 ' CG1' ' HB ' ' A' ' 187' ' ' VAL . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.497 ' N ' ' CG1' ' A' ' 137' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.485 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -146.79 144.29 29.26 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -157.29 159.04 37.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 109.3 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.72 104.2 0.38 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.477 1.11 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.573 0.808 . . . . 0.0 109.294 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER -176.97 124.04 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.336 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -37.29 -45.07 0.64 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.571 1.17 . . . . 0.0 110.294 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -41.35 -54.14 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 110.372 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 44.0 m-20 -77.06 107.27 9.3 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.315 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.582 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 9.3 tp -56.4 140.53 72.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 0.0 109.31 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.484 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' CD2' ' CD2' ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.559 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.454 HD12 ' CG2' ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.606 ' CE2' HG23 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.559 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.41 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.444 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.459 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.598 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.814 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.631 ' HB ' ' CG1' ' A' ' 137' ' ' VAL . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' O ' ' C ' ' A' ' 191' ' ' GLY . 42.6 t80 -81.61 150.37 28.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.512 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.978 0 O-C-N 124.516 1.135 . . . . 0.0 111.026 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 161.56 -60.05 0.29 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.496 1.122 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -87.4 144.61 26.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.51 ' CB ' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.407 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -140.51 176.81 8.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -114.97 178.72 4.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -95.65 -163.08 33.98 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.376 1.047 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.53 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 0.0 109.33 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.84 172.75 17.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.455 1.097 . . . . 0.0 109.262 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.67 35.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -96.84 -46.95 6.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -110.6 169.69 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.542 1.151 . . . . 0.0 109.289 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp -104.97 138.07 19.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.416 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.407 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.51 ' OD2' ' CB ' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.451 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD23 ' CA ' ' A' ' 174' ' ' ASP . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.55 ' CG ' ' HB3' ' A' ' 173' ' ' GLU . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.548 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.566 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.579 ' CD2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.444 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.549 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.511 ' CA ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.47 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.458 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.511 ' HA ' ' CZ3' ' A' ' 169' ' ' TRP . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.478 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.522 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.423 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -138.15 103.12 4.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.98 0 O-C-N 124.505 1.128 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.31 -49.23 0.93 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.496 1.122 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 25.0 m-85 -88.0 157.88 18.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 0.743 . . . . 0.0 111.02 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.538 ' CG2' ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.511 ' HG2' ' CD1' ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.435 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -131.89 156.3 46.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.01 141.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 109.29 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.03 115.37 0.54 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -171.67 -46.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 0.763 . . . . 0.0 109.338 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.31 165.44 33.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.58 1.175 . . . . 0.0 109.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.93 38.02 0.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 110.307 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.52 39.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.462 1.102 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.76 160.7 31.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' C ' ' CD2' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -105.65 152.32 40.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.517 1.136 . . . . 0.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.454 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.534 ' CE1' ' CD2' ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.576 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.576 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.511 ' CD1' ' HG2' ' A' ' 138' ' ' ARG . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.538 ' O ' ' CG2' ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.531 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.48 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.439 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.531 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.506 ' C ' ' H ' ' A' ' 176' ' ' GLU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.506 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.454 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.439 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.436 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.48 ' CD1' HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.606 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.489 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 -144.71 121.01 10.9 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.107 . . . . 0.0 110.982 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 135' ' ' GLY . 1.2 m . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' ' C ' ' A' ' 191' ' ' GLY . . . -58.03 -150.0 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.565 1.165 . . . . 0.0 111.041 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.25 -151.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.579 0.811 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.529 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.57 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 -152.7 136.51 16.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.67 -61.82 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.145 . . . . 0.0 109.267 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 47.36 -145.31 4.79 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.51 1.131 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.4 t30 177.72 47.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 0.789 . . . . 0.0 109.295 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.76 128.81 35.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.3 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.5 47.72 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 0.0 110.319 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -39.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.3 158.59 15.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.428 1.08 . . . . 0.0 109.259 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -111.64 142.38 26.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 0.0 109.24 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.599 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.429 ' CD1' HG12 ' A' ' 187' ' ' VAL . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.533 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.577 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.424 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.533 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.412 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.607 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.607 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.529 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.65 95.62 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.567 1.167 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.48 -45.44 1.32 Allowed Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.55 1.156 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -88.57 151.61 22.38 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.5 0.765 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.466 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.546 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.588 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' A' ' 145' ' ' GLY . 8.0 t80 -77.65 165.29 24.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -103.45 -79.94 0.53 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 109.306 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.594 ' O ' ' CD2' ' A' ' 143' ' ' PHE . . . -66.79 -172.84 5.33 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.481 1.113 . . . . 0.0 111.013 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 146' ' ' ASN . 4.9 p-10 164.47 88.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 0.0 109.293 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -40.82 160.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.88 44.58 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 0.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.408 ' H ' ' C ' ' A' ' 147' ' ' ASP . 6.7 pt-20 -140.7 -36.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.602 1.189 . . . . 0.0 110.29 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.417 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.48 163.9 12.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 0.0 109.227 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.579 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -98.14 136.48 20.98 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.11 . . . . 0.0 109.353 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.42 ' HB3' ' ND2' ' A' ' 146' ' ' ASN . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.516 ' O ' ' CD2' ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.516 ' CD2' ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.49 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.453 ' CG2' ' HE2' ' A' ' 164' ' ' LYS . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.498 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.569 ' CE3' HG23 ' A' ' 184' ' ' VAL . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.49 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.522 ' C ' ' H ' ' A' ' 176' ' ' GLU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . 0.513 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.407 ' O ' ' OD2' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.457 ' CD1' ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.551 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.588 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.454 ' CG1' ' O ' ' A' ' 183' ' ' PRO . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.54 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -135.32 80.77 1.85 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 0.0 110.993 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.39 -99.27 0.12 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.549 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 -88.54 -178.75 5.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 0.782 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.497 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.5 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.532 ' CB ' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 -163.56 158.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.554 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 5.9 p30 -143.36 164.67 29.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 109.262 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.16 -103.43 0.61 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.564 1.165 . . . . 0.0 111.036 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ASP . 9.5 p-10 -178.32 37.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.753 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 146' ' ' ASN . 5.4 m-20 54.44 170.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.531 1.144 . . . . 0.0 109.306 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 69.94 -60.94 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.459 1.099 . . . . 0.0 110.306 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -88.47 -21.66 24.08 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 0.0 110.33 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 181' ' ' MET . 0.1 OUTLIER 179.8 149.35 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 109.265 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -102.15 141.95 23.58 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.475 1.109 . . . . 0.0 109.279 179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.439 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.532 ' OD1' ' CB ' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.478 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.478 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.566 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.604 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.442 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.566 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.452 ' C ' ' H ' ' A' ' 176' ' ' GLU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.452 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.486 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.442 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.467 ' CG ' ' HB3' ' A' ' 169' ' ' TRP . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.573 ' CG2' ' HD2' ' A' ' 183' ' ' PRO . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.668 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.668 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.497 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 134' ' ' CYS . 88.8 t80 -77.03 107.93 9.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 O-C-N 124.546 1.154 . . . . 0.0 111.034 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.79 -57.5 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.461 1.1 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -92.64 -179.95 5.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.509 0.77 . . . . 0.0 111.046 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.435 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.54 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 -151.25 100.25 2.74 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 145' ' ' GLY . 32.8 t-20 -70.08 -71.12 0.25 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.13 . . . . 0.0 109.308 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 144' ' ' ASN . . . 35.8 -154.07 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.506 1.129 . . . . 0.0 111.008 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.57 39.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 0.762 . . . . 0.0 109.294 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.8 OUTLIER -91.4 101.59 14.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 109.315 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -38.35 -39.15 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.549 1.155 . . . . 0.0 110.262 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -42.15 -40.33 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -137.72 142.2 41.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.506 1.129 . . . . 0.0 109.341 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.402 ' HG ' ' N ' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -78.12 145.01 68.34 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 109.304 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.402 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . 0.458 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.424 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.555 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.512 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.51 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.547 ' O ' ' CG1' ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.578 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.555 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.427 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.484 ' C ' ' H ' ' A' ' 176' ' ' GLU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.484 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.427 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.457 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.402 HG12 ' CB ' ' A' ' 172' ' ' ALA . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.607 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.859 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 191' ' ' GLY . 20.4 t80 -72.03 132.9 44.89 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.46 1.1 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.456 ' N ' ' HA3' ' A' ' 191' ' ' GLY . . . 120.86 -42.45 1.71 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.522 1.139 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 -86.11 163.82 17.65 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 0.754 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.428 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.493 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -85.47 176.42 8.26 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.31 77.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 0.0 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' OD1' ' A' ' 146' ' ' ASN . . . 59.44 147.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.552 1.157 . . . . 0.0 110.981 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 2.4 p-10 173.9 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 0.772 . . . . 0.0 109.247 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.12 119.26 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.558 1.161 . . . . 0.0 109.231 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -42.21 -48.96 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -40.71 -48.46 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 0.0 110.267 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.616 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -61.23 154.93 22.18 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.479 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 12.9 tp -100.38 136.32 20.03 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.297 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.474 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.474 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' CG2' ' HD2' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.567 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.44 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.616 ' CE3' ' OD1' ' A' ' 150' ' ' ASP . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.575 ' CE3' HG22 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.468 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.427 ' CG ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.432 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.45 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.404 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.4 HD11 ' CD1' ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.644 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.644 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.48 HG11 ' CA ' ' A' ' 139' ' ' ALA . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.553 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 191' ' ' GLY . 28.2 t80 -123.13 -67.1 0.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.957 0 O-C-N 124.536 1.148 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 136' ' ' TYR . . . -136.99 66.73 0.54 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.562 1.164 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' A' ' 135' ' ' GLY . 13.5 m-85 -145.75 160.54 41.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.449 0.735 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.468 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 153' ' ' PHE . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.576 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 -69.12 164.01 23.5 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -103.43 -74.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 0.0 109.277 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -155.6 128.72 2.33 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.566 1.166 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 150' ' ' ASP . 8.3 m-20 160.76 51.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 0.751 . . . . 0.0 109.32 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -78.66 158.29 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 0.0 109.323 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 9.4 mm-40 66.69 -58.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 110.344 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 147' ' ' ASP . 1.2 pt-20 -66.17 -34.29 77.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.632 ' OD2' ' CE3' ' A' ' 169' ' ' TRP . 4.5 t70 -150.39 92.74 1.9 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.132 . . . . 0.0 109.267 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.413 ' C ' ' O ' ' A' ' 150' ' ' ASP . 0.6 OUTLIER -39.61 110.39 0.62 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.566 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 158' ' ' ILE . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.502 ' O ' ' CA ' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.508 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.518 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.451 ' O ' ' CG2' ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.632 ' CE3' ' OD2' ' A' ' 150' ' ' ASP . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.597 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.453 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.502 ' CA ' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.424 ' C ' ' H ' ' A' ' 176' ' ' GLU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.424 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.477 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.469 HD11 ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.556 ' HB2' ' HB2' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.576 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.524 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.402 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER -157.9 82.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 O-C-N 124.613 1.195 . . . . 0.0 110.968 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 136' ' ' TYR . 94.7 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 134' ' ' CYS . . . 35.15 -108.47 0.05 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.559 1.162 . . . . 0.0 111.001 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' TYR . . . . . 0.443 ' CB ' ' HA ' ' A' ' 160' ' ' ARG . 33.7 p90 -91.93 178.9 5.76 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.486 0.756 . . . . 0.0 110.978 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . 0.549 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' PHE . . . . . 0.61 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 18.2 t80 -96.19 175.4 6.46 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 145' ' ' GLY . 2.8 p30 -117.27 -50.62 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.237 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -45.97 173.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.108 . . . . 0.0 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 174.2 68.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.562 0.801 . . . . 0.0 109.33 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 157.35 38.01 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.151 . . . . 0.0 109.291 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -79.78 42.26 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 0.0 110.261 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.99 -41.84 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER -111.47 151.58 28.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.089 . . . . 0.0 109.301 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.407 ' HG ' ' N ' ' A' ' 152' ' ' PRO . 0.1 OUTLIER -85.25 144.16 40.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.263 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' PRO . . . . . 0.407 ' N ' ' HG ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.592 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . 0.466 ' HG ' ' C ' ' A' ' 158' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.514 ' O ' ' CB ' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' LYS . . . . . 0.523 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLU . . . . . 0.437 ' CG ' ' HE2' ' A' ' 181' ' ' MET . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.601 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLN . . . . . 0.601 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CZ3' HG12 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.514 ' CB ' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.423 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 176' ' ' GLU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLU . . . . . 0.445 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ARG . . . . . 0.423 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' MET . . . . . 0.437 ' HE2' ' CG ' ' A' ' 166' ' ' GLU . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ILE . . . . . 0.453 HD12 ' CB ' ' A' ' 172' ' ' ALA . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.592 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' VAL . . . . . 0.85 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.61 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' VAL . . . . . 0.477 HG23 ' HA ' ' A' ' 184' ' ' VAL . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLU . . . . . 0.592 ' OE2' ' CD1' ' A' ' 190' ' ' TYR . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -132.26 114.0 13.91 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.512 1.132 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.477 0.179 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 159' ' ' LEU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.898 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.555 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 1.127 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.898 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 151' ' ' LEU . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 1.127 HD12 ' HB3' ' A' ' 172' ' ' ALA . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.835 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.56 0.219 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 174' ' ' ASP . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.667 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CB ' HD11 ' A' ' 161' ' ' ILE . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 172' ' ' ALA . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 183' ' ' PRO . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.522 0.201 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 159' ' ' LEU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.827 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.849 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 138' ' ' ARG . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.853 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.679 ' HE3' HG21 ' A' ' 161' ' ' ILE . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.824 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.849 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 151' ' ' LEU . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.827 ' OE2' HD21 ' A' ' 140' ' ' LEU . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 190' ' ' TYR . 3.1 t80 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.497 0.189 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.447 ' HD2' ' HH ' ' A' ' 186' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.961 ' HD2' HD22 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.718 ' O ' HD23 ' A' ' 159' ' ' LEU . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB3' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.632 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.401 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 8.6 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.948 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.991 ' HB2' HD21 ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.948 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.802 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' O ' ' CD2' ' A' ' 190' ' ' TYR . 74.3 t80 . . . . . 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.533 0.206 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 161' ' ' ILE . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.622 HD11 ' HG3' ' A' ' 178' ' ' LYS . 10.3 tp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.651 HD13 HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.586 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 184' ' ' VAL . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.586 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.622 ' HG3' HD11 ' A' ' 151' ' ' LEU . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.427 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 . . . . . 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.504 0.192 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 153' ' ' PHE . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 182' ' ' ILE . 3.7 tp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 159' ' ' LEU . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.415 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 153' ' ' PHE . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.918 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CE2' ' HB3' ' A' ' 183' ' ' PRO . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.54 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.518 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.67 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.605 ' HB3' HD13 ' A' ' 151' ' ' LEU . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.689 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 181' ' ' MET . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 168' ' ' GLN . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.488 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.506 0.193 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG12 ' HB ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 178' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.511 ' OD2' HD11 ' A' ' 159' ' ' LEU . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD11 ' OD2' ' A' ' 157' ' ' ASP . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.712 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.632 ' CE3' HG22 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.509 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.521 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 137' ' ' VAL . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.535 0.207 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 153' ' ' PHE . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 182' ' ' ILE . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 1.046 ' O ' HG13 ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 181' ' ' MET . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 159' ' ' LEU . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 168' ' ' GLN . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.53 0.205 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 159' ' ' LEU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.737 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.812 ' CE2' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.781 ' HA ' HD23 ' A' ' 159' ' ' LEU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.461 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 159' ' ' LEU . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.426 ' HE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.467 0.175 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.994 HD12 ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.994 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.415 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.765 HD22 HG13 ' A' ' 182' ' ' ILE . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.662 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.765 HG13 HD22 ' A' ' 159' ' ' LEU . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.702 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.554 0.216 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 1.02 HG21 HD13 ' A' ' 161' ' ' ILE . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.434 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 174' ' ' ASP . 9.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.602 ' CD2' HD23 ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 1.02 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.835 ' CE3' HG22 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.798 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.835 HG22 ' CE3' ' A' ' 170' ' ' TRP . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.488 0.185 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.693 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.48 HD12 ' HE3' ' A' ' 170' ' ' TRP . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.547 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.765 ' CE2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.516 HD13 HD13 ' A' ' 159' ' ' LEU . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 137' ' ' VAL . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.425 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 25.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.421 0.153 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.616 ' HD3' HD11 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.453 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.968 ' O ' HD22 ' A' ' 159' ' ' LEU . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.694 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.73 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.801 HD13 HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.705 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.801 HG11 HD13 ' A' ' 182' ' ' ILE . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.467 0.175 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 187' ' ' VAL . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.839 HD13 HG21 ' A' ' 182' ' ' ILE . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.565 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.411 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 137' ' ' VAL . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 159' ' ' LEU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.953 HD11 ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 1.03 ' O ' HD22 ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.661 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.953 ' OD2' HD11 ' A' ' 151' ' ' LEU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.731 HD13 ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.674 ' O ' HG13 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 182' ' ' ILE . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.848 ' HB2' HD11 ' A' ' 140' ' ' LEU . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.557 0.218 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 159' ' ' LEU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.604 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.992 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.479 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 174' ' ' ASP . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 137' ' ' VAL . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.629 ' CH2' HG21 ' A' ' 184' ' ' VAL . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.811 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.487 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 182' ' ' ILE . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 181' ' ' MET . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 139' ' ' ALA . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.514 0.197 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.886 HD23 ' HA ' ' A' ' 174' ' ' ASP . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.961 ' O ' HG13 ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.775 ' CE2' HG11 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.886 ' HA ' HD23 ' A' ' 159' ' ' LEU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.428 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.961 HG13 ' O ' ' A' ' 168' ' ' GLN . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 187' ' ' VAL . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 178' ' ' LYS . 12.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.473 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 174' ' ' ASP . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG21 ' CE ' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.898 ' HA ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 174' ' ' ASP . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' LYS . . . . . 0.76 ' HG3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 151' ' ' LEU . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.754 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 183' ' ' PRO . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.487 0.184 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 . . . . . 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 174' ' ' ASP . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 164' ' ' LYS . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.509 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.722 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.793 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.401 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CB ' ' HA ' ' A' ' 160' ' ' ARG . 33.7 p90 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.523 0.201 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.2 t80 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.591 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.979 HD13 HD12 ' A' ' 182' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' LYS . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLN . . . . . 0.967 ' O ' HG13 ' A' ' 184' ' ' VAL . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.749 ' OD2' HD21 ' A' ' 151' ' ' LEU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ILE . . . . . 0.979 HD12 HD13 ' A' ' 159' ' ' LEU . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' PRO . . . . . 0.591 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 168' ' ' GLN . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 38.13 2.8 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.512 1.132 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -147.93 141.5 25.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 0.738 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 159' ' ' LEU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 13.9 t80 -93.44 157.29 16.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -95.75 -51.51 4.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.463 1.102 . . . . 0.0 109.265 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -36.54 154.46 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.501 1.125 . . . . 0.0 110.995 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -159.47 60.66 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 0.744 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 147' ' ' ASP . 1.3 p30 -68.67 152.46 45.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.142 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -86.63 39.16 0.82 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 110.33 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -144.49 -39.73 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 0.0 110.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.74 147.25 27.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.285 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.898 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -77.7 139.18 62.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.474 1.109 . . . . 0.0 109.288 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.555 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 1.127 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.898 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 151' ' ' LEU . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 1.127 HD12 ' HB3' ' A' ' 172' ' ' ALA . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.835 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -95.66 -42.26 8.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 O-C-N 124.462 1.101 . . . . 0.0 110.993 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.24 -66.38 0.48 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.513 1.133 . . . . 0.0 111.064 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 -88.75 153.11 21.34 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 -117.88 163.31 16.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 22.8 t-20 -150.1 118.17 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.518 1.136 . . . . 0.0 109.328 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' ASN . . . -157.0 -139.96 2.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.444 1.09 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' GLY . 11.4 t30 176.38 48.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.29 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.29 129.87 34.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 0.0 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -81.64 45.87 0.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.544 1.153 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.41 -37.63 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.564 1.165 . . . . 0.0 110.313 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -103.4 161.89 13.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 0.0 109.28 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -112.91 139.8 23.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 174' ' ' ASP . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.667 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CB ' HD11 ' A' ' 161' ' ' ILE . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 172' ' ' ALA . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 183' ' ' PRO . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.28 -26.21 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.468 1.105 . . . . 0.0 110.955 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 63.0 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 53.41 69.2 1.29 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.466 1.104 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 52.0 m-85 -150.53 155.83 40.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 0.753 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 159' ' ' LEU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.827 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -134.76 125.44 26.94 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -135.54 117.03 14.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.322 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.99 111.71 3.19 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.386 1.054 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -173.7 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.455 0.739 . . . . 0.0 109.301 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 166.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.403 1.065 . . . . 0.0 109.29 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -38.31 -42.53 0.72 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 1.103 . . . . 0.0 110.302 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -37.13 -50.08 0.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 0.0 110.278 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.452 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -87.47 113.0 22.78 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.425 1.078 . . . . 0.0 109.222 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.849 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -52.86 149.51 11.5 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 0.0 109.248 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 138' ' ' ARG . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.853 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.679 ' HE3' HG21 ' A' ' 161' ' ' ILE . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.824 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.849 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 151' ' ' LEU . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.827 ' OE2' HD21 ' A' ' 140' ' ' LEU . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.444 ' C ' ' CD1' ' A' ' 190' ' ' TYR . 3.1 t80 -88.8 -44.2 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.447 1.092 . . . . 0.0 111.025 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -56.43 -109.28 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.458 1.099 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -99.4 -176.52 3.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.556 0.798 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.447 ' HD2' ' HH ' ' A' ' 186' ' ' TYR . 0.7 OUTLIER -142.79 164.35 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -102.67 166.71 10.35 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.543 1.152 . . . . 0.0 109.385 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.81 -131.5 7.39 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.464 1.102 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 178.03 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 0.776 . . . . 0.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.64 -170.67 3.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 0.0 109.288 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.06 31.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.546 1.154 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -37.16 4.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.528 1.143 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 165.49 12.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 0.0 109.253 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -107.13 125.39 32.61 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.961 ' HD2' HD22 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.718 ' O ' HD23 ' A' ' 159' ' ' LEU . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB3' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.632 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 8.6 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.948 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.991 ' HB2' HD21 ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.948 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.802 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' O ' ' CD2' ' A' ' 190' ' ' TYR . 74.3 t80 -111.18 75.34 0.91 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 O-C-N 124.605 1.191 . . . . 0.0 111.04 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' TYR . 5.2 p . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 119.62 -111.63 2.08 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 -144.45 -144.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 0.732 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 161' ' ' ILE . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -97.04 108.7 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -68.12 142.38 55.79 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.517 1.136 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 127.55 -165.79 20.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.428 1.08 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 146' ' ' ASN . 6.1 p-10 -179.05 74.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 0.768 . . . . 0.0 109.318 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.39 144.71 54.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 0.0 109.27 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -86.14 43.18 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.495 1.122 . . . . 0.0 110.3 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -154.83 -41.0 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.58 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 14.1 m-20 -101.29 170.43 8.24 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.395 1.06 . . . . 0.0 109.282 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.622 HD11 ' HG3' ' A' ' 178' ' ' LYS . 10.3 tp -103.94 120.73 50.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 109.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.651 HD13 HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.586 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 184' ' ' VAL . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.58 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.586 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.622 ' HG3' HD11 ' A' ' 151' ' ' LEU . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.427 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 -70.8 132.31 45.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.446 1.091 . . . . 0.0 110.985 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.45 -59.82 0.19 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.542 1.151 . . . . 0.0 111.005 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.82 161.41 16.01 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.526 0.78 . . . . 0.0 111.001 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 153' ' ' PHE . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 -100.48 156.91 17.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 1.1 t-20 -110.99 153.35 25.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.62 173.79 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.591 1.182 . . . . 0.0 110.985 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.494 0.761 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.54 153.67 19.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.128 . . . . 0.0 109.273 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.02 39.34 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -45.04 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 0.0 110.282 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.593 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -94.36 169.03 10.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.272 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 182' ' ' ILE . 3.7 tp -110.57 120.73 43.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 159' ' ' LEU . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.415 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 153' ' ' PHE . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.918 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.54 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.518 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.67 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.605 ' HB3' HD13 ' A' ' 151' ' ' LEU . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.689 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 181' ' ' MET . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 168' ' ' GLN . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.488 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -119.18 100.85 7.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.568 1.168 . . . . 0.0 111.006 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 136' ' ' TYR . 1.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.49 0.5 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.508 1.13 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -86.5 145.1 26.93 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.495 0.762 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG12 ' HB ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -153.22 135.09 14.62 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.1 174.92 7.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 0.0 109.25 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -173.28 -139.13 2.79 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.439 1.087 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 178.57 43.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 109.363 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.72 174.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.42 1.075 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 4.1 tt0 52.12 44.08 29.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 110.21 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 17.4 pt-20 178.6 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 0.0 110.288 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER 167.81 124.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.582 1.177 . . . . 0.0 109.269 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -56.68 152.62 25.26 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 109.338 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.511 ' OD2' HD11 ' A' ' 159' ' ' LEU . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD11 ' OD2' ' A' ' 157' ' ' ASP . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.712 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.632 ' CE3' HG22 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.509 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.521 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 137' ' ' VAL . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -48.35 18.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 O-C-N 124.532 1.145 . . . . 0.0 111.017 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -78.35 1.17 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.494 1.121 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 -87.64 151.3 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 0.82 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.78 147.25 10.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -139.93 156.35 46.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.464 1.103 . . . . 0.0 109.313 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.88 -108.63 0.86 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.436 1.085 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 177.34 38.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.547 0.792 . . . . 0.0 109.342 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 74.7 42.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.315 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.36 46.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.456 1.098 . . . . 0.0 110.308 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 73.65 27.29 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.135 . . . . 0.0 110.323 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.38 132.32 3.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 0.0 109.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.86 147.3 48.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 0.0 109.256 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 153' ' ' PHE . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 182' ' ' ILE . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 1.046 ' O ' HG13 ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 181' ' ' MET . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 159' ' ' LEU . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 168' ' ' GLN . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -69.04 -46.19 68.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.54 1.15 . . . . 0.0 110.998 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.422 ' SG ' ' O ' ' A' ' 134' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.14 -59.22 0.34 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.557 1.161 . . . . 0.0 110.989 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 -88.15 145.71 25.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 0.742 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 159' ' ' LEU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 146' ' ' ASN . 0.8 OUTLIER -94.7 136.82 34.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.411 ' O ' ' O ' ' A' ' 145' ' ' GLY . 37.2 p-10 -131.21 92.58 3.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.611 1.195 . . . . 0.0 109.3 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.45 ' N ' ' CE1' ' A' ' 143' ' ' PHE . . . 54.78 164.47 0.02 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.577 1.173 . . . . 0.0 111.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 143' ' ' PHE . 0.4 OUTLIER 169.69 -54.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.532 0.783 . . . . 0.0 109.334 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -166.79 150.07 6.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.452 1.095 . . . . 0.0 109.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -85.97 36.55 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.518 1.136 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.61 -11.39 9.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 0.0 110.358 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.9 OUTLIER -131.39 143.03 50.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 0.0 109.307 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -75.03 144.12 78.75 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.481 1.113 . . . . 0.0 109.224 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.737 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.812 ' CE2' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.781 ' HA ' HD23 ' A' ' 159' ' ' LEU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.461 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 159' ' ' LEU . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.426 ' HE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -111.58 82.43 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 124.529 1.143 . . . . 0.0 111.026 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.02 51.07 0.18 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.474 1.109 . . . . 0.0 110.983 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.45 171.64 8.64 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.562 0.801 . . . . 0.0 111.011 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 -111.49 141.28 45.26 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.545 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 1.7 t30 -98.76 155.37 17.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 0.0 109.327 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -40.23 158.26 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.442 1.088 . . . . 0.0 110.978 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -170.0 -42.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 0.752 . . . . 0.0 109.29 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -161.46 120.44 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.2 pt-20 -49.6 -47.61 49.39 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 1.133 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 150' ' ' ASP . 17.2 pt-20 -45.74 -36.82 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.245 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 149' ' ' GLU . 7.9 m-20 -92.95 112.08 23.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.561 1.163 . . . . 0.0 109.303 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.994 HD12 ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp -63.8 131.77 95.02 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 0.0 109.37 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.994 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.415 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.765 HD22 HG13 ' A' ' 182' ' ' ILE . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.662 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.765 HG13 HD22 ' A' ' 159' ' ' LEU . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.702 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.15 139.53 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.911 0 O-C-N 124.554 1.159 . . . . 0.0 111.066 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.27 -45.34 0.22 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.531 1.144 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -87.8 170.56 11.1 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 0.792 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 1.02 HG21 HD13 ' A' ' 161' ' ' ILE . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.434 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -146.79 144.29 29.26 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -157.29 159.04 37.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 109.3 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.72 104.2 0.38 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.477 1.11 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.573 0.808 . . . . 0.0 109.294 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER -176.97 124.04 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.336 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -37.29 -45.07 0.64 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.571 1.17 . . . . 0.0 110.294 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -41.35 -54.14 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 110.372 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 181' ' ' MET . 44.0 m-20 -77.06 107.27 9.3 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 174' ' ' ASP . 9.3 tp -56.4 140.53 72.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 0.0 109.31 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.602 ' CD2' HD23 ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 1.02 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.835 ' CE3' HG22 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.798 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.835 HG22 ' CE3' ' A' ' 170' ' ' TRP . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' O ' ' C ' ' A' ' 191' ' ' GLY . 42.6 t80 -81.61 150.37 28.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.512 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.978 0 O-C-N 124.516 1.135 . . . . 0.0 111.026 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 161.56 -60.05 0.29 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.496 1.122 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -87.4 144.61 26.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -140.51 176.81 8.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -114.97 178.72 4.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -95.65 -163.08 33.98 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.376 1.047 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.53 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 0.0 109.33 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.84 172.75 17.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.455 1.097 . . . . 0.0 109.262 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.67 35.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -96.84 -46.95 6.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -110.6 169.69 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.542 1.151 . . . . 0.0 109.289 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp -104.97 138.07 19.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.693 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.48 HD12 ' HE3' ' A' ' 170' ' ' TRP . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.547 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.765 ' CE2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.516 HD13 HD13 ' A' ' 159' ' ' LEU . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 137' ' ' VAL . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.425 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -138.15 103.12 4.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.98 0 O-C-N 124.505 1.128 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.31 -49.23 0.93 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.496 1.122 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 25.0 m-85 -88.0 157.88 18.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 0.743 . . . . 0.0 111.02 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.616 ' HD3' HD11 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -131.89 156.3 46.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.01 141.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 109.29 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.03 115.37 0.54 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -171.67 -46.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 0.763 . . . . 0.0 109.338 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.31 165.44 33.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.58 1.175 . . . . 0.0 109.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.93 38.02 0.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 110.307 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.52 39.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.462 1.102 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.76 160.7 31.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.784 HD22 ' C ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -105.65 152.32 40.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.517 1.136 . . . . 0.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.453 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.968 ' O ' HD22 ' A' ' 159' ' ' LEU . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.694 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.73 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.801 HD13 HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.705 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.801 HG11 HD13 ' A' ' 182' ' ' ILE . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 -144.71 121.01 10.9 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.107 . . . . 0.0 110.982 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 135' ' ' GLY . 1.2 m . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' ' C ' ' A' ' 191' ' ' GLY . . . -58.03 -150.0 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.565 1.165 . . . . 0.0 111.041 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.25 -151.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.579 0.811 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 187' ' ' VAL . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 -152.7 136.51 16.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.67 -61.82 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.145 . . . . 0.0 109.267 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 47.36 -145.31 4.79 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.51 1.131 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.4 t30 177.72 47.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 0.789 . . . . 0.0 109.295 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.76 128.81 35.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.3 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.5 47.72 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 0.0 110.319 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -39.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.3 158.59 15.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.428 1.08 . . . . 0.0 109.259 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -111.64 142.38 26.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 0.0 109.24 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.839 HD13 HG21 ' A' ' 182' ' ' ILE . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.565 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.411 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 137' ' ' VAL . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.65 95.62 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.567 1.167 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.48 -45.44 1.32 Allowed Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.55 1.156 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -88.57 151.61 22.38 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.5 0.765 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 159' ' ' LEU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' A' ' 145' ' ' GLY . 8.0 t80 -77.65 165.29 24.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -103.45 -79.94 0.53 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 109.306 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.594 ' O ' ' CD2' ' A' ' 143' ' ' PHE . . . -66.79 -172.84 5.33 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.481 1.113 . . . . 0.0 111.013 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.455 ' OD1' ' N ' ' A' ' 146' ' ' ASN . 4.9 p-10 164.47 88.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 0.0 109.293 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -40.82 160.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.88 44.58 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 0.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 147' ' ' ASP . 6.7 pt-20 -140.7 -36.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.602 1.189 . . . . 0.0 110.29 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.417 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.48 163.9 12.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 0.0 109.227 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.953 HD11 ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -98.14 136.48 20.98 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.11 . . . . 0.0 109.353 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 1.03 ' O ' HD22 ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.661 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.953 ' OD2' HD11 ' A' ' 151' ' ' LEU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.731 HD13 ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.674 ' O ' HG13 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 182' ' ' ILE . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.848 ' HB2' HD11 ' A' ' 140' ' ' LEU . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -135.32 80.77 1.85 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 0.0 110.993 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.39 -99.27 0.12 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 -88.54 -178.75 5.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 0.782 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 159' ' ' LEU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.604 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 -163.56 158.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.554 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 5.9 p30 -143.36 164.67 29.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 109.262 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.16 -103.43 0.61 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.564 1.165 . . . . 0.0 111.036 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ASP . 9.5 p-10 -178.32 37.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.753 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 146' ' ' ASN . 5.4 m-20 54.44 170.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.531 1.144 . . . . 0.0 109.306 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 69.94 -60.94 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.459 1.099 . . . . 0.0 110.306 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -88.47 -21.66 24.08 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 0.0 110.33 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 181' ' ' MET . 0.1 OUTLIER 179.8 149.35 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 109.265 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -102.15 141.95 23.58 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.475 1.109 . . . . 0.0 109.279 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.992 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.479 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 174' ' ' ASP . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 137' ' ' VAL . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 165' ' ' PRO . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.629 ' CH2' HG21 ' A' ' 184' ' ' VAL . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.811 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.487 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 182' ' ' ILE . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 181' ' ' MET . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 139' ' ' ALA . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 134' ' ' CYS . 88.8 t80 -77.03 107.93 9.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 O-C-N 124.546 1.154 . . . . 0.0 111.034 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.79 -57.5 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.461 1.1 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -92.64 -179.95 5.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.509 0.77 . . . . 0.0 111.046 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 -151.25 100.25 2.74 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 145' ' ' GLY . 32.8 t-20 -70.08 -71.12 0.25 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.13 . . . . 0.0 109.308 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 144' ' ' ASN . . . 35.8 -154.07 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.506 1.129 . . . . 0.0 111.008 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.57 39.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 0.762 . . . . 0.0 109.294 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.8 OUTLIER -91.4 101.59 14.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 109.315 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -38.35 -39.15 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.549 1.155 . . . . 0.0 110.262 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -42.15 -40.33 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -137.72 142.2 41.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.506 1.129 . . . . 0.0 109.341 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -78.12 145.01 68.34 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 109.304 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.886 HD23 ' HA ' ' A' ' 174' ' ' ASP . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.961 ' O ' HG13 ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.775 ' CE2' HG11 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.886 ' HA ' HD23 ' A' ' 159' ' ' LEU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.428 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.961 HG13 ' O ' ' A' ' 168' ' ' GLN . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 191' ' ' GLY . 20.4 t80 -72.03 132.9 44.89 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.46 1.1 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' N ' ' HA3' ' A' ' 191' ' ' GLY . . . 120.86 -42.45 1.71 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.522 1.139 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 -86.11 163.82 17.65 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 0.754 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 187' ' ' VAL . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -85.47 176.42 8.26 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.31 77.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 0.0 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' OD1' ' A' ' 146' ' ' ASN . . . 59.44 147.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.552 1.157 . . . . 0.0 110.981 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 2.4 p-10 173.9 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 0.772 . . . . 0.0 109.247 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.12 119.26 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.558 1.161 . . . . 0.0 109.231 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -42.21 -48.96 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -40.71 -48.46 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 0.0 110.267 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.616 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -61.23 154.93 22.18 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 178' ' ' LYS . 12.9 tp -100.38 136.32 20.03 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.297 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.473 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 174' ' ' ASP . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG21 ' CE ' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.616 ' CE3' ' OD1' ' A' ' 150' ' ' ASP . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.898 ' HA ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 174' ' ' ASP . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' LYS . . . . . 0.76 ' HG3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.754 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 183' ' ' PRO . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 191' ' ' GLY . 28.2 t80 -123.13 -67.1 0.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.957 0 O-C-N 124.536 1.148 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 136' ' ' TYR . . . -136.99 66.73 0.54 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.562 1.164 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' A' ' 135' ' ' GLY . 13.5 m-85 -145.75 160.54 41.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.449 0.735 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 -69.12 164.01 23.5 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -103.43 -74.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 0.0 109.277 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -155.6 128.72 2.33 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.566 1.166 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 150' ' ' ASP . 8.3 m-20 160.76 51.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 0.751 . . . . 0.0 109.32 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -78.66 158.29 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 0.0 109.323 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 9.4 mm-40 66.69 -58.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 110.344 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 147' ' ' ASP . 1.2 pt-20 -66.17 -34.29 77.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.632 ' OD2' ' CE3' ' A' ' 169' ' ' TRP . 4.5 t70 -150.39 92.74 1.9 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.132 . . . . 0.0 109.267 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -39.61 110.39 0.62 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 174' ' ' ASP . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 164' ' ' LYS . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.509 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.632 ' CE3' ' OD2' ' A' ' 150' ' ' ASP . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.722 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.618 HD13 ' O ' ' A' ' 182' ' ' ILE . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.793 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.401 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER -157.9 82.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 O-C-N 124.613 1.195 . . . . 0.0 110.968 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 136' ' ' TYR . 94.7 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 134' ' ' CYS . . . 35.15 -108.47 0.05 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.559 1.162 . . . . 0.0 111.001 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' CYS . 33.7 p90 -91.93 178.9 5.76 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.486 0.756 . . . . 0.0 110.978 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 18.2 t80 -96.19 175.4 6.46 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 145' ' ' GLY . 2.8 p30 -117.27 -50.62 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.237 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -45.97 173.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.108 . . . . 0.0 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 174.2 68.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.562 0.801 . . . . 0.0 109.33 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 157.35 38.01 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.151 . . . . 0.0 109.291 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -79.78 42.26 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 0.0 110.261 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.99 -41.84 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER -111.47 151.58 28.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.089 . . . . 0.0 109.301 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -85.25 144.16 40.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.263 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.591 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' CE ' ' O ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.979 HD13 HD12 ' A' ' 182' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' LYS . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLN . . . . . 0.967 ' O ' HG13 ' A' ' 184' ' ' VAL . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.749 ' OD2' HD21 ' A' ' 151' ' ' LEU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ILE . . . . . 0.979 HD12 HD13 ' A' ' 159' ' ' LEU . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.591 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 168' ' ' GLN . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -132.26 114.0 13.91 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.512 1.132 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.477 0.179 . . . . 0.0 111.018 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 159' ' ' LEU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 13.9 t80 . . . . . 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.898 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.316 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.555 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 1.127 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.898 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 151' ' ' LEU . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 1.127 HD12 ' HB3' ' A' ' 172' ' ' ALA . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.835 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 . . . . . 0 N--CA 1.454 -0.26 0 CA-C-O 120.56 0.219 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 . . . . . 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 174' ' ' ASP . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.667 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CB ' HD11 ' A' ' 161' ' ' ILE . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 172' ' ' ALA . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 183' ' ' PRO . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.522 0.201 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 159' ' ' LEU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.827 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.849 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.302 0 N-CA-C 109.248 -0.649 . . . . 0.0 109.248 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 138' ' ' ARG . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.853 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.679 ' HE3' HG21 ' A' ' 161' ' ' ILE . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.824 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.849 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 151' ' ' LEU . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.827 ' OE2' HD21 ' A' ' 140' ' ' LEU . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 3.1 t80 . . . . . 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 . . . . . 0 N--CA 1.454 -0.261 0 CA-C-O 120.497 0.189 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.447 ' HD2' ' HH ' ' A' ' 186' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER . . . . . 0 N--CA 1.454 -0.269 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.961 ' HD2' HD22 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.718 ' O ' HD23 ' A' ' 159' ' ' LEU . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB3' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.632 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.401 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 28.4 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.948 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.991 ' HB2' HD21 ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.948 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.802 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 190' ' ' TYR . 74.3 t80 . . . . . 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 . . . . . 0 N--CA 1.453 -0.301 0 CA-C-O 120.533 0.206 . . . . 0.0 110.956 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 161' ' ' ILE . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.622 HD11 ' HG3' ' A' ' 178' ' ' LYS . 10.3 tp . . . . . 0 N--CA 1.453 -0.277 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.651 HD13 HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.586 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 184' ' ' VAL . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.43 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.586 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.622 ' HG3' HD11 ' A' ' 151' ' ' LEU . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.427 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 . . . . . 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 . . . . . 0 N--CA 1.453 -0.323 0 CA-C-O 120.504 0.192 . . . . 0.0 111.001 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 153' ' ' PHE . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 . . . . . 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 182' ' ' ILE . 3.7 tp . . . . . 0 N--CA 1.454 -0.268 0 N-CA-C 109.293 -0.632 . . . . 0.0 109.293 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 159' ' ' LEU . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.415 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 153' ' ' PHE . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.918 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.522 ' CE2' ' HB3' ' A' ' 183' ' ' PRO . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.54 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.518 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.67 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.605 ' HB3' HD13 ' A' ' 151' ' ' LEU . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.689 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 181' ' ' MET . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 168' ' ' GLN . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.488 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 . . . . . 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.314 0 CA-C-O 120.506 0.193 . . . . 0.0 111.015 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.679 HG12 ' HB ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER . . . . . 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 178' ' ' LYS . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.511 ' OD2' HD11 ' A' ' 159' ' ' LEU . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.511 HD11 ' OD2' ' A' ' 157' ' ' ASP . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.712 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.632 ' CE3' HG22 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.509 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.521 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 137' ' ' VAL . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.535 0.207 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.453 -0.284 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 153' ' ' PHE . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 182' ' ' ILE . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 1.046 ' O ' HG13 ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 181' ' ' MET . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 159' ' ' LEU . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 168' ' ' GLN . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER . . . . . 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 . . . . . 0 N--CA 1.453 -0.277 0 CA-C-O 120.53 0.205 . . . . 0.0 111.005 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 159' ' ' LEU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.737 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.812 ' CE2' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.781 ' HA ' HD23 ' A' ' 159' ' ' LEU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.461 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 159' ' ' LEU . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.426 ' HE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 . . . . . 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 . . . . . 0 N--CA 1.454 -0.274 0 CA-C-O 120.467 0.175 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 . . . . . 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.994 HD12 ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp . . . . . 0 N--CA 1.452 -0.352 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.994 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.415 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.765 HD22 HG13 ' A' ' 182' ' ' ILE . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.662 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.765 HG13 HD22 ' A' ' 159' ' ' LEU . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.702 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.554 0.216 . . . . 0.0 110.971 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 1.02 HG21 HD13 ' A' ' 161' ' ' ILE . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.434 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 174' ' ' ASP . 9.3 tp . . . . . 0 N--CA 1.453 -0.3 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.602 ' CD2' HD23 ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 1.02 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.835 ' CE3' HG22 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.416 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.798 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.835 HG22 ' CE3' ' A' ' 170' ' ' TRP . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 42.6 t80 . . . . . 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 . . . . . 0 N--CA 1.453 -0.294 0 CA-C-O 120.488 0.185 . . . . 0.0 111.014 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.406 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 . . . . . 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp . . . . . 0 N--CA 1.453 -0.29 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.693 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.48 HD12 ' HE3' ' A' ' 170' ' ' TRP . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.547 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.765 ' CE2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.516 HD13 HD13 ' A' ' 159' ' ' LEU . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 137' ' ' VAL . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.425 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 25.0 m-85 . . . . . 0 N--CA 1.453 -0.3 0 CA-C-O 120.421 0.153 . . . . 0.0 111.02 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.616 ' HD3' HD11 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 . . . . . 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.784 ' C ' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.453 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.577 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.968 ' O ' HD22 ' A' ' 159' ' ' LEU . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.694 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.73 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.801 HD13 HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.705 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.801 HG11 HD13 ' A' ' 182' ' ' ILE . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 . . . . . 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 120.467 0.175 . . . . 0.0 110.994 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 187' ' ' VAL . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 . . . . . 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.262 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.839 HD13 HG21 ' A' ' 182' ' ' ILE . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.565 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.411 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 137' ' ' VAL . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.516 0.198 . . . . 0.0 110.942 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 159' ' ' LEU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 8.0 t80 . . . . . 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.953 HD11 ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.345 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 1.03 ' O ' HD22 ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.661 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.953 ' OD2' HD11 ' A' ' 151' ' ' LEU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.731 HD13 ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.674 ' O ' HG13 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 182' ' ' ILE . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.848 ' HB2' HD11 ' A' ' 140' ' ' LEU . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 . . . . . 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 . . . . . 0 N--CA 1.454 -0.247 0 CA-C-O 120.557 0.218 . . . . 0.0 110.95 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 159' ' ' LEU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.604 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 . . . . . 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.246 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.992 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.479 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 174' ' ' ASP . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 137' ' ' VAL . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 164' ' ' LYS . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.629 ' CH2' HG21 ' A' ' 184' ' ' VAL . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.811 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.487 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 182' ' ' ILE . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 181' ' ' MET . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 139' ' ' ALA . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 88.8 t80 . . . . . 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 . . . . . 0 N--CA 1.453 -0.317 0 CA-C-O 120.514 0.197 . . . . 0.0 111.046 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.886 HD23 ' HA ' ' A' ' 174' ' ' ASP . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.961 ' O ' HG13 ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.775 ' CE2' HG11 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.886 ' HA ' HD23 ' A' ' 159' ' ' LEU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.428 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.961 HG13 ' O ' ' A' ' 168' ' ' GLN . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 20.4 t80 . . . . . 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 120.528 0.204 . . . . 0.0 111.038 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 187' ' ' VAL . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 178' ' ' LYS . 12.9 tp . . . . . 0 N--CA 1.454 -0.271 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.473 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 174' ' ' ASP . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.442 HG21 ' CE ' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.478 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.898 ' HA ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 174' ' ' ASP . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . 0.76 ' HG3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.449 ' O ' ' N ' ' A' ' 151' ' ' LEU . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.754 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 183' ' ' PRO . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 28.2 t80 . . . . . 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 . . . . . 0 N--CA 1.452 -0.352 0 CA-C-O 120.487 0.184 . . . . 0.0 110.997 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 . . . . . 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 174' ' ' ASP . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 164' ' ' LYS . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.509 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.722 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.793 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.401 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' TYR . . . . . 0.433 ' CB ' ' HA ' ' A' ' 160' ' ' ARG . 33.7 p90 . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.523 0.201 . . . . 0.0 110.978 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 18.2 t80 . . . . . 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.1 OUTLIER . . . . . 0 N--CA 1.453 -0.285 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.591 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.979 HD13 HD12 ' A' ' 182' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' LYS . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLN . . . . . 0.967 ' O ' HG13 ' A' ' 184' ' ' VAL . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.749 ' OD2' HD21 ' A' ' 151' ' ' LEU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ILE . . . . . 0.979 HD12 HD13 ' A' ' 159' ' ' LEU . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' PRO . . . . . 0.591 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 168' ' ' GLN . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 25.7 p . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 103.85 38.13 2.8 Favored Glycine 0 CA--C 1.53 0.978 0 O-C-N 124.512 1.132 . . . . 0.0 111.012 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 53.4 m-85 -147.93 141.5 25.47 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.454 0.738 . . . . 0.0 111.018 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 159' ' ' LEU . 31.9 m -131.73 174.12 13.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.506 1.129 . . . . 0.0 109.248 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.567 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 0.0 OUTLIER -147.37 133.74 19.61 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.476 1.11 . . . . 0.0 110.302 179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.487 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.7 122.12 30.16 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.463 1.102 . . . . 0.0 109.284 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.477 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -107.01 38.39 2.11 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.519 1.137 . . . . 0.0 109.324 179.954 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.608 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -169.99 133.91 1.23 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.438 1.086 . . . . 0.0 111.007 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.44 123.06 32.61 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.536 1.148 . . . . 0.0 109.337 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 13.9 t80 -93.44 157.29 16.29 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.439 1.087 . . . . 0.0 110.975 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.418 ' O ' ' C ' ' A' ' 145' ' ' GLY . 0.8 OUTLIER -95.75 -51.51 4.47 Favored 'General case' 0 C--N 1.326 -0.436 0 O-C-N 124.463 1.102 . . . . 0.0 109.265 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.58 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -36.54 154.46 0.01 OUTLIER Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.501 1.125 . . . . 0.0 110.995 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 49.9 m-20 -159.47 60.66 0.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.464 0.744 . . . . 0.0 109.279 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 147' ' ' ASP . 1.3 p30 -68.67 152.46 45.31 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.142 . . . . 0.0 109.328 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 17.6 pt-20 -86.63 39.16 0.82 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.53 1.144 . . . . 0.0 110.33 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -144.49 -39.73 0.27 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.464 1.103 . . . . 0.0 110.293 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -103.74 147.25 27.48 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.517 1.136 . . . . 0.0 109.285 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.898 HD21 ' CG ' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -77.7 139.18 62.44 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 124.474 1.109 . . . . 0.0 109.288 -179.975 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.514 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 145.6 31.52 Favored 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.508 1.793 . . . . 0.0 110.956 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.576 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -112.9 159.79 18.7 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.462 1.102 . . . . 0.0 111.037 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.67 162.77 32.97 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.514 1.134 . . . . 0.0 109.251 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.49 120.73 13.39 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.486 1.116 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.83 42.77 60.34 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.54 1.15 . . . . 0.0 110.999 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -95.25 157.9 15.69 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.506 0.768 . . . . 0.0 109.309 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.407 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 2.4 mm -106.95 131.71 56.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.497 1.123 . . . . 0.0 109.313 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.697 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.8 OUTLIER -144.43 122.53 12.14 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.553 1.158 . . . . 0.0 109.314 -179.943 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.703 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.9 ttp180 -91.06 147.75 22.86 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.475 1.11 . . . . 0.0 110.333 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.437 HD11 ' CG1' ' A' ' 137' ' ' VAL . 97.0 mt -86.78 132.8 31.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.495 1.122 . . . . 0.0 109.283 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 5.3 ttt-85 -119.98 -56.97 1.98 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.515 1.135 . . . . 0.0 110.272 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.467 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 16.5 m-20 -141.29 138.58 33.28 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.469 1.105 . . . . 0.0 109.336 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.555 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 6.6 mtpt -122.41 77.05 44.83 Favored Pre-proline 0 C--N 1.325 -0.469 0 O-C-N 124.457 1.098 . . . . 0.0 109.308 -179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.01 -43.61 0.38 Allowed 'Trans proline' 0 C--N 1.359 1.129 0 O-C-N 124.51 1.795 . . . . 0.0 110.988 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.412 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 4.7 mm-40 -87.38 -179.01 6.3 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.567 1.167 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -115.4 29.71 7.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.441 1.088 . . . . 0.0 110.362 179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -155.4 -49.93 0.08 Allowed 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.466 1.104 . . . . 0.0 110.297 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.412 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 9.3 m0 -116.59 125.63 52.1 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.555 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 14.4 m0 -120.21 162.84 18.7 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.55 1.156 . . . . 0.0 108.001 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.492 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 24.3 t-20 -85.39 106.89 17.09 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.491 1.119 . . . . 0.0 109.308 179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 1.127 ' HB3' HD12 ' A' ' 182' ' ' ILE . . . -116.61 152.21 34.65 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.531 1.144 . . . . 0.0 109.297 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.0 tm-20 -98.08 108.55 21.28 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.499 1.124 . . . . 0.0 110.276 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.898 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -57.41 176.69 0.12 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.518 1.137 . . . . 0.0 109.286 179.983 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 95.4 p -85.35 28.14 0.76 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 109.984 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -131.75 -5.11 3.63 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.496 1.123 . . . . 0.0 110.316 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . 0.441 ' O ' ' NH2' ' A' ' 179' ' ' ARG . . . 94.88 0.16 64.2 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.546 1.154 . . . . 0.0 110.99 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.48 ' HB3' HD13 ' A' ' 151' ' ' LEU . 12.5 tttt -84.31 111.18 19.18 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.449 0.735 . . . . 0.0 109.306 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.441 ' NH2' ' O ' ' A' ' 177' ' ' GLY . 0.0 OUTLIER -96.75 116.72 29.63 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.534 1.146 . . . . 0.0 110.33 -179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.492 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.55 -170.41 18.96 Favored Glycine 0 CA--C 1.53 0.98 0 O-C-N 124.46 1.1 . . . . 0.0 110.991 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 1.8 mtp -82.36 131.56 35.22 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.509 0.77 . . . . 0.0 111.016 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 1.127 HD12 ' HB3' ' A' ' 172' ' ' ALA . 9.5 mt -130.76 145.24 56.8 Favored Pre-proline 0 C--N 1.326 -0.455 0 O-C-N 124.49 1.119 . . . . 0.0 109.269 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.835 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.92 137.96 22.61 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.537 1.809 . . . . 0.0 111.059 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.848 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 72.6 t -80.76 -29.59 0.54 Allowed Pre-proline 0 C--N 1.325 -0.481 0 O-C-N 124.484 1.115 . . . . 0.0 109.314 179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.848 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.0 -45.86 0.26 Allowed 'Trans proline' 0 C--N 1.36 1.153 0 O-C-N 124.512 1.796 . . . . 0.0 110.951 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.608 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -64.91 -23.55 67.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.505 1.128 . . . . 0.0 110.986 -179.963 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.697 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.3 m -106.64 -179.01 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.314 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.594 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 8.2 tt0 -140.56 165.5 27.28 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.517 1.136 . . . . 0.0 110.305 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 17.4 ttpt -86.58 110.9 20.13 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.561 1.163 . . . . 0.0 109.284 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.567 ' CD1' ' HB2' ' A' ' 138' ' ' ARG . 0.1 OUTLIER -95.66 -42.26 8.48 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.511 1.132 . . . . 0.0 111.019 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.987 0 O-C-N 124.462 1.101 . . . . 0.0 110.993 179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.452 -0.337 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 142.24 -66.38 0.48 Allowed Glycine 0 CA--C 1.53 0.975 0 O-C-N 124.513 1.133 . . . . 0.0 111.064 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.512 ' HB2' ' CD1' ' A' ' 190' ' ' TYR . 57.3 m-85 -88.75 153.11 21.34 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.488 0.758 . . . . 0.0 110.972 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 6.1 m -121.19 159.74 22.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.472 1.107 . . . . 0.0 109.34 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.545 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.3 OUTLIER -136.11 129.48 31.89 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.492 1.12 . . . . 0.0 110.261 -179.959 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.533 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.23 25.83 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.512 1.132 . . . . 0.0 109.29 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.548 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -102.02 36.1 2.19 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.489 1.118 . . . . 0.0 109.327 179.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.566 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.1 m-85 -168.51 124.88 1.0 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.454 1.096 . . . . 0.0 110.989 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 42.4 t0 -74.98 137.06 41.31 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.093 . . . . 0.0 109.29 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.582 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 11.0 t80 -117.88 163.31 16.74 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.492 1.12 . . . . 0.0 110.961 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.473 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 5.5 t30 -150.1 118.17 6.33 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.518 1.136 . . . . 0.0 109.328 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.4 ' O ' ' HB2' ' A' ' 146' ' ' ASN . . . -157.0 -139.96 2.84 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.444 1.09 . . . . 0.0 110.967 -179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.4 ' HB2' ' O ' ' A' ' 145' ' ' GLY . 11.4 t30 176.38 48.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.504 0.767 . . . . 0.0 109.29 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -84.29 129.87 34.85 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.524 1.14 . . . . 0.0 109.292 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -81.64 45.87 0.92 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.544 1.153 . . . . 0.0 110.244 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -160.41 -37.63 0.05 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.564 1.165 . . . . 0.0 110.313 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -103.4 161.89 13.47 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.498 1.124 . . . . 0.0 109.28 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.41 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -112.91 139.8 23.34 Favored Pre-proline 0 C--N 1.325 -0.459 0 O-C-N 124.481 1.113 . . . . 0.0 109.286 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.7 Cg_endo -74.97 136.98 21.19 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.412 1.743 . . . . 0.0 110.985 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 0.2 OUTLIER -118.79 154.98 31.95 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.618 1.198 . . . . 0.0 110.995 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 27.0 mttm -105.39 171.16 7.47 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.417 1.073 . . . . 0.0 109.311 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.53 129.21 38.62 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.457 1.098 . . . . 0.0 109.285 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 66.73 39.7 93.69 Favored Glycine 0 CA--C 1.531 1.063 0 O-C-N 124.419 1.074 . . . . 0.0 110.948 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -94.01 164.39 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.561 0.801 . . . . 0.0 109.263 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.439 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.9 OUTLIER -108.6 142.27 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 124.562 1.164 . . . . 0.0 109.286 -179.98 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.661 HD23 ' HA ' ' A' ' 174' ' ' ASP . 10.6 mt -148.7 118.74 7.18 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.442 1.089 . . . . 0.0 109.236 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.626 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 12.5 ttm180 -87.25 123.69 32.53 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.511 1.132 . . . . 0.0 110.23 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.667 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -83.19 123.04 38.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 O-C-N 124.469 1.106 . . . . 0.0 109.305 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.442 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 0.0 OUTLIER -121.22 -30.86 4.23 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.519 1.137 . . . . 0.0 110.285 -179.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.523 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -140.58 130.42 24.46 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.507 1.13 . . . . 0.0 109.247 179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -140.65 66.44 27.79 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.246 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -51.77 0.11 Allowed 'Trans proline' 0 C--N 1.36 1.172 0 O-C-N 124.522 1.801 . . . . 0.0 110.974 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -64.21 179.51 0.56 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.491 1.12 . . . . 0.0 110.304 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -119.3 46.39 1.91 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.519 1.137 . . . . 0.0 110.305 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -171.67 -60.89 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.499 1.125 . . . . 0.0 110.346 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.471 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 5.2 m95 -107.89 131.66 54.28 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.547 1.154 . . . . 0.0 108.022 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.667 ' CB ' HD11 ' A' ' 161' ' ' ILE . 19.5 m0 -125.44 159.26 32.35 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.465 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.14 117.19 25.71 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.429 1.08 . . . . 0.0 109.32 179.97 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.626 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -129.63 150.64 50.87 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 109.297 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -93.89 106.49 18.46 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.53 1.144 . . . . 0.0 110.289 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.661 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.6 t70 -55.02 171.07 0.15 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.608 1.192 . . . . 0.0 109.301 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 48.2 t -77.94 29.93 0.17 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.528 1.143 . . . . 0.0 109.973 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.5 ' H ' ' C ' ' A' ' 174' ' ' ASP . 14.6 mt-10 -135.81 -4.77 2.22 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.495 1.122 . . . . 0.0 110.324 179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.46 -4.56 66.87 Favored Glycine 0 CA--C 1.531 1.076 0 O-C-N 124.487 1.117 . . . . 0.0 110.942 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.3 mmtp -78.87 106.87 11.2 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.588 0.816 . . . . 0.0 109.334 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 13.1 mtt180 -93.7 116.33 28.82 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.461 1.101 . . . . 0.0 110.347 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.465 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.32 -174.46 22.91 Favored Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.503 1.127 . . . . 0.0 111.003 -179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.452 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.56 134.73 33.62 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.486 0.757 . . . . 0.0 110.98 179.951 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.438 HG12 ' HB3' ' A' ' 172' ' ' ALA . 2.8 pp -135.24 155.45 78.81 Favored Pre-proline 0 C--N 1.326 -0.435 0 O-C-N 124.461 1.1 . . . . 0.0 109.288 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.591 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 139.9 24.84 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.484 1.781 . . . . 0.0 110.992 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.831 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 70.1 t -82.26 -29.92 0.5 Allowed Pre-proline 0 C--N 1.325 -0.468 0 O-C-N 124.512 1.132 . . . . 0.0 109.257 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.831 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.6 Cg_endo -74.87 -34.26 4.13 Favored 'Trans proline' 0 C--N 1.358 1.079 0 O-C-N 124.512 1.796 . . . . 0.0 111.021 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.585 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -82.62 9.83 8.67 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.543 1.152 . . . . 0.0 111.031 -179.958 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 183' ' ' PRO . 34.8 m -136.85 171.33 16.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 O-C-N 124.493 1.121 . . . . 0.0 109.288 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.595 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 7.5 pt-20 -133.96 165.14 25.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.494 1.121 . . . . 0.0 110.33 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.57 111.7 21.5 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.515 1.134 . . . . 0.0 109.26 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -58.28 -26.21 62.71 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.451 1.095 . . . . 0.0 110.99 -179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.984 0 O-C-N 124.468 1.105 . . . . 0.0 110.955 -179.99 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.547 ' O ' ' CD2' ' A' ' 136' ' ' TYR . 63.0 m . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 53.41 69.2 1.29 Allowed Glycine 0 CA--C 1.529 0.935 0 O-C-N 124.466 1.104 . . . . 0.0 111.019 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.547 ' CD2' ' O ' ' A' ' 134' ' ' CYS . 52.0 m-85 -150.53 155.83 40.23 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.479 0.753 . . . . 0.0 110.966 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.853 HG22 ' O ' ' A' ' 159' ' ' LEU . 11.0 m -136.79 165.1 29.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.492 1.12 . . . . 0.0 109.336 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.524 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 1.3 mtm180 -142.51 136.39 29.3 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.481 1.113 . . . . 0.0 110.339 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.566 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -85.9 120.08 26.91 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.459 1.1 . . . . 0.0 109.296 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.827 HD21 ' OE2' ' A' ' 188' ' ' GLU . 1.2 mt -103.03 35.74 2.44 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 109.321 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.634 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -170.62 135.14 1.13 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.551 1.157 . . . . 0.0 110.978 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -79.61 137.38 37.1 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.538 1.149 . . . . 0.0 109.312 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 186' ' ' TYR . 0.2 OUTLIER -134.76 125.44 26.94 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.972 179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -135.54 117.03 14.78 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.518 1.136 . . . . 0.0 109.322 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 98.99 111.71 3.19 Favored Glycine 0 CA--C 1.529 0.956 0 O-C-N 124.386 1.054 . . . . 0.0 111.012 -179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -173.7 -58.64 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.455 0.739 . . . . 0.0 109.301 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.407 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.3 OUTLIER 166.09 123.91 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.403 1.065 . . . . 0.0 109.29 179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.422 ' O ' ' C ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -38.31 -42.53 0.72 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.464 1.103 . . . . 0.0 110.302 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 148' ' ' GLU . 0.0 OUTLIER -37.13 -50.08 0.92 Allowed 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.516 1.135 . . . . 0.0 110.278 -179.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.452 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.1 OUTLIER -87.47 113.0 22.78 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.425 1.078 . . . . 0.0 109.222 -179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.849 HD13 ' OD2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -52.86 149.51 11.5 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.439 1.087 . . . . 0.0 109.248 179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.05 148.02 34.51 Favored 'Trans proline' 0 C--N 1.361 1.205 0 O-C-N 124.482 1.78 . . . . 0.0 110.978 -179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' CE2' ' O ' ' A' ' 151' ' ' LEU . 0.8 OUTLIER -150.48 140.5 22.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 110.986 -179.946 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -111.35 169.19 8.96 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.512 1.132 . . . . 0.0 109.326 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.435 ' HD2' ' N ' ' A' ' 156' ' ' GLY . 0.1 OUTLIER -54.54 134.74 46.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.524 1.14 . . . . 0.0 109.353 -179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.545 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 65.49 37.6 93.9 Favored Glycine 0 CA--C 1.53 1.022 0 O-C-N 124.519 1.137 . . . . 0.0 110.996 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.566 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 10.4 t70 -90.79 156.84 17.75 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.518 0.775 . . . . 0.0 109.292 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.517 HD13 ' HG2' ' A' ' 138' ' ' ARG . 6.8 mm -103.42 132.08 50.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 O-C-N 124.489 1.118 . . . . 0.0 109.311 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.853 ' O ' HG22 ' A' ' 137' ' ' VAL . 2.4 mt -146.31 116.65 7.47 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.425 1.078 . . . . 0.0 109.356 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.52 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -91.98 109.15 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.502 1.126 . . . . 0.0 110.28 -179.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.824 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -83.26 130.3 36.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 O-C-N 124.52 1.137 . . . . 0.0 109.314 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -127.99 -37.15 1.92 Allowed 'General case' 0 C--N 1.324 -0.528 0 O-C-N 124.546 1.154 . . . . 0.0 110.261 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.438 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 2.0 m-20 -111.74 118.39 35.47 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.54 1.15 . . . . 0.0 109.303 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.679 ' HE3' HG21 ' A' ' 161' ' ' ILE . 6.7 mtpt -130.64 68.98 82.19 Favored Pre-proline 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 109.282 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.06 -62.89 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.192 0 O-C-N 124.501 1.79 . . . . 0.0 110.955 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 13.6 pt-20 -71.06 -174.65 1.0 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.43 1.081 . . . . 0.0 110.304 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -121.49 70.82 0.95 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 110.31 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.547 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 2.2 mt-30 170.15 -66.52 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.54 1.15 . . . . 0.0 110.273 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.547 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 6.7 m95 -104.44 120.71 41.85 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.559 1.162 . . . . 0.0 107.979 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.824 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -117.34 157.9 25.33 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.514 1.134 . . . . 0.0 108.007 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.451 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -85.81 115.04 23.21 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.565 1.166 . . . . 0.0 109.289 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.805 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -128.7 156.67 43.11 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.507 1.129 . . . . 0.0 109.275 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.463 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 4.8 tm-20 -104.34 110.54 22.82 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.524 1.14 . . . . 0.0 110.24 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.849 ' OD2' HD13 ' A' ' 151' ' ' LEU . 0.8 OUTLIER -61.24 172.7 1.01 Allowed 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.526 1.141 . . . . 0.0 109.362 179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.59 31.61 0.3 Allowed 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.572 1.17 . . . . 0.0 109.983 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.454 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -131.77 -8.75 3.56 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.444 1.09 . . . . 0.0 110.336 179.984 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.94 -1.7 59.64 Favored Glycine 0 CA--C 1.531 1.092 0 O-C-N 124.395 1.06 . . . . 0.0 110.951 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.445 ' CB ' ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -85.22 117.27 24.06 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.569 0.805 . . . . 0.0 109.288 179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.463 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 85.4 mtt180 -105.62 117.15 33.28 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.529 1.143 . . . . 0.0 110.344 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.66 -171.34 20.04 Favored Glycine 0 CA--C 1.53 0.981 0 O-C-N 124.443 1.09 . . . . 0.0 111.027 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.431 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -86.42 134.48 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.477 0.751 . . . . 0.0 111.045 -179.999 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.533 HG23 HD21 ' A' ' 151' ' ' LEU . 2.2 pt -135.62 153.17 77.36 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.507 1.129 . . . . 0.0 109.267 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.619 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.5 Cg_endo -74.95 134.32 17.75 Favored 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.412 1.743 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.84 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 97.2 t -77.92 -30.18 0.72 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.518 1.136 . . . . 0.0 109.317 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.84 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -74.93 -20.87 16.6 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.464 1.77 . . . . 0.0 110.986 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.634 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.4 OUTLIER -93.18 1.32 57.16 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.478 1.111 . . . . 0.0 110.978 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.524 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 21.6 m -130.4 174.97 12.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 O-C-N 124.466 1.104 . . . . 0.0 109.303 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.827 ' OE2' HD21 ' A' ' 140' ' ' LEU . 14.5 pt-20 -133.49 165.86 23.89 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.595 1.184 . . . . 0.0 110.289 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.91 110.57 20.65 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.45 1.094 . . . . 0.0 109.328 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.444 ' CD1' ' C ' ' A' ' 190' ' ' TYR . 3.1 t80 -88.8 -44.2 10.68 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.497 1.123 . . . . 0.0 111.032 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.518 ' O ' ' N ' ' A' ' 136' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.991 0 O-C-N 124.447 1.092 . . . . 0.0 111.025 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 14.0 p . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.385 -0.968 . . . . 0.0 108.385 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -56.43 -109.28 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.458 1.099 . . . . 0.0 111.0 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -99.4 -176.52 3.32 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.556 0.798 . . . . 0.0 110.99 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.541 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 11.1 m -115.72 168.37 7.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 O-C-N 124.558 1.161 . . . . 0.0 109.272 -179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.48 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.1 OUTLIER -140.07 132.04 27.77 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.455 1.097 . . . . 0.0 110.333 179.993 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 159' ' ' LEU . . . -85.09 122.45 29.33 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.332 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.52 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -105.05 35.08 2.93 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.507 1.129 . . . . 0.0 109.265 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.526 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 19.7 m-85 -165.2 118.45 1.21 Allowed 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.512 1.132 . . . . 0.0 110.998 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -71.77 132.46 44.52 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.444 1.09 . . . . 0.0 109.275 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.447 ' HD2' ' HH ' ' A' ' 186' ' ' TYR . 0.7 OUTLIER -142.79 164.35 30.32 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.521 1.138 . . . . 0.0 110.947 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -102.67 166.71 10.35 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.543 1.152 . . . . 0.0 109.385 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -101.81 -131.5 7.39 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.464 1.102 . . . . 0.0 110.963 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.8 p-10 178.03 -36.36 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.52 0.776 . . . . 0.0 109.245 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -156.64 -170.67 3.4 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.543 1.152 . . . . 0.0 109.288 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -87.06 31.71 0.7 Allowed 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.546 1.154 . . . . 0.0 110.249 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -113.3 -37.16 4.78 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.528 1.143 . . . . 0.0 110.258 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -92.85 165.49 12.88 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.462 1.101 . . . . 0.0 109.253 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.991 HD21 ' HB2' ' A' ' 174' ' ' ASP . 1.0 OUTLIER -107.13 125.39 32.61 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.961 ' HD2' HD22 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.96 100.99 1.41 Allowed 'Trans proline' 0 C--N 1.359 1.116 0 O-C-N 124.507 1.793 . . . . 0.0 110.974 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.586 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 1.7 m-85 -81.38 -179.18 7.26 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.485 1.116 . . . . 0.0 111.025 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.492 ' CG ' ' HB2' ' A' ' 157' ' ' ASP . 0.1 OUTLIER -165.25 152.13 10.48 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 124.54 1.15 . . . . 0.0 109.289 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.16 106.77 0.09 Allowed 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.469 1.106 . . . . 0.0 109.303 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 70.18 50.41 28.03 Favored Glycine 0 CA--C 1.53 0.993 0 O-C-N 124.582 1.176 . . . . 0.0 111.011 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.492 ' HB2' ' CG ' ' A' ' 154' ' ' LYS . 28.6 t0 -92.28 153.02 19.5 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.509 0.77 . . . . 0.0 109.287 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.718 ' O ' HD23 ' A' ' 159' ' ' LEU . 2.3 mm -98.09 139.01 21.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 O-C-N 124.435 1.084 . . . . 0.0 109.302 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.789 ' HB3' HD13 ' A' ' 182' ' ' ILE . 0.2 OUTLIER -147.94 132.11 17.37 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.425 1.078 . . . . 0.0 109.335 179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.632 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -103.56 135.6 44.84 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.49 1.119 . . . . 0.0 110.254 -179.964 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.485 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 76.6 mt -83.21 124.38 39.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 124.567 1.167 . . . . 0.0 109.299 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.441 ' HB2' ' NH1' ' A' ' 160' ' ' ARG . 4.0 ttp85 -113.32 -43.83 3.31 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.473 1.108 . . . . 0.0 110.32 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.401 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -145.94 135.93 23.59 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.536 1.148 . . . . 0.0 109.275 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.533 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -131.77 65.11 74.97 Favored Pre-proline 0 C--N 1.324 -0.516 0 O-C-N 124.553 1.158 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.4 Cg_endo -74.99 -42.16 0.55 Allowed 'Trans proline' 0 C--N 1.36 1.142 0 O-C-N 124.564 1.823 . . . . 0.0 111.006 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 5.2 mp0 -81.42 -168.47 1.87 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.561 1.163 . . . . 0.0 110.293 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 3.4 pt-20 -120.9 138.87 53.88 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.497 1.123 . . . . 0.0 110.308 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.454 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 28.4 mt-30 79.43 -51.95 0.42 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.487 1.117 . . . . 0.0 110.372 -179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 47.3 m95 -106.98 134.93 49.38 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.538 1.149 . . . . 0.0 108.0 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.698 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 19.2 m0 -135.49 163.49 29.96 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 107.979 -1.119 . . . . 0.0 107.979 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.48 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 37.7 t-20 -87.25 108.2 18.83 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.501 1.126 . . . . 0.0 109.289 179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.948 ' HB3' ' CD1' ' A' ' 182' ' ' ILE . . . -122.48 163.31 20.11 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.518 1.136 . . . . 0.0 109.312 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -111.53 114.69 27.94 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.45 1.094 . . . . 0.0 110.324 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.991 ' HB2' HD21 ' A' ' 151' ' ' LEU . 46.6 t0 -62.36 177.36 0.51 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.478 1.111 . . . . 0.0 109.292 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.65 28.99 0.72 Allowed 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.541 1.151 . . . . 0.0 110.0 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -131.88 -5.15 3.57 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.506 1.129 . . . . 0.0 110.295 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.08 -3.19 61.94 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.534 1.146 . . . . 0.0 110.999 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.7 mmtp -77.98 112.97 15.43 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.487 0.757 . . . . 0.0 109.36 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -103.93 112.89 26.06 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.084 . . . . 0.0 110.352 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.44 -159.6 9.22 Favored Glycine 0 CA--C 1.531 1.056 0 O-C-N 124.429 1.08 . . . . 0.0 111.038 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -85.23 141.41 30.14 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.536 0.786 . . . . 0.0 110.994 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.948 ' CD1' ' HB3' ' A' ' 172' ' ' ALA . 51.9 mt -139.26 139.12 21.98 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.532 1.145 . . . . 0.0 109.222 -179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.802 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.03 140.72 25.69 Favored 'Trans proline' 0 C--N 1.361 1.206 0 O-C-N 124.424 1.749 . . . . 0.0 111.031 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.836 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 53.0 t -83.1 -30.85 0.49 Allowed Pre-proline 0 C--N 1.324 -0.502 0 O-C-N 124.55 1.157 . . . . 0.0 109.356 179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.93 -47.92 0.19 Allowed 'Trans proline' 0 C--N 1.361 1.186 0 O-C-N 124.498 1.788 . . . . 0.0 110.956 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.543 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.03 -34.99 77.25 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.405 1.066 . . . . 0.0 111.003 -179.955 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.802 HG22 ' O ' ' A' ' 183' ' ' PRO . 19.4 m -88.87 176.71 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.487 1.117 . . . . 0.0 109.251 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.541 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.3 tt0 -133.33 158.85 41.94 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.497 1.123 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -87.01 112.31 21.72 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.513 1.133 . . . . 0.0 109.299 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 190' ' ' TYR . 74.3 t80 -111.18 75.34 0.91 Allowed 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.519 1.137 . . . . 0.0 110.983 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.012 0 O-C-N 124.605 1.191 . . . . 0.0 111.04 -179.981 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.48 ' N ' ' O ' ' A' ' 190' ' ' TYR . 5.2 p . . . . . 0 N--CA 1.452 -0.332 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 119.62 -111.63 2.08 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.512 1.133 . . . . 0.0 110.979 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 160' ' ' ARG . 24.2 m-85 -144.45 -144.83 0.16 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.444 0.732 . . . . 0.0 110.956 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG11 HD13 ' A' ' 161' ' ' ILE . 1.7 m -101.23 172.32 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.478 1.111 . . . . 0.0 109.302 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.628 ' NH2' ' CE2' ' A' ' 190' ' ' TYR . 0.8 OUTLIER -149.38 129.48 13.57 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.461 1.101 . . . . 0.0 110.287 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.73 119.07 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.434 1.083 . . . . 0.0 109.357 179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -99.51 40.11 1.25 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.522 1.139 . . . . 0.0 109.289 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -168.45 124.16 0.97 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.477 1.111 . . . . 0.0 111.021 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -83.46 110.13 17.93 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.511 1.132 . . . . 0.0 109.298 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.58 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 0.7 OUTLIER -97.04 108.7 21.48 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.448 1.092 . . . . 0.0 111.017 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -68.12 142.38 55.79 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.517 1.136 . . . . 0.0 109.329 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 127.55 -165.79 20.5 Favored Glycine 0 CA--C 1.53 0.984 0 O-C-N 124.428 1.08 . . . . 0.0 111.001 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -179.05 74.55 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.505 0.768 . . . . 0.0 109.318 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.39 144.71 54.64 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.493 1.121 . . . . 0.0 109.27 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -86.14 43.18 1.03 Allowed 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.495 1.122 . . . . 0.0 110.3 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -154.83 -41.0 0.09 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.463 1.102 . . . . 0.0 110.291 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.58 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 14.1 m-20 -101.29 170.43 8.24 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.395 1.06 . . . . 0.0 109.282 -179.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.622 HD11 ' HG3' ' A' ' 178' ' ' LYS . 10.3 tp -103.94 120.73 50.27 Favored Pre-proline 0 C--N 1.325 -0.497 0 O-C-N 124.475 1.109 . . . . 0.0 109.256 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -74.97 127.47 10.73 Favored 'Trans proline' 0 C--N 1.361 1.188 0 O-C-N 124.481 1.78 . . . . 0.0 111.022 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 143' ' ' PHE . 1.5 p90 -113.91 174.49 5.91 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.515 1.134 . . . . 0.0 110.973 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -125.36 168.12 13.99 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.563 1.164 . . . . 0.0 109.32 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -65.58 111.84 3.34 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.498 1.124 . . . . 0.0 109.325 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.4 43.78 23.85 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.472 1.108 . . . . 0.0 111.014 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 24.4 t70 -100.05 162.18 13.14 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.506 0.768 . . . . 0.0 109.348 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.421 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.7 OUTLIER -100.03 148.64 6.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.42 1.075 . . . . 0.0 109.348 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.525 HD13 HD13 ' A' ' 182' ' ' ILE . 4.1 mt -147.76 119.69 8.17 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.486 1.116 . . . . 0.0 109.309 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -88.77 110.98 21.46 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.117 . . . . 0.0 110.307 -179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.651 HD13 HG11 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -81.21 126.03 39.68 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.493 1.121 . . . . 0.0 109.313 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.439 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 2.2 ptt180 -123.52 -29.96 3.7 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.582 1.176 . . . . 0.0 110.235 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 1.1 t70 -135.11 129.8 34.5 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.512 1.133 . . . . 0.0 109.332 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.586 ' HG2' ' CE3' ' A' ' 170' ' ' TRP . 1.0 OUTLIER -133.62 63.07 62.61 Favored Pre-proline 0 C--N 1.326 -0.443 0 O-C-N 124.466 1.104 . . . . 0.0 109.32 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.445 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.94 -65.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.187 0 O-C-N 124.469 1.773 . . . . 0.0 110.983 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -51.61 176.67 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.515 1.135 . . . . 0.0 110.299 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -116.91 47.8 1.41 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.502 1.126 . . . . 0.0 110.33 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.708 ' O ' HG23 ' A' ' 184' ' ' VAL . 2.4 mt-30 -175.84 -56.71 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 O-C-N 124.443 1.089 . . . . 0.0 110.241 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.58 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 25.7 m95 -106.13 133.28 51.09 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.548 1.155 . . . . 0.0 107.982 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.586 ' CE3' ' HG2' ' A' ' 164' ' ' LYS . 50.7 m0 -122.12 153.79 38.23 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.522 1.139 . . . . 0.0 108.011 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.406 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -86.61 111.91 21.09 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.469 1.105 . . . . 0.0 109.362 179.939 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -130.3 154.21 47.86 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.601 1.188 . . . . 0.0 109.253 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.427 ' CG ' ' HG2' ' A' ' 179' ' ' ARG . 0.2 OUTLIER -95.54 109.0 21.29 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 1.139 . . . . 0.0 110.308 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.465 ' C ' ' H ' ' A' ' 176' ' ' GLU . 0.2 OUTLIER -54.39 173.43 0.08 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.452 1.095 . . . . 0.0 109.303 -179.929 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -80.09 29.51 0.28 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.446 1.091 . . . . 0.0 110.021 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.465 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.8 mt-10 -129.5 -11.43 4.51 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.484 1.115 . . . . 0.0 110.233 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 101.15 -0.47 54.48 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 110.989 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.622 ' HG3' HD11 ' A' ' 151' ' ' LEU . 2.8 ptpp? -87.37 124.14 33.08 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 0.731 . . . . 0.0 109.299 179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.427 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 11.0 mtt180 -103.48 118.75 37.45 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.456 1.097 . . . . 0.0 110.255 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -154.18 -175.16 25.09 Favored Glycine 0 CA--C 1.531 1.075 0 O-C-N 124.551 1.157 . . . . 0.0 110.95 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.435 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.5 OUTLIER -87.19 136.38 32.95 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.451 0.736 . . . . 0.0 111.05 179.957 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.587 HG23 ' HB3' ' A' ' 151' ' ' LEU . 1.0 OUTLIER -133.33 157.12 78.93 Favored Pre-proline 0 C--N 1.325 -0.492 0 O-C-N 124.54 1.15 . . . . 0.0 109.256 -179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.61 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.0 Cg_endo -75.07 139.57 24.25 Favored 'Trans proline' 0 C--N 1.36 1.173 0 O-C-N 124.513 1.797 . . . . 0.0 110.956 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 93.5 t -82.21 -30.78 0.53 Allowed Pre-proline 0 C--N 1.325 -0.476 0 O-C-N 124.522 1.139 . . . . 0.0 109.337 -180.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.1 -36.46 2.48 Favored 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.546 1.814 . . . . 0.0 111.051 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.1 m-85 -85.22 21.58 1.66 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.551 1.157 . . . . 0.0 110.938 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.61 HG22 ' O ' ' A' ' 183' ' ' PRO . 35.6 m -144.63 172.36 5.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.533 1.145 . . . . 0.0 109.285 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.518 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.4 OUTLIER -146.16 144.22 29.8 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.524 1.14 . . . . 0.0 110.31 179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.423 ' O ' ' HG3' ' A' ' 189' ' ' LYS . 0.2 OUTLIER -85.11 106.88 16.9 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.461 1.101 . . . . 0.0 109.28 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.628 ' CE2' ' NH2' ' A' ' 138' ' ' ARG . 5.7 t80 -70.8 132.31 45.13 Favored 'General case' 0 C--N 1.326 -0.424 0 O-C-N 124.511 1.132 . . . . 0.0 110.985 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.446 1.091 . . . . 0.0 110.985 -179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.8 p . . . . . 0 N--CA 1.452 -0.326 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.45 -59.82 0.19 Allowed Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.542 1.151 . . . . 0.0 111.005 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -89.82 161.41 16.01 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.526 0.78 . . . . 0.0 111.001 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.569 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 15.6 m -130.05 171.75 16.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 124.444 1.09 . . . . 0.0 109.311 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 8.9 mtm-85 -141.48 128.43 20.65 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.523 1.139 . . . . 0.0 110.293 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.562 ' HB1' ' CD2' ' A' ' 153' ' ' PHE . . . -85.78 120.04 26.76 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.456 1.097 . . . . 0.0 109.304 -179.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.12 42.17 1.3 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.544 1.152 . . . . 0.0 109.26 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.508 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -166.08 125.01 1.57 Allowed 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.464 1.102 . . . . 0.0 110.944 -179.966 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -77.1 119.93 21.48 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.511 1.132 . . . . 0.0 109.3 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.544 ' HB2' ' CZ ' ' A' ' 153' ' ' PHE . 52.1 t80 -100.48 156.91 17.01 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.483 1.115 . . . . 0.0 110.979 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.417 ' O ' ' CE2' ' A' ' 143' ' ' PHE . 1.1 t-20 -110.99 153.35 25.67 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.528 1.143 . . . . 0.0 109.285 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -47.62 173.79 0.02 OUTLIER Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.591 1.182 . . . . 0.0 110.985 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -174.34 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.494 0.761 . . . . 0.0 109.328 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -161.54 153.67 19.67 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.504 1.128 . . . . 0.0 109.273 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -86.02 39.34 0.81 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.537 1.148 . . . . 0.0 110.289 179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -115.42 -45.04 2.94 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.485 1.116 . . . . 0.0 110.282 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.593 ' OD2' ' CZ3' ' A' ' 169' ' ' TRP . 0.2 OUTLIER -94.36 169.03 10.51 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.536 1.148 . . . . 0.0 109.272 -179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.654 HD23 HD11 ' A' ' 182' ' ' ILE . 3.7 tp -110.57 120.73 43.14 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.293 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -74.95 154.32 42.66 Favored 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.479 1.778 . . . . 0.0 111.014 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.679 ' HB3' HD11 ' A' ' 159' ' ' LEU . 3.5 p90 -128.61 153.75 46.93 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.482 1.114 . . . . 0.0 111.056 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.536 ' HG2' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -96.46 147.05 24.24 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.497 1.123 . . . . 0.0 109.3 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.536 ' N ' ' HG2' ' A' ' 154' ' ' LYS . 0.8 OUTLIER -52.48 112.44 0.82 Allowed 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.448 1.092 . . . . 0.0 109.32 179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.98 40.88 24.12 Favored Glycine 0 CA--C 1.53 1.004 0 O-C-N 124.551 1.157 . . . . 0.0 110.984 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -98.84 170.37 8.8 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.491 0.759 . . . . 0.0 109.272 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.415 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.8 OUTLIER -103.86 141.88 18.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.47 1.106 . . . . 0.0 109.298 179.974 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.679 HD11 ' HB3' ' A' ' 153' ' ' PHE . 13.1 mt -148.31 122.29 9.42 Favored 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.496 1.123 . . . . 0.0 109.339 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 11.2 ttt180 -95.78 154.89 16.99 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.524 1.14 . . . . 0.0 110.289 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.455 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 24.4 mm -91.49 120.42 40.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.517 1.136 . . . . 0.0 109.308 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.24 -64.87 1.01 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.535 1.147 . . . . 0.0 110.282 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.451 ' O ' ' CB ' ' A' ' 164' ' ' LYS . 0.3 OUTLIER -150.76 -173.61 4.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.445 1.09 . . . . 0.0 109.263 -179.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.524 ' HB3' ' HA ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER 84.78 100.14 0.03 OUTLIER Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.529 1.143 . . . . 0.0 109.257 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.499 ' O ' ' C ' ' A' ' 166' ' ' GLU . 18.0 Cg_endo -75.07 -60.46 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.14 0 O-C-N 124.5 1.79 . . . . 0.0 110.969 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.499 ' C ' ' O ' ' A' ' 165' ' ' PRO . 4.7 mm-40 30.99 -145.73 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.432 1.083 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -165.74 44.96 0.08 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.463 1.102 . . . . 0.0 110.28 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.918 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER -175.23 -60.61 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.462 1.101 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.593 ' CZ3' ' OD2' ' A' ' 150' ' ' ASP . 36.5 m95 -118.25 130.94 56.35 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.538 1.149 . . . . 0.0 108.084 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.54 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 6.7 m0 -129.78 167.79 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.511 1.132 . . . . 0.0 108.025 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.518 ' H ' ' HB3' ' A' ' 164' ' ' LYS . 0.5 OUTLIER -86.92 94.66 9.65 Favored 'General case' 0 C--N 1.324 -0.54 0 O-C-N 124.503 1.127 . . . . 0.0 109.316 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -100.1 152.14 20.58 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.557 1.161 . . . . 0.0 109.313 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -104.11 112.85 26.02 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.437 1.086 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.67 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.4 OUTLIER -57.33 172.55 0.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 O-C-N 124.537 1.148 . . . . 0.0 109.243 -179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 37.7 t -82.72 27.32 0.53 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.552 1.157 . . . . 0.0 109.953 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.41 ' H ' ' C ' ' A' ' 174' ' ' ASP . 13.8 mt-10 -134.21 -4.81 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.407 1.067 . . . . 0.0 110.298 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 100.21 -5.96 57.8 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.537 1.148 . . . . 0.0 111.038 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.605 ' HB3' HD13 ' A' ' 151' ' ' LEU . 13.0 mttm -74.08 109.31 7.47 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.524 0.779 . . . . 0.0 109.332 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 6.1 mtm180 -98.92 117.1 32.67 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.429 1.081 . . . . 0.0 110.329 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.456 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.17 -169.89 18.12 Favored Glycine 0 CA--C 1.529 0.948 0 O-C-N 124.474 1.109 . . . . 0.0 111.028 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.689 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.7 OUTLIER -84.34 133.29 34.54 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.471 0.748 . . . . 0.0 110.993 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.689 HD13 ' O ' ' A' ' 181' ' ' MET . 45.7 mm -129.05 142.45 45.21 Favored Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.544 1.152 . . . . 0.0 109.31 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.618 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.5 Cg_endo -74.95 143.9 29.77 Favored 'Trans proline' 0 C--N 1.359 1.093 0 O-C-N 124.497 1.788 . . . . 0.0 111.04 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.918 HG23 ' O ' ' A' ' 168' ' ' GLN . 85.2 t -82.27 -33.61 0.63 Allowed Pre-proline 0 C--N 1.324 -0.503 0 O-C-N 124.609 1.193 . . . . 0.0 109.352 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.795 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.86 -41.73 0.66 Allowed 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.48 1.779 . . . . 0.0 111.05 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.488 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 1.2 m-85 -84.99 40.58 0.82 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.546 1.154 . . . . 0.0 110.977 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 183' ' ' PRO . 14.1 m -152.27 -178.26 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.426 1.079 . . . . 0.0 109.209 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.569 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.6 OUTLIER -138.64 153.27 48.59 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.565 1.166 . . . . 0.0 110.328 179.976 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.16 110.14 20.44 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.511 1.132 . . . . 0.0 109.32 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -119.18 100.85 7.59 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.556 1.16 . . . . 0.0 111.011 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.033 0 O-C-N 124.568 1.168 . . . . 0.0 111.006 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.429 ' O ' ' N ' ' A' ' 136' ' ' TYR . 1.5 t . . . . . 0 N--CA 1.453 -0.324 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 68.75 -59.49 0.5 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.508 1.13 . . . . 0.0 111.028 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.502 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -86.5 145.1 26.93 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 124.495 0.762 . . . . 0.0 111.015 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.679 HG12 ' HB ' ' A' ' 187' ' ' VAL . 0.5 OUTLIER -114.89 164.7 11.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 O-C-N 124.464 1.103 . . . . 0.0 109.257 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.509 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -147.02 120.3 8.94 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.496 1.123 . . . . 0.0 110.292 179.939 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.5 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.05 124.03 32.02 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.47 1.106 . . . . 0.0 109.362 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.424 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -107.77 47.45 0.89 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.501 1.125 . . . . 0.0 109.361 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.424 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 0.6 OUTLIER 178.12 134.4 0.08 Allowed 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.43 1.081 . . . . 0.0 110.958 -179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -78.45 146.33 34.53 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.498 1.124 . . . . 0.0 109.27 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.601 ' HB3' ' CE1' ' A' ' 153' ' ' PHE . 0.3 OUTLIER -153.22 135.09 14.62 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.516 1.135 . . . . 0.0 110.947 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -91.1 174.92 7.15 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.462 1.101 . . . . 0.0 109.25 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -173.28 -139.13 2.79 Favored Glycine 0 CA--C 1.53 0.974 0 O-C-N 124.439 1.087 . . . . 0.0 111.001 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.403 ' ND2' ' OE2' ' A' ' 149' ' ' GLU . 6.2 p30 178.57 43.55 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.546 0.792 . . . . 0.0 109.363 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 54.72 174.22 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.42 1.075 . . . . 0.0 109.216 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.421 ' O ' ' HB3' ' A' ' 149' ' ' GLU . 4.1 tt0 52.12 44.08 29.94 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.474 1.109 . . . . 0.0 110.21 179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.421 ' HB3' ' O ' ' A' ' 148' ' ' GLU . 17.4 pt-20 178.6 -34.95 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.5 1.125 . . . . 0.0 110.288 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.425 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER 167.81 124.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.582 1.177 . . . . 0.0 109.269 -179.993 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.509 HD13 ' HG2' ' A' ' 178' ' ' LYS . 0.2 OUTLIER -56.68 152.62 25.26 Favored Pre-proline 0 C--N 1.325 -0.498 0 O-C-N 124.508 1.13 . . . . 0.0 109.338 179.957 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.91 128.4 11.53 Favored 'Trans proline' 0 C--N 1.359 1.114 0 O-C-N 124.47 1.773 . . . . 0.0 111.048 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HB3' ' A' ' 143' ' ' PHE . 4.4 p90 -142.42 164.89 28.91 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.516 1.135 . . . . 0.0 111.039 -179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.8 mttt -118.74 174.21 6.41 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.486 1.116 . . . . 0.0 109.305 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.66 138.07 57.17 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.566 1.166 . . . . 0.0 109.312 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.5 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.87 32.06 54.35 Favored Glycine 0 CA--C 1.529 0.962 0 O-C-N 124.474 1.109 . . . . 0.0 111.027 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.511 ' OD2' HD11 ' A' ' 159' ' ' LEU . 53.9 t0 -84.81 159.7 20.36 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.511 0.771 . . . . 0.0 109.351 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.473 ' N ' ' OD1' ' A' ' 157' ' ' ASP . 1.1 mp -119.87 116.55 50.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 109.315 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.511 HD11 ' OD2' ' A' ' 157' ' ' ASP . 1.5 mp -141.6 126.86 18.59 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.478 1.111 . . . . 0.0 109.299 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.656 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 1.1 ppp_? -91.59 168.18 11.69 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.441 1.088 . . . . 0.0 110.282 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.425 HG12 ' CG2' ' A' ' 137' ' ' VAL . 36.3 mm -87.34 129.01 39.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.49 1.119 . . . . 0.0 109.301 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 162' ' ' ARG . 0.0 OUTLIER -119.87 -47.09 2.42 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.503 1.127 . . . . 0.0 110.277 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.503 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 0.9 OUTLIER -148.19 151.59 35.79 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.517 1.136 . . . . 0.0 109.201 -179.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.712 ' N ' ' HD3' ' A' ' 165' ' ' PRO . 4.3 mtpt -138.87 48.86 1.93 Allowed Pre-proline 0 C--N 1.326 -0.43 0 O-C-N 124.457 1.098 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.712 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 6.74 3.22 Favored 'Trans proline' 0 C--N 1.359 1.113 0 O-C-N 124.514 1.797 . . . . 0.0 110.999 179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -132.11 178.6 6.67 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.49 1.118 . . . . 0.0 110.268 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 1.1 mm-40 -114.4 144.86 42.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.542 1.151 . . . . 0.0 110.294 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 167' ' ' GLU . 32.4 mt-30 76.27 -52.45 0.6 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.565 1.165 . . . . 0.0 110.356 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 29.7 m95 -105.53 137.04 44.02 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.483 1.114 . . . . 0.0 108.064 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.632 ' CE3' HG22 ' A' ' 184' ' ' VAL . 37.1 m0 -125.28 156.44 38.58 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.549 1.156 . . . . 0.0 107.993 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.2 m-20 -85.25 91.39 8.14 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.516 1.135 . . . . 0.0 109.319 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.656 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -90.38 148.94 22.5 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.483 1.114 . . . . 0.0 109.304 -180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.411 ' OE1' ' O ' ' A' ' 174' ' ' ASP . 1.4 tm-20 -105.26 110.29 22.6 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.539 1.149 . . . . 0.0 110.264 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.411 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 0.4 OUTLIER -56.7 173.78 0.18 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.454 1.096 . . . . 0.0 109.272 -179.973 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -83.78 26.74 0.68 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.036 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -136.21 -0.95 2.42 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.466 1.104 . . . . 0.0 110.267 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.37 -5.64 65.26 Favored Glycine 0 CA--C 1.53 0.979 0 O-C-N 124.503 1.127 . . . . 0.0 110.975 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.509 ' HG2' HD13 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -70.4 102.12 2.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.472 0.748 . . . . 0.0 109.275 179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 19.5 mtt-85 -94.41 117.25 29.84 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.483 1.114 . . . . 0.0 110.322 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.18 -174.68 22.3 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.496 1.123 . . . . 0.0 110.994 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.432 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.8 mtm -83.7 140.6 32.03 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.461 0.742 . . . . 0.0 111.006 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.521 ' CG2' HG11 ' A' ' 187' ' ' VAL . 0.9 OUTLIER -140.41 144.85 38.53 Favored Pre-proline 0 C--N 1.324 -0.5 0 O-C-N 124.448 1.092 . . . . 0.0 109.303 179.967 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.586 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -74.99 138.11 22.64 Favored 'Trans proline' 0 C--N 1.36 1.169 0 O-C-N 124.488 1.783 . . . . 0.0 110.95 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.813 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.5 t -79.72 -32.35 0.73 Allowed Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.485 1.116 . . . . 0.0 109.312 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.813 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.96 -36.1 2.78 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.451 1.764 . . . . 0.0 110.99 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.53 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 1.6 m-85 -91.55 33.74 1.0 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.094 . . . . 0.0 110.99 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.679 ' HB ' HG12 ' A' ' 137' ' ' VAL . 33.0 m -152.32 177.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.527 1.142 . . . . 0.0 109.304 179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.469 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 2.1 tt0 -149.57 164.78 34.16 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.551 1.157 . . . . 0.0 110.352 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.12 113.86 23.23 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.408 1.067 . . . . 0.0 109.307 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -76.88 -48.35 18.55 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.551 1.157 . . . . 0.0 111.054 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.063 0 O-C-N 124.532 1.145 . . . . 0.0 111.017 179.959 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 75.54 -78.35 1.17 Allowed Glycine 0 CA--C 1.531 1.041 0 O-C-N 124.494 1.121 . . . . 0.0 111.029 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.582 ' CD2' ' HB3' ' A' ' 160' ' ' ARG . 18.8 m-85 -87.64 151.3 23.06 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.593 0.82 . . . . 0.0 111.005 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.94 HG22 ' O ' ' A' ' 159' ' ' LEU . 3.0 m -120.1 173.16 6.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.475 1.109 . . . . 0.0 109.284 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.442 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 17.2 mtt180 -146.31 128.86 16.04 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.521 1.138 . . . . 0.0 110.292 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.499 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.22 118.84 26.9 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.485 1.116 . . . . 0.0 109.302 -179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.567 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -97.86 41.63 1.12 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.416 1.072 . . . . 0.0 109.36 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -166.62 124.88 1.4 Allowed 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.493 1.121 . . . . 0.0 110.961 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -77.64 137.46 38.55 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.507 1.129 . . . . 0.0 109.296 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -163.78 147.25 10.01 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.435 1.085 . . . . 0.0 111.051 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.7 m-80 -139.93 156.35 46.71 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.464 1.103 . . . . 0.0 109.313 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -137.88 -108.63 0.86 Allowed Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.436 1.085 . . . . 0.0 110.978 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 177.34 38.42 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.547 0.792 . . . . 0.0 109.342 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 74.7 42.9 0.26 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.551 1.157 . . . . 0.0 109.315 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.36 46.91 1.0 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.456 1.098 . . . . 0.0 110.308 179.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 73.65 27.29 1.79 Allowed 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.517 1.135 . . . . 0.0 110.323 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -163.38 132.32 3.95 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.512 1.133 . . . . 0.0 109.296 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.617 ' O ' ' CZ ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -84.86 147.3 48.13 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.57 1.169 . . . . 0.0 109.256 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.544 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.88 109.53 2.94 Favored 'Trans proline' 0 C--N 1.361 1.19 0 O-C-N 124.511 1.795 . . . . 0.0 110.993 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.617 ' CZ ' ' O ' ' A' ' 151' ' ' LEU . 0.5 OUTLIER -100.43 158.82 15.62 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.487 1.117 . . . . 0.0 110.97 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 20.8 mtpp -110.85 160.41 16.79 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.445 1.091 . . . . 0.0 109.255 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.35 109.22 0.37 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.494 1.121 . . . . 0.0 109.275 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 80.97 41.35 10.56 Favored Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.522 1.139 . . . . 0.0 111.011 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.419 ' OD2' ' HA ' ' A' ' 153' ' ' PHE . 6.9 t0 -75.09 159.2 31.97 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.571 0.806 . . . . 0.0 109.276 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.413 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 65.9 mt -116.54 118.01 57.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.536 1.147 . . . . 0.0 109.23 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.987 HD13 HD11 ' A' ' 182' ' ' ILE . 3.3 mp -144.27 132.46 21.78 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.505 1.128 . . . . 0.0 109.293 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.599 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -95.49 156.36 16.35 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 110.35 179.979 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 33.6 mt -85.64 123.84 39.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.505 1.128 . . . . 0.0 109.363 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -109.23 -50.77 2.96 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.476 1.11 . . . . 0.0 110.352 179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -136.65 125.55 24.19 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.539 1.15 . . . . 0.0 109.283 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . . . . . . . . . 3.6 ptpt -123.08 76.74 51.12 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 124.482 1.114 . . . . 0.0 109.256 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.99 -59.33 0.04 OUTLIER 'Trans proline' 0 C--N 1.359 1.126 0 O-C-N 124.521 1.801 . . . . 0.0 111.006 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 3.3 pt-20 -78.74 -168.34 1.38 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.474 1.109 . . . . 0.0 110.292 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.477 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 6.9 mt-10 -124.17 75.46 1.38 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.431 1.082 . . . . 0.0 110.331 179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 1.046 ' O ' HG13 ' A' ' 184' ' ' VAL . 0.9 OUTLIER 162.04 -60.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.499 1.124 . . . . 0.0 110.289 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.525 ' CD1' ' HB3' ' A' ' 168' ' ' GLN . 8.5 m95 -107.24 119.05 38.32 Favored 'General case' 0 C--N 1.324 -0.533 0 O-C-N 124.566 1.166 . . . . 0.0 107.953 -179.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.438 ' O ' ' HA ' ' A' ' 181' ' ' MET . 20.6 m0 -122.15 158.87 28.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.482 1.113 . . . . 0.0 108.042 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 61.4 m-20 -83.9 96.13 8.71 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.497 1.123 . . . . 0.0 109.324 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.599 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -94.88 150.97 19.62 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.568 1.168 . . . . 0.0 109.316 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.45 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 1.2 tm-20 -103.87 110.55 22.72 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.567 1.167 . . . . 0.0 110.344 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.409 ' O ' ' OE1' ' A' ' 173' ' ' GLU . 7.2 t70 -59.04 175.95 0.25 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.508 1.13 . . . . 0.0 109.236 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 26.5 p -85.36 26.39 0.91 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.467 1.104 . . . . 0.0 110.066 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 9.2 mt-10 -136.78 0.89 2.48 Favored 'General case' 0 C--N 1.326 -0.435 0 O-C-N 124.485 1.116 . . . . 0.0 110.265 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 94.44 -6.1 71.09 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.45 1.094 . . . . 0.0 110.984 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -72.17 106.92 4.57 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.555 0.797 . . . . 0.0 109.319 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 12.8 mtp180 -99.62 119.26 37.79 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.498 1.124 . . . . 0.0 110.296 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -150.91 -176.25 23.62 Favored Glycine 0 CA--C 1.529 0.951 0 O-C-N 124.566 1.167 . . . . 0.0 111.005 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.438 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -83.74 130.29 34.95 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.45 0.736 . . . . 0.0 110.985 -179.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.987 HD11 HD13 ' A' ' 159' ' ' LEU . 1.4 tt -126.96 144.7 51.22 Favored Pre-proline 0 C--N 1.325 -0.478 0 O-C-N 124.481 1.113 . . . . 0.0 109.307 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.516 ' C ' ' HD2' ' A' ' 185' ' ' PRO . 18.2 Cg_endo -75.0 137.85 22.27 Favored 'Trans proline' 0 C--N 1.36 1.156 0 O-C-N 124.523 1.802 . . . . 0.0 111.017 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 1.046 HG13 ' O ' ' A' ' 168' ' ' GLN . 22.7 m -77.86 -30.47 0.74 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.553 1.158 . . . . 0.0 109.329 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.836 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -75.01 -41.48 0.65 Allowed 'Trans proline' 0 C--N 1.36 1.161 0 O-C-N 124.489 1.784 . . . . 0.0 110.987 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 1.5 m-85 -88.9 44.38 1.21 Allowed 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.458 1.099 . . . . 0.0 111.013 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.53 HG22 ' C ' ' A' ' 184' ' ' VAL . 17.4 m -151.93 175.97 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 O-C-N 124.447 1.092 . . . . 0.0 109.262 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.567 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.5 tt0 -145.18 164.44 31.3 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.466 1.104 . . . . 0.0 110.313 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.34 107.35 18.78 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.478 1.111 . . . . 0.0 109.283 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.407 ' CD1' ' HB2' ' A' ' 136' ' ' TYR . 0.9 OUTLIER -69.04 -46.19 68.54 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.558 1.161 . . . . 0.0 110.997 -179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.54 1.15 . . . . 0.0 110.998 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.422 ' O ' ' SG ' ' A' ' 134' ' ' CYS . 19.5 p . . . . . 0 N--CA 1.452 -0.328 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 158.14 -59.22 0.34 Allowed Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.557 1.161 . . . . 0.0 110.989 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.435 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 4.1 m-85 -88.15 145.71 25.78 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.462 0.742 . . . . 0.0 111.005 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.902 HG22 ' O ' ' A' ' 159' ' ' LEU . 15.8 m -119.61 168.93 11.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 124.467 1.105 . . . . 0.0 109.316 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.464 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -139.03 131.91 29.31 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 110.286 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.445 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.74 116.55 24.91 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.477 1.111 . . . . 0.0 109.282 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.562 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -104.44 43.72 1.08 Allowed 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.532 1.145 . . . . 0.0 109.317 179.974 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.619 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 26.5 m-85 -167.29 120.13 0.94 Allowed 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.453 1.095 . . . . 0.0 110.928 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -65.82 124.82 23.48 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.451 1.094 . . . . 0.0 109.294 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 146' ' ' ASN . 0.8 OUTLIER -94.7 136.82 34.56 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.566 1.166 . . . . 0.0 110.976 -179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.411 ' O ' ' O ' ' A' ' 145' ' ' GLY . 37.2 p-10 -131.21 92.58 3.22 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.611 1.195 . . . . 0.0 109.3 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.45 ' N ' ' CE1' ' A' ' 143' ' ' PHE . . . 54.78 164.47 0.02 OUTLIER Glycine 0 CA--C 1.53 1.026 0 O-C-N 124.577 1.173 . . . . 0.0 111.048 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.577 ' HB2' ' CE2' ' A' ' 143' ' ' PHE . 0.4 OUTLIER 169.69 -54.84 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.532 0.783 . . . . 0.0 109.334 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -166.79 150.07 6.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.452 1.095 . . . . 0.0 109.335 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -85.97 36.55 0.67 Allowed 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.518 1.136 . . . . 0.0 110.325 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -119.61 -11.39 9.44 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.442 1.089 . . . . 0.0 110.358 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.509 ' CB ' ' O ' ' A' ' 181' ' ' MET . 0.9 OUTLIER -131.39 143.03 50.17 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.482 1.114 . . . . 0.0 109.307 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.502 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -75.03 144.12 78.75 Favored Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.481 1.113 . . . . 0.0 109.224 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.03 136.85 20.89 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.546 1.814 . . . . 0.0 111.002 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 0.3 OUTLIER -133.62 160.7 36.73 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.5 1.125 . . . . 0.0 110.986 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 8.2 mtpt -114.73 170.14 8.55 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.52 1.137 . . . . 0.0 109.276 -179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.421 ' HE2' ' N ' ' A' ' 156' ' ' GLY . 0.0 OUTLIER -63.11 127.15 29.93 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.45 1.094 . . . . 0.0 109.261 -179.971 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 83.2 31.15 29.07 Favored Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.458 1.099 . . . . 0.0 111.029 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.434 ' O ' ' HA ' ' A' ' 138' ' ' ARG . 0.2 OUTLIER -85.09 157.49 20.69 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.496 0.763 . . . . 0.0 109.283 -179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.572 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 2.8 mt -119.0 126.88 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 O-C-N 124.554 1.159 . . . . 0.0 109.308 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.902 ' O ' HG22 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -147.94 128.02 13.7 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.45 1.094 . . . . 0.0 109.311 -179.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.649 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.5 OUTLIER -93.07 156.21 17.02 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.577 1.173 . . . . 0.0 110.272 -179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.629 HD11 ' CB ' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.38 128.52 39.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 109.306 -179.991 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.94 -53.28 2.39 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.429 1.08 . . . . 0.0 110.258 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.436 ' CB ' ' HB2' ' A' ' 171' ' ' ASN . 0.3 OUTLIER -130.41 140.83 50.56 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.473 1.108 . . . . 0.0 109.292 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.563 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 9.9 ttpp -137.2 61.43 33.19 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.446 1.091 . . . . 0.0 109.374 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.467 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.02 -66.53 0.02 OUTLIER 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.507 1.793 . . . . 0.0 110.978 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.606 ' OE2' ' N ' ' A' ' 168' ' ' GLN . 0.6 OUTLIER -61.8 -175.83 0.07 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 110.312 179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.573 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 2.8 mm-40 -120.03 81.83 1.8 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.544 1.152 . . . . 0.0 110.26 -179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.737 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 154.83 -74.49 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.459 1.099 . . . . 0.0 110.352 -179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.551 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 37.3 m95 -91.1 126.32 36.15 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.135 . . . . 0.0 108.074 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.812 ' CE2' HG21 ' A' ' 184' ' ' VAL . 20.5 m0 -114.06 156.9 23.3 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.487 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.6 m-80 -84.88 91.06 7.93 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.534 1.146 . . . . 0.0 109.345 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.649 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -96.39 150.26 20.79 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.504 1.127 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.461 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 0.1 OUTLIER -106.47 111.3 23.8 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.47 1.106 . . . . 0.0 110.333 179.957 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.781 ' HA ' HD23 ' A' ' 159' ' ' LEU . 47.6 t0 -60.63 175.07 0.5 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.498 1.124 . . . . 0.0 109.321 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . 0.407 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.5 OUTLIER -81.74 31.41 0.36 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.465 1.103 . . . . 0.0 110.002 -179.985 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.423 ' H ' ' C ' ' A' ' 174' ' ' ASP . 11.4 mt-10 -131.7 -8.54 3.6 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.469 1.106 . . . . 0.0 110.283 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 97.71 -2.16 60.26 Favored Glycine 0 CA--C 1.529 0.961 0 O-C-N 124.566 1.166 . . . . 0.0 111.022 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 178' ' ' LYS . 1.3 ptpm? -81.43 114.03 19.9 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.522 0.778 . . . . 0.0 109.28 -179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.461 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 3.9 mtt-85 -103.81 119.29 38.62 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.491 1.12 . . . . 0.0 110.332 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.69 179.98 27.85 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.541 1.151 . . . . 0.0 111.011 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.509 ' O ' ' CB ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -84.45 129.08 34.9 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.515 0.774 . . . . 0.0 110.964 -179.94 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.545 HD13 HD13 ' A' ' 159' ' ' LEU . 26.0 pt -132.17 155.7 81.0 Favored Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.477 1.111 . . . . 0.0 109.268 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.628 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.02 137.59 21.87 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.468 1.773 . . . . 0.0 110.988 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 84.5 t -79.94 -30.72 0.62 Allowed Pre-proline 0 C--N 1.326 -0.448 0 O-C-N 124.492 1.12 . . . . 0.0 109.354 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.97 -24.67 12.65 Favored 'Trans proline' 0 C--N 1.36 1.146 0 O-C-N 124.595 1.84 . . . . 0.0 110.985 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.628 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -92.6 16.88 11.11 Favored 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.563 1.165 . . . . 0.0 110.973 -179.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 28.7 m -139.69 174.21 9.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.479 1.112 . . . . 0.0 109.279 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 3.6 tt0 -135.04 164.31 27.91 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.505 1.128 . . . . 0.0 110.308 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.426 ' HE2' HG12 ' A' ' 137' ' ' VAL . 0.0 OUTLIER -88.21 97.23 10.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.539 1.15 . . . . 0.0 109.29 -179.976 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 31.0 t80 -111.58 82.43 1.61 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.472 1.107 . . . . 0.0 110.978 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.947 0 O-C-N 124.529 1.143 . . . . 0.0 111.026 -179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -172.02 51.07 0.18 Allowed Glycine 0 CA--C 1.531 1.048 0 O-C-N 124.474 1.109 . . . . 0.0 110.983 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -121.45 171.64 8.64 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.562 0.801 . . . . 0.0 111.011 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.607 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -137.99 167.8 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.565 1.166 . . . . 0.0 109.314 179.996 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.551 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 9.8 mtp180 -145.99 139.45 26.16 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.465 1.103 . . . . 0.0 110.269 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.448 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -87.98 123.23 32.49 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.49 1.119 . . . . 0.0 109.258 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.692 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.1 OUTLIER -113.86 43.81 1.75 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.51 1.131 . . . . 0.0 109.263 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.531 ' CG ' ' O ' ' A' ' 140' ' ' LEU . 22.1 m-85 -168.26 129.35 1.34 Allowed 'General case' 0 C--N 1.326 -0.444 0 O-C-N 124.495 1.122 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -73.58 121.5 20.76 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.454 1.096 . . . . 0.0 109.305 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.579 ' HB2' ' CE2' ' A' ' 153' ' ' PHE . 40.7 t80 -111.49 141.28 45.26 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.508 1.13 . . . . 0.0 110.984 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.545 ' O ' ' CE1' ' A' ' 143' ' ' PHE . 1.7 t30 -98.76 155.37 17.38 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.51 1.131 . . . . 0.0 109.327 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -40.23 158.26 0.02 OUTLIER Glycine 0 CA--C 1.529 0.942 0 O-C-N 124.442 1.088 . . . . 0.0 110.978 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -170.0 -42.82 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.478 0.752 . . . . 0.0 109.29 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -161.46 120.44 2.46 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.478 1.111 . . . . 0.0 109.296 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.408 ' HG3' ' N ' ' A' ' 149' ' ' GLU . 19.2 pt-20 -49.6 -47.61 49.39 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.513 1.133 . . . . 0.0 110.276 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.412 ' HG3' ' N ' ' A' ' 150' ' ' ASP . 17.2 pt-20 -45.74 -36.82 5.33 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.485 1.116 . . . . 0.0 110.245 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.412 ' N ' ' HG3' ' A' ' 149' ' ' GLU . 7.9 m-20 -92.95 112.08 23.93 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.561 1.163 . . . . 0.0 109.303 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.994 HD12 ' HD2' ' A' ' 152' ' ' PRO . 2.1 tp -63.8 131.77 95.02 Favored Pre-proline 0 C--N 1.325 -0.465 0 O-C-N 124.439 1.087 . . . . 0.0 109.37 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.994 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.3 Cg_endo -75.01 145.76 31.8 Favored 'Trans proline' 0 C--N 1.36 1.145 0 O-C-N 124.46 1.769 . . . . 0.0 111.008 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' N ' ' CD1' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -116.86 175.75 5.44 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.481 1.113 . . . . 0.0 110.98 -179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -119.29 166.76 12.6 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.84 56.25 0.94 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.523 1.139 . . . . 0.0 109.295 179.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 132.68 48.2 0.1 Allowed Glycine 0 CA--C 1.53 1.008 0 O-C-N 124.554 1.159 . . . . 0.0 111.055 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -103.6 166.25 10.54 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.489 0.758 . . . . 0.0 109.302 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.415 ' HA ' ' CG ' ' A' ' 138' ' ' ARG . 10.5 mt -104.05 135.56 41.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.482 1.114 . . . . 0.0 109.314 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.765 HD22 HG13 ' A' ' 182' ' ' ILE . 3.7 mt -143.32 119.83 11.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.491 1.12 . . . . 0.0 109.306 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.621 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 4.0 ttm180 -87.59 146.49 25.73 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.57 1.169 . . . . 0.0 110.31 -179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.424 ' N ' ' HG2' ' A' ' 160' ' ' ARG . 47.0 mm -85.13 124.23 39.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.503 1.127 . . . . 0.0 109.279 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -113.92 -48.03 2.93 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.473 1.108 . . . . 0.0 110.291 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.407 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 0.6 OUTLIER -144.58 143.04 30.6 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.484 1.115 . . . . 0.0 109.298 179.998 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.484 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 22.7 mtmt -128.34 69.73 78.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.511 1.132 . . . . 0.0 109.323 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.407 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.1 Cg_endo -75.0 -65.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.361 1.225 0 O-C-N 124.465 1.771 . . . . 0.0 111.011 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -60.83 -178.1 0.09 Allowed 'General case' 0 C--N 1.325 -0.5 0 O-C-N 124.501 1.126 . . . . 0.0 110.32 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 8.4 mm-40 -119.53 29.55 7.55 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.443 1.089 . . . . 0.0 110.329 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -153.62 -45.01 0.09 Allowed 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.525 1.14 . . . . 0.0 110.327 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 26.9 m95 -119.26 134.79 55.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.043 -1.095 . . . . 0.0 108.043 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.647 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 14.7 m0 -118.56 157.23 27.73 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.487 1.117 . . . . 0.0 108.006 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 4.5 m-80 -85.72 92.7 8.67 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.453 1.096 . . . . 0.0 109.307 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.621 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -106.21 157.63 17.43 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 124.519 1.137 . . . . 0.0 109.249 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 28.5 tt0 -106.7 107.26 18.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.48 1.113 . . . . 0.0 110.265 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.662 ' HA ' HD23 ' A' ' 159' ' ' LEU . 4.1 t70 -52.14 179.59 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.526 1.141 . . . . 0.0 109.309 179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 17.7 p -84.15 27.83 0.65 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.459 1.1 . . . . 0.0 110.009 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . . . . . . . . . 78.4 mt-10 -131.99 -3.59 3.58 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.439 1.087 . . . . 0.0 110.285 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 92.81 -0.32 69.81 Favored Glycine 0 CA--C 1.53 0.987 0 O-C-N 124.452 1.095 . . . . 0.0 111.019 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 6.5 mtpt -78.57 108.85 12.26 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.468 0.746 . . . . 0.0 109.309 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.28 114.22 25.98 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.525 1.141 . . . . 0.0 110.313 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.77 -170.04 18.7 Favored Glycine 0 CA--C 1.53 0.989 0 O-C-N 124.47 1.106 . . . . 0.0 110.955 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . . . . . . . . . 2.5 mtm -83.3 132.01 35.05 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.502 0.766 . . . . 0.0 111.076 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.765 HG13 HD22 ' A' ' 159' ' ' LEU . 28.8 mm -128.08 143.06 46.5 Favored Pre-proline 0 C--N 1.324 -0.514 0 O-C-N 124.492 1.12 . . . . 0.0 109.379 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.702 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.98 139.48 24.39 Favored 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.455 1.766 . . . . 0.0 111.019 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 94.7 t -80.31 -32.05 0.67 Allowed Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.499 1.125 . . . . 0.0 109.292 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -74.99 -36.24 2.68 Favored 'Trans proline' 0 C--N 1.361 1.185 0 O-C-N 124.423 1.749 . . . . 0.0 111.014 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.503 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -90.95 30.65 1.17 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.489 1.118 . . . . 0.0 110.992 179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.646 HG22 ' O ' ' A' ' 183' ' ' PRO . 21.9 m -152.54 -177.8 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 O-C-N 124.477 1.11 . . . . 0.0 109.306 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.692 ' HB2' HD11 ' A' ' 140' ' ' LEU . 1.9 tt0 -144.46 135.09 24.76 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.511 1.132 . . . . 0.0 110.295 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 4.1 ttmt -82.7 112.25 19.39 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.444 1.09 . . . . 0.0 109.268 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.15 139.53 47.11 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 124.481 1.113 . . . . 0.0 110.998 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.911 0 O-C-N 124.554 1.159 . . . . 0.0 111.066 -179.971 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.7 m . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 169.27 -45.34 0.22 Allowed Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.531 1.144 . . . . 0.0 110.91 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -87.8 170.56 11.1 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.546 0.792 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 1.02 HG21 HD13 ' A' ' 161' ' ' ILE . 22.4 t -129.74 165.07 30.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.45 1.094 . . . . 0.0 109.243 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.503 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -148.45 134.25 18.96 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.437 1.086 . . . . 0.0 110.296 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.465 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -92.9 125.45 37.51 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.556 1.16 . . . . 0.0 109.305 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.568 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -110.7 47.41 0.98 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.509 1.131 . . . . 0.0 109.292 -179.975 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.57 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 8.3 m-85 -174.48 125.08 0.31 Allowed 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.442 1.089 . . . . 0.0 111.003 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -79.93 120.19 23.8 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.555 1.159 . . . . 0.0 109.342 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.434 ' CE1' ' OH ' ' A' ' 186' ' ' TYR . 0.1 OUTLIER -146.79 144.29 29.26 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.471 1.107 . . . . 0.0 110.986 -179.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -157.29 159.04 37.15 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.521 1.138 . . . . 0.0 109.3 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 81.72 104.2 0.38 Allowed Glycine 0 CA--C 1.53 0.999 0 O-C-N 124.477 1.11 . . . . 0.0 111.021 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -177.94 -61.77 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 O-C-N 124.573 0.808 . . . . 0.0 109.294 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.414 ' O ' ' C ' ' A' ' 148' ' ' GLU . 0.4 OUTLIER -176.97 124.04 0.14 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.523 1.139 . . . . 0.0 109.336 179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.414 ' C ' ' O ' ' A' ' 147' ' ' ASP . 0.0 OUTLIER -37.29 -45.07 0.64 Allowed 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.571 1.17 . . . . 0.0 110.294 -179.996 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -41.35 -54.14 3.1 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.47 1.106 . . . . 0.0 110.372 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.435 ' HA ' ' O ' ' A' ' 181' ' ' MET . 44.0 m-20 -77.06 107.27 9.3 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.503 1.127 . . . . 0.0 109.315 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.604 HD21 ' HB2' ' A' ' 174' ' ' ASP . 9.3 tp -56.4 140.53 72.69 Favored Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.518 1.136 . . . . 0.0 109.31 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.522 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.4 Cg_endo -74.92 125.66 9.51 Favored 'Trans proline' 0 C--N 1.359 1.085 0 O-C-N 124.465 1.771 . . . . 0.0 110.973 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.582 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -102.16 146.61 27.71 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.967 179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 61.9 tttt -112.26 154.82 25.04 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.591 1.182 . . . . 0.0 109.326 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.16 102.34 0.07 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.503 1.127 . . . . 0.0 109.332 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 75.24 48.14 11.6 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.469 1.106 . . . . 0.0 110.954 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -96.06 164.79 12.55 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.412 0.713 . . . . 0.0 109.36 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.416 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 3.1 mt -102.08 131.33 50.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 O-C-N 124.513 1.133 . . . . 0.0 109.301 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.602 ' CD2' HD23 ' A' ' 151' ' ' LEU . 1.5 mt -142.95 115.72 8.71 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.465 1.103 . . . . 0.0 109.337 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.605 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 13.0 tpt180 -88.83 126.41 35.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.542 1.151 . . . . 0.0 110.327 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 1.02 HD13 HG21 ' A' ' 137' ' ' VAL . 0.5 OUTLIER -81.77 128.4 38.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 O-C-N 124.446 1.091 . . . . 0.0 109.281 -179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 9.1 mtp85 -124.47 -39.76 2.29 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.492 1.12 . . . . 0.0 110.294 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -119.79 140.37 50.86 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.547 1.155 . . . . 0.0 109.336 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.526 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 4.7 ttmm -136.94 59.77 25.04 Favored Pre-proline 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.31 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.515 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.03 -63.57 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.13 0 O-C-N 124.511 1.795 . . . . 0.0 110.988 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -62.71 175.35 0.83 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.577 1.173 . . . . 0.0 110.33 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -117.37 27.18 9.24 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.511 1.132 . . . . 0.0 110.283 -179.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -148.97 -47.58 0.14 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.522 1.139 . . . . 0.0 110.266 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' HA ' ' O ' ' A' ' 182' ' ' ILE . 21.8 m95 -114.16 132.98 55.89 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.522 1.139 . . . . 0.0 108.094 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.835 ' CE3' HG22 ' A' ' 184' ' ' VAL . 35.9 m0 -113.42 149.72 33.76 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.544 1.153 . . . . 0.0 107.946 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.479 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 11.9 t30 -88.31 100.55 13.09 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.459 1.099 . . . . 0.0 109.333 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.679 ' HB2' HD12 ' A' ' 161' ' ' ILE . . . -114.72 163.18 15.83 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.457 1.098 . . . . 0.0 109.324 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.422 ' N ' ' O ' ' A' ' 160' ' ' ARG . 2.2 tm-20 -110.69 108.79 18.8 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.471 1.107 . . . . 0.0 110.324 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.604 ' HB2' HD21 ' A' ' 151' ' ' LEU . 0.4 OUTLIER -55.37 178.22 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.446 1.091 . . . . 0.0 109.315 179.968 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 99.9 p -82.52 27.69 0.5 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.598 1.186 . . . . 0.0 110.021 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.417 ' H ' ' C ' ' A' ' 174' ' ' ASP . 57.0 mt-10 -130.34 -5.49 4.29 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.47 1.106 . . . . 0.0 110.338 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.65 -3.5 65.55 Favored Glycine 0 CA--C 1.531 1.034 0 O-C-N 124.551 1.157 . . . . 0.0 111.013 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.445 ' HB3' ' CD1' ' A' ' 151' ' ' LEU . 18.0 mttm -77.97 113.73 16.16 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.524 0.779 . . . . 0.0 109.265 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.415 ' HG3' ' CG ' ' A' ' 173' ' ' GLU . 0.2 OUTLIER -104.54 115.89 31.14 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 124.544 1.152 . . . . 0.0 110.312 179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -153.58 -175.47 24.94 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.504 1.127 . . . . 0.0 111.014 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 150' ' ' ASP . 0.0 OUTLIER -85.86 131.42 34.31 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.53 0.782 . . . . 0.0 110.988 -179.98 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.555 HD13 ' O ' ' A' ' 170' ' ' TRP . 0.1 OUTLIER -129.79 162.57 52.63 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.465 1.103 . . . . 0.0 109.307 -179.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.798 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.08 138.97 23.54 Favored 'Trans proline' 0 C--N 1.359 1.108 0 O-C-N 124.499 1.789 . . . . 0.0 110.927 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.835 HG22 ' CE3' ' A' ' 170' ' ' TRP . 51.2 t -81.16 -31.67 0.6 Allowed Pre-proline 0 C--N 1.325 -0.463 0 O-C-N 124.422 1.076 . . . . 0.0 109.277 -179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.814 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -75.03 -48.4 0.17 Allowed 'Trans proline' 0 C--N 1.36 1.162 0 O-C-N 124.41 1.742 . . . . 0.0 111.024 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.598 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -62.37 -31.65 72.33 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.435 1.085 . . . . 0.0 110.972 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.798 HG22 ' O ' ' A' ' 183' ' ' PRO . 11.0 m -95.27 -177.98 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 O-C-N 124.522 1.139 . . . . 0.0 109.312 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.565 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 17.2 pt-20 -144.63 148.27 34.1 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.536 1.147 . . . . 0.0 110.278 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.6 104.97 16.53 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.508 1.13 . . . . 0.0 109.319 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.512 ' O ' ' C ' ' A' ' 191' ' ' GLY . 42.6 t80 -81.61 150.37 28.15 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.464 1.102 . . . . 0.0 111.007 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.512 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 0.978 0 O-C-N 124.516 1.135 . . . . 0.0 111.026 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 84.5 m . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 191' ' ' GLY . . . 161.56 -60.05 0.29 Allowed Glycine 0 CA--C 1.53 1.025 0 O-C-N 124.496 1.122 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.548 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 39.8 m-85 -87.4 144.61 26.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.457 0.739 . . . . 0.0 111.014 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.0 OUTLIER -122.91 161.62 24.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 O-C-N 124.47 1.106 . . . . 0.0 109.305 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.517 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -125.54 124.25 40.88 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.473 1.108 . . . . 0.0 110.276 -179.984 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.693 ' HB3' ' OD2' ' A' ' 157' ' ' ASP . . . -86.17 115.36 23.69 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.512 1.132 . . . . 0.0 109.334 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.598 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -108.54 45.37 1.03 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 109.346 179.954 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.614 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 19.1 m-85 -171.73 125.72 0.59 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.538 1.149 . . . . 0.0 110.941 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.406 ' N ' ' HB2' ' A' ' 155' ' ' LYS . 12.4 t0 -82.36 148.91 28.0 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.476 1.11 . . . . 0.0 109.304 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 14.6 t80 -140.51 176.81 8.47 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.465 1.103 . . . . 0.0 111.018 -179.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 6.5 m120 -114.97 178.72 4.18 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.503 1.127 . . . . 0.0 109.31 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -95.65 -163.08 33.98 Favored Glycine 0 CA--C 1.529 0.949 0 O-C-N 124.376 1.047 . . . . 0.0 111.04 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -178.53 -42.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.504 0.767 . . . . 0.0 109.33 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -158.84 172.75 17.66 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.455 1.097 . . . . 0.0 109.262 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -85.67 35.37 0.61 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.51 1.131 . . . . 0.0 110.287 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -96.84 -46.95 6.04 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.547 1.154 . . . . 0.0 110.308 -179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 25.8 p-10 -110.6 169.69 8.59 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.542 1.151 . . . . 0.0 109.289 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 4.4 tp -104.97 138.07 19.4 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.457 1.098 . . . . 0.0 109.289 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.0 159.47 41.32 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.492 1.785 . . . . 0.0 111.039 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.409 ' HE2' ' CD2' ' A' ' 186' ' ' TYR . 5.5 p90 -156.99 158.37 36.44 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.52 1.138 . . . . 0.0 111.065 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.7 170.2 8.18 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.556 1.16 . . . . 0.0 109.352 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.406 ' HB2' ' N ' ' A' ' 142' ' ' ASP . 0.0 OUTLIER -73.03 134.69 44.71 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 109.291 179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.506 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.84 35.23 58.55 Favored Glycine 0 CA--C 1.531 1.032 0 O-C-N 124.47 1.106 . . . . 0.0 111.011 179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.693 ' OD2' ' HB3' ' A' ' 139' ' ' ALA . 0.3 OUTLIER -93.9 171.06 9.1 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 124.516 0.774 . . . . 0.0 109.271 -179.997 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.453 ' CD1' ' HG3' ' A' ' 138' ' ' ARG . 36.3 mm -117.51 131.0 71.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.402 1.063 . . . . 0.0 109.349 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.628 ' O ' HG22 ' A' ' 137' ' ' VAL . 1.5 mt -150.9 131.66 14.06 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.543 1.152 . . . . 0.0 109.268 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.598 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -100.41 161.03 13.87 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.133 . . . . 0.0 110.305 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.48 HD12 ' HE3' ' A' ' 170' ' ' TRP . 43.0 mm -86.48 131.83 33.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.507 1.129 . . . . 0.0 109.214 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 19.1 ttp85 -117.63 -54.34 2.36 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.498 1.124 . . . . 0.0 110.265 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -135.28 135.81 41.15 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.463 1.102 . . . . 0.0 109.323 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.547 ' HG3' ' CD2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -124.88 73.63 64.53 Favored Pre-proline 0 C--N 1.324 -0.523 0 O-C-N 124.511 1.132 . . . . 0.0 109.375 -179.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.96 -61.64 0.04 OUTLIER 'Trans proline' 0 C--N 1.36 1.166 0 O-C-N 124.483 1.781 . . . . 0.0 110.994 -179.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.488 ' HG2' ' O ' ' A' ' 169' ' ' TRP . 13.5 pt-20 -85.45 -178.88 6.81 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.532 1.145 . . . . 0.0 110.3 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -113.8 57.55 0.69 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.5 1.125 . . . . 0.0 110.304 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -67.84 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.501 1.126 . . . . 0.0 110.284 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.567 ' CZ3' ' HD3' ' A' ' 183' ' ' PRO . 32.0 m95 -105.34 120.03 40.56 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.529 1.143 . . . . 0.0 107.992 -179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.765 ' CE2' HG21 ' A' ' 184' ' ' VAL . 14.2 m0 -115.4 158.59 22.26 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.576 1.172 . . . . 0.0 107.995 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 5.6 t30 -85.48 99.8 11.46 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.466 1.104 . . . . 0.0 109.302 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.598 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -97.87 150.24 21.51 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.412 1.07 . . . . 0.0 109.317 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.55 ' HB3' ' CG ' ' A' ' 160' ' ' ARG . 2.9 tm-20 -103.54 110.85 23.04 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.522 1.139 . . . . 0.0 110.296 179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.548 ' N ' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -60.08 173.43 0.63 Allowed 'General case' 0 C--N 1.324 -0.534 0 O-C-N 124.582 1.177 . . . . 0.0 109.353 179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -82.26 28.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.548 1.155 . . . . 0.0 110.016 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.419 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.9 mm-40 -136.92 -2.02 2.14 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.516 1.135 . . . . 0.0 110.322 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.83 -6.42 64.55 Favored Glycine 0 CA--C 1.53 1.011 0 O-C-N 124.53 1.144 . . . . 0.0 111.024 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 32.7 mttt -72.84 105.72 4.49 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.49 0.759 . . . . 0.0 109.318 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.468 ' HG2' ' CG ' ' A' ' 173' ' ' GLU . 5.0 mtm-85 -101.68 119.62 39.06 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.561 1.163 . . . . 0.0 110.306 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.467 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.58 174.79 30.63 Favored Glycine 0 CA--C 1.529 0.946 0 O-C-N 124.45 1.094 . . . . 0.0 110.978 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 35.1 mtp -83.75 131.36 34.92 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.436 0.727 . . . . 0.0 110.978 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.516 HD13 HD13 ' A' ' 159' ' ' LEU . 3.7 pt -138.74 160.84 61.51 Favored Pre-proline 0 C--N 1.326 -0.429 0 O-C-N 124.442 1.089 . . . . 0.0 109.271 179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.67 ' HG2' ' CB ' ' A' ' 186' ' ' TYR . 18.1 Cg_endo -75.08 138.3 22.66 Favored 'Trans proline' 0 C--N 1.36 1.149 0 O-C-N 124.629 1.858 . . . . 0.0 110.98 -179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 50.7 t -79.27 -30.9 0.67 Allowed Pre-proline 0 C--N 1.325 -0.488 0 O-C-N 124.493 1.12 . . . . 0.0 109.257 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.0 -14.03 21.25 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.484 1.781 . . . . 0.0 110.954 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.67 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -96.86 9.61 41.37 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.445 1.091 . . . . 0.0 110.977 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.557 ' HB ' HG23 ' A' ' 137' ' ' VAL . 29.2 m -137.74 172.13 14.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 O-C-N 124.498 1.124 . . . . 0.0 109.341 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.56 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.9 OUTLIER -124.9 159.29 31.48 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.492 1.12 . . . . 0.0 110.239 -179.948 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.91 112.62 23.52 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.559 1.162 . . . . 0.0 109.29 -179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.425 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.8 OUTLIER -138.15 103.12 4.85 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.482 1.114 . . . . 0.0 111.03 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.425 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.53 0.98 0 O-C-N 124.505 1.128 . . . . 0.0 111.028 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 52.2 t . . . . . 0 N--CA 1.453 -0.319 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 130.31 -49.23 0.93 Allowed Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.496 1.122 . . . . 0.0 111.024 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 160' ' ' ARG . 25.0 m-85 -88.0 157.88 18.79 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.462 0.743 . . . . 0.0 111.02 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.994 HG22 ' O ' ' A' ' 159' ' ' LEU . 1.5 m -117.03 165.9 11.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 O-C-N 124.54 1.15 . . . . 0.0 109.285 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.616 ' HD3' HD11 ' A' ' 158' ' ' ILE . 0.7 OUTLIER -134.73 118.17 16.81 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.424 1.078 . . . . 0.0 110.247 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.558 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.6 115.23 23.16 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.476 1.11 . . . . 0.0 109.284 -180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -94.27 41.19 1.09 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.561 1.163 . . . . 0.0 109.361 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.427 ' HD2' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.9 130.42 0.11 Allowed 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.47 1.106 . . . . 0.0 110.934 179.999 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.49 129.08 38.77 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.516 1.135 . . . . 0.0 109.31 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . . . . . . . . . 75.5 t80 -131.89 156.3 46.35 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.547 1.154 . . . . 0.0 111.032 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 176.01 141.77 0.06 Allowed 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.528 1.143 . . . . 0.0 109.29 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 83.03 115.37 0.54 Allowed Glycine 0 CA--C 1.531 1.049 0 O-C-N 124.513 1.133 . . . . 0.0 110.993 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -171.67 -46.08 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.497 0.763 . . . . 0.0 109.338 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -159.31 165.44 33.4 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.58 1.175 . . . . 0.0 109.324 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -83.93 38.02 0.63 Allowed 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.467 1.104 . . . . 0.0 110.307 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -160.52 39.85 0.17 Allowed 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.462 1.102 . . . . 0.0 110.299 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -128.76 160.7 31.71 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.504 1.127 . . . . 0.0 109.315 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.784 ' C ' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -105.65 152.32 40.05 Favored Pre-proline 0 C--N 1.326 -0.445 0 O-C-N 124.517 1.136 . . . . 0.0 109.28 -179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.453 ' CG ' ' HE3' ' A' ' 178' ' ' LYS . 18.2 Cg_endo -75.03 138.89 23.55 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.457 1.767 . . . . 0.0 110.962 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.751 ' CE1' HD23 ' A' ' 159' ' ' LEU . 0.2 OUTLIER -109.11 -163.53 0.88 Allowed 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.468 1.105 . . . . 0.0 110.959 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.577 ' HG3' ' N ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -177.44 147.37 0.52 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.415 1.072 . . . . 0.0 109.353 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.577 ' N ' ' HG3' ' A' ' 154' ' ' LYS . 0.0 OUTLIER -50.34 111.69 0.57 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.527 1.142 . . . . 0.0 109.338 -179.995 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.558 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 72.66 47.08 28.41 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 124.496 1.123 . . . . 0.0 111.055 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 0.4 OUTLIER -88.96 171.66 9.71 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.576 0.809 . . . . 0.0 109.316 -179.961 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.968 ' O ' HD22 ' A' ' 159' ' ' LEU . 39.6 mm -117.74 124.07 72.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 O-C-N 124.513 1.133 . . . . 0.0 109.304 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.994 ' O ' HG22 ' A' ' 137' ' ' VAL . 4.0 mm? -136.64 121.68 18.95 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.537 1.148 . . . . 0.0 109.299 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.608 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 3.9 ptm180 -92.81 141.43 28.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.522 1.139 . . . . 0.0 110.275 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 75.4 mt -85.25 125.71 40.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.493 1.121 . . . . 0.0 109.309 -179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -118.93 -35.77 3.58 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.533 1.146 . . . . 0.0 110.295 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -149.93 160.96 43.19 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.503 1.127 . . . . 0.0 109.313 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.582 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -150.44 58.44 3.05 Favored Pre-proline 0 C--N 1.324 -0.508 0 O-C-N 124.54 1.15 . . . . 0.0 109.314 -179.993 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.537 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -74.99 19.64 0.48 Allowed 'Trans proline' 0 C--N 1.359 1.107 0 O-C-N 124.564 1.823 . . . . 0.0 110.997 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.487 ' H ' ' C ' ' A' ' 164' ' ' LYS . 21.5 mm-40 -145.15 -177.83 5.74 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.133 . . . . 0.0 110.278 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.498 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.0 OUTLIER -116.15 139.59 50.16 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.549 1.155 . . . . 0.0 110.295 -179.987 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.498 ' CB ' ' O ' ' A' ' 167' ' ' GLU . 1.1 mt-30 85.49 -56.97 0.08 Allowed 'General case' 0 C--N 1.324 -0.524 0 O-C-N 124.481 1.113 . . . . 0.0 110.341 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.428 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 10.8 m95 -110.47 141.77 43.14 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.694 ' CZ2' HG21 ' A' ' 184' ' ' VAL . 7.4 m0 -129.58 163.91 24.97 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.463 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 6.1 m-20 -85.26 113.68 21.79 Favored 'General case' 0 C--N 1.324 -0.504 0 O-C-N 124.445 1.09 . . . . 0.0 109.291 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.608 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -122.03 157.49 31.25 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.534 1.146 . . . . 0.0 109.288 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.466 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 26.8 tt0 -104.3 114.25 28.35 Favored 'General case' 0 C--N 1.324 -0.52 0 O-C-N 124.629 1.206 . . . . 0.0 110.321 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.73 ' OD2' HD21 ' A' ' 159' ' ' LEU . 4.3 t70 -64.93 170.59 4.17 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.464 1.103 . . . . 0.0 109.341 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 31.0 t -77.19 28.79 0.14 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.01 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.516 ' H ' ' C ' ' A' ' 174' ' ' ASP . 5.6 mt-10 -134.24 -4.72 2.69 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.43 1.081 . . . . 0.0 110.305 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.3 -6.76 68.75 Favored Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.53 1.144 . . . . 0.0 110.95 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.453 ' HE3' ' CG ' ' A' ' 152' ' ' PRO . 12.7 mtmm -74.04 113.7 11.52 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.52 0.776 . . . . 0.0 109.327 -179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -100.07 117.12 33.67 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.505 1.128 . . . . 0.0 110.315 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.46 -171.82 20.38 Favored Glycine 0 CA--C 1.53 1.016 0 O-C-N 124.494 1.121 . . . . 0.0 111.004 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.461 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 2.6 tpp -84.94 141.36 30.42 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.484 0.755 . . . . 0.0 110.999 179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.801 HD13 HG11 ' A' ' 187' ' ' VAL . 1.4 pp -137.71 147.72 58.24 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.52 1.138 . . . . 0.0 109.237 -179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.705 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 141.26 26.26 Favored 'Trans proline' 0 C--N 1.36 1.182 0 O-C-N 124.492 1.785 . . . . 0.0 111.004 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.805 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 58.2 t -82.91 -32.34 0.55 Allowed Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.469 1.106 . . . . 0.0 109.246 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.805 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.99 -50.01 0.14 Allowed 'Trans proline' 0 C--N 1.36 1.17 0 O-C-N 124.578 1.83 . . . . 0.0 110.992 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.605 ' HB2' ' HB2' ' A' ' 183' ' ' PRO . 0.3 OUTLIER -59.76 -37.99 80.56 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.542 1.151 . . . . 0.0 110.982 -179.957 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.801 HG11 HD13 ' A' ' 182' ' ' ILE . 4.2 m -88.27 173.41 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 O-C-N 124.474 1.109 . . . . 0.0 109.338 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.2 OUTLIER -139.34 174.04 10.92 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.468 1.105 . . . . 0.0 110.292 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mttm -88.5 121.06 30.47 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.512 1.133 . . . . 0.0 109.294 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.421 ' CG ' ' HG3' ' A' ' 138' ' ' ARG . 53.6 t80 -144.71 121.01 10.9 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.413 1.071 . . . . 0.0 111.004 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.107 . . . . 0.0 110.982 179.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.423 ' O ' ' O ' ' A' ' 135' ' ' GLY . 1.2 m . . . . . 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.479 ' N ' ' C ' ' A' ' 191' ' ' GLY . . . -58.03 -150.0 0.01 OUTLIER Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.565 1.165 . . . . 0.0 111.041 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 20.0 m-85 -109.25 -151.87 0.48 Allowed 'General case' 0 C--N 1.326 -0.451 0 O-C-N 124.579 0.811 . . . . 0.0 110.994 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 187' ' ' VAL . 3.3 m -110.45 170.16 3.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 O-C-N 124.499 1.124 . . . . 0.0 109.299 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.526 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.77 133.58 27.23 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 124.488 1.117 . . . . 0.0 110.271 -179.991 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.526 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -85.29 128.24 34.62 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.429 1.081 . . . . 0.0 109.342 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.426 HD11 ' OE1' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -109.74 37.13 2.74 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.576 1.172 . . . . 0.0 109.278 179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.603 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -173.96 131.43 0.41 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.526 1.141 . . . . 0.0 110.952 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -74.18 151.54 39.99 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.521 1.138 . . . . 0.0 109.279 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.572 ' HB3' ' CD2' ' A' ' 153' ' ' PHE . 7.6 t80 -152.7 136.51 16.22 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.507 1.129 . . . . 0.0 110.955 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 41.9 t30 -117.67 -61.82 1.64 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.145 . . . . 0.0 109.267 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 47.36 -145.31 4.79 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.51 1.131 . . . . 0.0 111.023 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 6.4 t30 177.72 47.99 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.541 0.789 . . . . 0.0 109.295 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -86.76 128.81 35.04 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.471 1.107 . . . . 0.0 109.3 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.5 47.72 0.97 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.449 1.093 . . . . 0.0 110.319 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -165.96 -39.02 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.502 1.126 . . . . 0.0 110.258 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -95.3 158.59 15.39 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.428 1.08 . . . . 0.0 109.259 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.489 ' O ' ' CE1' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -111.64 142.38 26.48 Favored Pre-proline 0 C--N 1.325 -0.48 0 O-C-N 124.533 1.145 . . . . 0.0 109.24 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.03 149.26 36.31 Favored 'Trans proline' 0 C--N 1.361 1.222 0 O-C-N 124.474 1.776 . . . . 0.0 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.601 ' CE1' ' HD3' ' A' ' 183' ' ' PRO . 0.0 OUTLIER -123.41 -179.19 4.23 Favored 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.457 1.098 . . . . 0.0 110.992 -179.974 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.37 164.21 20.12 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.502 1.126 . . . . 0.0 109.288 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.06 129.37 37.93 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.518 1.136 . . . . 0.0 109.325 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 57.34 48.47 80.26 Favored Glycine 0 CA--C 1.529 0.954 0 O-C-N 124.383 1.052 . . . . 0.0 110.977 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -107.14 169.7 8.4 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.455 0.738 . . . . 0.0 109.29 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.429 HG13 ' CD ' ' A' ' 138' ' ' ARG . 1.7 mt -105.42 145.34 13.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 O-C-N 124.397 1.061 . . . . 0.0 109.385 179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.839 HD13 HG21 ' A' ' 182' ' ' ILE . 2.8 mt -144.56 123.71 12.91 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.499 1.125 . . . . 0.0 109.381 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.579 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.1 OUTLIER -91.77 128.7 37.7 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.406 1.066 . . . . 0.0 110.281 -179.966 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -82.89 128.84 38.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.45 1.093 . . . . 0.0 109.305 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 28.1 ttt180 -119.99 -49.12 2.32 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.576 1.172 . . . . 0.0 110.256 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 12.5 t0 -135.8 149.84 49.24 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.511 1.132 . . . . 0.0 109.27 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -156.58 63.78 3.32 Favored Pre-proline 0 C--N 1.325 -0.49 0 O-C-N 124.521 1.138 . . . . 0.0 109.269 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.429 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.0 15.4 0.74 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.443 1.76 . . . . 0.0 110.995 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.508 ' CG ' ' O ' ' A' ' 169' ' ' TRP . 9.3 pt-20 -144.71 -178.93 6.26 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.469 1.106 . . . . 0.0 110.333 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -122.52 72.75 1.08 Allowed 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.558 1.161 . . . . 0.0 110.319 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 171.73 -67.83 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.556 1.16 . . . . 0.0 110.281 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.508 ' O ' ' CG ' ' A' ' 166' ' ' GLU . 39.6 m95 -108.58 122.21 46.61 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.514 1.134 . . . . 0.0 108.047 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.576 ' CD1' ' HB2' ' A' ' 164' ' ' LYS . 48.8 m0 -118.08 154.75 31.54 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 107.953 -1.128 . . . . 0.0 107.953 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.452 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 52.2 t-20 -85.6 99.15 11.08 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.506 1.129 . . . . 0.0 109.314 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -115.05 154.21 29.27 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.445 1.09 . . . . 0.0 109.296 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.408 ' OE2' ' O ' ' A' ' 174' ' ' ASP . 1.7 tm-20 -98.3 110.03 22.68 Favored 'General case' 0 C--N 1.324 -0.514 0 O-C-N 124.509 1.131 . . . . 0.0 110.332 179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.565 ' HA ' HD23 ' A' ' 159' ' ' LEU . 0.5 OUTLIER -55.75 174.88 0.1 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.494 1.121 . . . . 0.0 109.343 179.999 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.0 p -80.95 29.99 0.33 Allowed 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.505 1.128 . . . . 0.0 109.999 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 174' ' ' ASP . 27.1 mt-10 -132.41 -6.78 3.33 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.502 1.126 . . . . 0.0 110.322 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.2 -2.72 63.65 Favored Glycine 0 CA--C 1.53 1.015 0 O-C-N 124.519 1.137 . . . . 0.0 110.987 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.411 ' CD ' ' HB2' ' A' ' 176' ' ' GLU . 0.3 OUTLIER -82.16 115.72 21.4 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.571 0.807 . . . . 0.0 109.272 179.989 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 8.4 mtm-85 -97.7 117.83 32.86 Favored 'General case' 0 C--N 1.326 -0.434 0 O-C-N 124.487 1.117 . . . . 0.0 110.359 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.452 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.9 -172.18 21.01 Favored Glycine 0 CA--C 1.53 0.982 0 O-C-N 124.558 1.161 . . . . 0.0 111.023 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.402 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 18.1 mtt -84.68 129.84 34.78 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.498 0.763 . . . . 0.0 111.013 -179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.839 HG21 HD13 ' A' ' 159' ' ' LEU . 3.4 mt -129.27 144.67 53.67 Favored Pre-proline 0 C--N 1.325 -0.467 0 O-C-N 124.475 1.109 . . . . 0.0 109.321 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.817 ' HD2' HG23 ' A' ' 182' ' ' ILE . 18.4 Cg_endo -74.88 132.02 15.1 Favored 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.529 1.805 . . . . 0.0 111.034 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.866 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.0 t -77.46 -28.24 0.62 Allowed Pre-proline 0 C--N 1.325 -0.471 0 O-C-N 124.486 1.116 . . . . 0.0 109.303 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.866 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.7 Cg_endo -74.97 -24.72 12.61 Favored 'Trans proline' 0 C--N 1.359 1.121 0 O-C-N 124.511 1.795 . . . . 0.0 111.045 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.606 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.1 OUTLIER -80.12 -41.0 26.3 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.525 1.141 . . . . 0.0 111.052 179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.742 HG21 HG21 ' A' ' 137' ' ' VAL . 15.3 m -89.33 -178.31 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.5 1.125 . . . . 0.0 109.279 179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.574 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 23.1 pt-20 -133.93 158.55 43.19 Favored 'General case' 0 C--N 1.326 -0.438 0 O-C-N 124.584 1.178 . . . . 0.0 110.283 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.46 112.66 22.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.484 1.115 . . . . 0.0 109.257 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -119.65 95.62 4.85 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.485 1.116 . . . . 0.0 110.992 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.479 ' C ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.037 0 O-C-N 124.567 1.167 . . . . 0.0 111.002 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 30.1 p . . . . . 0 N--CA 1.452 -0.334 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 109.48 -45.44 1.32 Allowed Glycine 0 CA--C 1.53 1.024 0 O-C-N 124.55 1.156 . . . . 0.0 110.963 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 54.2 m-85 -88.57 151.61 22.38 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.5 0.765 . . . . 0.0 110.942 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.723 HG22 ' O ' ' A' ' 159' ' ' LEU . 6.2 m -129.62 172.29 15.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.278 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.425 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 4.6 mtt180 -145.68 136.65 24.59 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.529 1.143 . . . . 0.0 110.266 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.467 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.69 115.26 24.02 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.535 1.147 . . . . 0.0 109.298 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.848 HD11 ' HB2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -103.26 43.67 1.06 Allowed 'General case' 0 C--N 1.325 -0.457 0 O-C-N 124.492 1.12 . . . . 0.0 109.201 -179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.587 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 5.8 m-85 -174.52 121.36 0.26 Allowed 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.49 1.119 . . . . 0.0 110.961 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.32 111.78 15.91 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.476 1.11 . . . . 0.0 109.306 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.594 ' CD2' ' O ' ' A' ' 145' ' ' GLY . 8.0 t80 -77.65 165.29 24.44 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.499 1.124 . . . . 0.0 111.035 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -103.45 -79.94 0.53 Allowed 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.504 1.128 . . . . 0.0 109.306 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.594 ' O ' ' CD2' ' A' ' 143' ' ' PHE . . . -66.79 -172.84 5.33 Favored Glycine 0 CA--C 1.53 0.972 0 O-C-N 124.481 1.113 . . . . 0.0 111.013 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.455 ' N ' ' OD1' ' A' ' 146' ' ' ASN . 4.9 p-10 164.47 88.68 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 0.762 . . . . 0.0 109.293 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.416 ' C ' ' H ' ' A' ' 149' ' ' GLU . 0.3 OUTLIER -40.82 160.93 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.516 1.135 . . . . 0.0 109.333 179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 12.5 mm-40 -76.88 44.58 0.39 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.542 1.151 . . . . 0.0 110.307 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 147' ' ' ASP . 6.7 pt-20 -140.7 -36.82 0.46 Allowed 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.602 1.189 . . . . 0.0 110.29 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.417 ' CG ' ' N ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -97.48 163.9 12.67 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.465 1.103 . . . . 0.0 109.227 -179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.953 HD11 ' OD2' ' A' ' 174' ' ' ASP . 0.0 OUTLIER -98.14 136.48 20.98 Favored Pre-proline 0 C--N 1.326 -0.452 0 O-C-N 124.477 1.11 . . . . 0.0 109.353 179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.475 ' HD2' HD12 ' A' ' 151' ' ' LEU . 18.2 Cg_endo -75.06 141.86 26.97 Favored 'Trans proline' 0 C--N 1.359 1.089 0 O-C-N 124.565 1.823 . . . . 0.0 110.954 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.579 ' CE1' ' O ' ' A' ' 151' ' ' LEU . 0.0 OUTLIER -120.46 179.48 4.3 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.509 1.131 . . . . 0.0 110.98 -179.981 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 3.8 ptpt -146.68 158.99 44.02 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.514 1.134 . . . . 0.0 109.351 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.88 117.31 3.83 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.508 1.13 . . . . 0.0 109.275 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.466 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 76.74 40.4 26.56 Favored Glycine 0 CA--C 1.53 0.983 0 O-C-N 124.493 1.12 . . . . 0.0 110.997 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.479 ' OD2' ' CD2' ' A' ' 159' ' ' LEU . 38.1 t70 -95.6 158.32 15.51 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.419 0.717 . . . . 0.0 109.319 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 1.03 ' O ' HD22 ' A' ' 159' ' ' LEU . 2.4 mm -98.16 141.95 15.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 1.03 HD22 ' O ' ' A' ' 158' ' ' ILE . 1.1 mm? -149.97 118.27 6.42 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.524 1.14 . . . . 0.0 109.306 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.54 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 38.6 ttt180 -94.71 113.14 24.88 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.477 1.111 . . . . 0.0 110.285 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 170' ' ' TRP . 0.6 OUTLIER -81.3 129.84 36.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 O-C-N 124.536 1.148 . . . . 0.0 109.294 179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.451 ' HG3' ' N ' ' A' ' 163' ' ' ASP . 8.7 ptm180 -124.82 -41.25 2.13 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.479 1.112 . . . . 0.0 110.339 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.462 ' O ' ' HB3' ' A' ' 170' ' ' TRP . 0.7 OUTLIER -125.08 133.28 52.96 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.479 1.112 . . . . 0.0 109.269 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.497 ' HB3' ' CE2' ' A' ' 170' ' ' TRP . 19.4 mtmt -129.04 71.58 81.97 Favored Pre-proline 0 C--N 1.324 -0.504 0 O-C-N 124.509 1.131 . . . . 0.0 109.285 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.95 -76.35 0.01 OUTLIER 'Trans proline' 0 C--N 1.359 1.112 0 O-C-N 124.443 1.759 . . . . 0.0 111.005 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 169' ' ' TRP . 0.8 OUTLIER -51.92 179.06 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.477 1.111 . . . . 0.0 110.341 179.932 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.8 pt-20 -116.68 30.67 7.2 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.515 1.134 . . . . 0.0 110.299 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -155.03 -43.35 0.08 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.496 1.123 . . . . 0.0 110.262 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.42 ' O ' ' HB2' ' A' ' 166' ' ' GLU . 11.8 m95 -121.55 134.23 55.03 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.661 ' HB2' HD11 ' A' ' 161' ' ' ILE . 42.9 m0 -126.02 159.01 33.88 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.427 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 14.3 m120 -87.65 117.33 26.39 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.512 1.133 . . . . 0.0 109.3 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.54 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -128.63 149.01 50.83 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.463 1.102 . . . . 0.0 109.263 -179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' A' ' 160' ' ' ARG . 29.1 tt0 -94.36 112.58 24.38 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.414 1.072 . . . . 0.0 110.315 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.953 ' OD2' HD11 ' A' ' 151' ' ' LEU . 3.7 t0 -62.73 169.66 3.01 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.417 1.073 . . . . 0.0 109.294 -179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -75.79 30.19 0.11 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.466 1.104 . . . . 0.0 110.022 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.532 ' H ' ' C ' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -131.53 -7.28 3.69 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.517 1.136 . . . . 0.0 110.364 -179.979 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.15 -4.07 67.23 Favored Glycine 0 CA--C 1.531 1.037 0 O-C-N 124.577 1.173 . . . . 0.0 111.006 179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.512 ' HD2' ' CD1' ' A' ' 151' ' ' LEU . 2.0 ptpp? -84.43 117.07 23.41 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.526 0.78 . . . . 0.0 109.33 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.443 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 0.7 OUTLIER -98.72 122.29 41.76 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.393 1.058 . . . . 0.0 110.272 -179.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.23 -177.12 25.59 Favored Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.518 1.136 . . . . 0.0 111.017 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.428 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -85.51 137.28 33.0 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.509 0.77 . . . . 0.0 111.029 179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.731 HD13 ' HG ' ' A' ' 159' ' ' LEU . 25.6 pt -137.03 158.8 72.09 Favored Pre-proline 0 C--N 1.326 -0.454 0 O-C-N 124.499 1.124 . . . . 0.0 109.255 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.674 ' O ' HG13 ' A' ' 187' ' ' VAL . 18.2 Cg_endo -75.06 140.49 25.34 Favored 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.543 1.812 . . . . 0.0 110.99 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.823 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 69.0 t -82.36 -31.07 0.53 Allowed Pre-proline 0 C--N 1.326 -0.441 0 O-C-N 124.425 1.078 . . . . 0.0 109.355 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.823 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.1 Cg_endo -75.08 -49.57 0.15 Allowed 'Trans proline' 0 C--N 1.362 1.243 0 O-C-N 124.464 1.77 . . . . 0.0 110.978 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.587 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -59.93 -27.91 67.17 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.447 1.092 . . . . 0.0 110.97 179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 182' ' ' ILE . 5.3 m -95.19 175.61 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 O-C-N 124.441 1.088 . . . . 0.0 109.331 179.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.848 ' HB2' HD11 ' A' ' 140' ' ' LEU . 3.3 tt0 -140.95 161.16 38.48 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.514 1.134 . . . . 0.0 110.295 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -88.13 112.51 22.79 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.524 1.14 . . . . 0.0 109.266 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -135.32 80.77 1.85 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.51 1.131 . . . . 0.0 110.998 179.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.995 0 O-C-N 124.537 1.148 . . . . 0.0 110.993 179.981 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.439 ' N ' ' O ' ' A' ' 190' ' ' TYR . 1.8 t . . . . . 0 N--CA 1.453 -0.296 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -171.39 -99.27 0.12 Allowed Glycine 0 CA--C 1.53 0.99 0 O-C-N 124.481 1.113 . . . . 0.0 111.017 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 2.4 m-85 -88.54 -178.75 5.91 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.53 0.782 . . . . 0.0 110.95 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.62 HG22 ' O ' ' A' ' 159' ' ' LEU . 27.2 m -112.34 163.42 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 O-C-N 124.489 1.118 . . . . 0.0 109.302 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.541 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.6 OUTLIER -129.01 122.8 30.83 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.506 1.129 . . . . 0.0 110.236 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.992 ' HB3' ' OD1' ' A' ' 157' ' ' ASP . . . -85.99 121.88 29.23 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.522 1.139 . . . . 0.0 109.376 179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.502 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -109.37 48.08 0.89 Allowed 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.494 1.121 . . . . 0.0 109.268 -179.946 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.604 ' HB2' ' CD2' ' A' ' 186' ' ' TYR . 90.4 m-85 -161.46 120.13 2.42 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.498 1.124 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . 0.409 ' CG ' ' HB2' ' A' ' 155' ' ' LYS . 0.1 OUTLIER -69.71 125.64 27.34 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.523 1.139 . . . . 0.0 109.267 -179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 153' ' ' PHE . 14.2 t80 -163.56 158.11 20.33 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.481 1.113 . . . . 0.0 110.961 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.554 ' N ' ' CD1' ' A' ' 143' ' ' PHE . 5.9 p30 -143.36 164.67 29.63 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.508 1.13 . . . . 0.0 109.262 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -138.16 -103.43 0.61 Allowed Glycine 0 CA--C 1.53 1.014 0 O-C-N 124.564 1.165 . . . . 0.0 111.036 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.402 ' O ' ' O ' ' A' ' 147' ' ' ASP . 9.5 p-10 -178.32 37.22 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.481 0.753 . . . . 0.0 109.341 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.402 ' O ' ' O ' ' A' ' 146' ' ' ASN . 5.4 m-20 54.44 170.61 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.531 1.144 . . . . 0.0 109.306 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 69.94 -60.94 0.47 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.459 1.099 . . . . 0.0 110.306 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -88.47 -21.66 24.08 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 124.497 1.123 . . . . 0.0 110.33 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.419 ' OD1' ' HB3' ' A' ' 181' ' ' MET . 0.1 OUTLIER 179.8 149.35 0.31 Allowed 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.568 1.167 . . . . 0.0 109.265 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.2 OUTLIER -102.15 141.95 23.58 Favored Pre-proline 0 C--N 1.325 -0.499 0 O-C-N 124.475 1.109 . . . . 0.0 109.279 179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.0 Cg_endo -75.14 122.42 7.12 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.465 1.771 . . . . 0.0 110.949 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 143' ' ' PHE . 5.5 p90 -129.15 173.76 10.18 Favored 'General case' 0 C--N 1.327 -0.413 0 O-C-N 124.463 1.102 . . . . 0.0 110.994 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.445 ' O ' ' OD1' ' A' ' 157' ' ' ASP . 0.0 OUTLIER -119.06 161.5 20.16 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.5 1.125 . . . . 0.0 109.261 -179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.443 ' HG2' ' C ' ' A' ' 140' ' ' LEU . 0.2 OUTLIER -59.21 131.46 51.07 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.455 1.097 . . . . 0.0 109.367 179.954 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.44 ' N ' ' HD2' ' A' ' 155' ' ' LYS . . . 79.44 31.83 40.15 Favored Glycine 0 CA--C 1.531 1.078 0 O-C-N 124.534 1.146 . . . . 0.0 110.935 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.992 ' OD1' ' HB3' ' A' ' 139' ' ' ALA . 9.6 p-10 -90.04 162.52 15.31 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 124.554 0.796 . . . . 0.0 109.233 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.479 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 11.5 mt -117.99 132.51 67.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 O-C-N 124.427 1.08 . . . . 0.0 109.277 179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.811 HD23 ' HA ' ' A' ' 174' ' ' ASP . 1.3 mt -143.92 129.96 19.57 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.521 1.138 . . . . 0.0 109.235 -179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.612 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -90.13 146.65 24.13 Favored 'General case' 0 C--N 1.324 -0.518 0 O-C-N 124.479 1.112 . . . . 0.0 110.305 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.428 HD11 HG11 ' A' ' 137' ' ' VAL . 90.5 mt -88.58 121.41 38.79 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.529 1.143 . . . . 0.0 109.289 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . 0.454 ' NH2' ' OD2' ' A' ' 163' ' ' ASP . 0.2 OUTLIER -117.32 -33.89 4.49 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.479 1.112 . . . . 0.0 110.271 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.454 ' OD2' ' NH2' ' A' ' 162' ' ' ARG . 5.0 m-20 -142.56 153.74 43.82 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.461 1.101 . . . . 0.0 109.369 179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.604 ' HB2' ' CD1' ' A' ' 170' ' ' TRP . 0.8 OUTLIER -155.48 57.51 1.61 Allowed Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 124.501 1.126 . . . . 0.0 109.296 -179.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.55 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.3 Cg_endo -75.01 40.16 0.64 Allowed 'Trans proline' 0 C--N 1.361 1.204 0 O-C-N 124.478 1.778 . . . . 0.0 110.976 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.455 ' H ' ' C ' ' A' ' 164' ' ' LYS . 36.6 mt-10 -157.9 -177.7 6.77 Favored 'General case' 0 C--N 1.325 -0.469 0 O-C-N 124.558 1.161 . . . . 0.0 110.225 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -122.21 51.6 1.35 Allowed 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.526 1.141 . . . . 0.0 110.309 179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 176.14 -62.88 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.441 1.088 . . . . 0.0 110.318 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.467 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 42.5 m95 -98.5 131.69 44.54 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -179.968 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.629 ' CH2' HG21 ' A' ' 184' ' ' VAL . 23.0 m0 -125.77 156.41 39.49 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.552 1.157 . . . . 0.0 107.955 179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.468 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -87.05 109.62 19.53 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.442 1.089 . . . . 0.0 109.248 -179.924 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.612 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -110.48 150.87 28.25 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.508 1.13 . . . . 0.0 109.318 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.492 ' HB3' ' CD ' ' A' ' 160' ' ' ARG . 0.2 OUTLIER -106.21 110.22 22.4 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.456 1.098 . . . . 0.0 110.285 -179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.811 ' HA ' HD23 ' A' ' 159' ' ' LEU . 24.3 t70 -57.29 172.72 0.29 Allowed 'General case' 0 C--N 1.324 -0.512 0 O-C-N 124.471 1.107 . . . . 0.0 109.299 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.54 27.6 0.27 Allowed 'General case' 0 C--N 1.326 -0.417 0 O-C-N 124.429 1.081 . . . . 0.0 110.044 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.464 ' H ' ' C ' ' A' ' 174' ' ' ASP . 39.1 mt-10 -135.51 -1.49 2.54 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.564 1.165 . . . . 0.0 110.284 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 95.56 -6.44 67.87 Favored Glycine 0 CA--C 1.53 1.029 0 O-C-N 124.488 1.118 . . . . 0.0 111.009 -179.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 10.6 mmtm -70.96 107.67 4.18 Favored 'General case' 0 C--N 1.326 -0.437 0 O-C-N 124.516 0.774 . . . . 0.0 109.28 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.487 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -101.27 119.92 39.48 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.514 1.134 . . . . 0.0 110.315 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.468 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.96 -179.5 27.65 Favored Glycine 0 CA--C 1.53 1.005 0 O-C-N 124.466 1.104 . . . . 0.0 110.984 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.611 ' O ' HD13 ' A' ' 182' ' ' ILE . 3.9 tpp -84.6 138.09 32.92 Favored 'General case' 0 C--N 1.324 -0.53 0 O-C-N 124.561 0.8 . . . . 0.0 110.998 179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.611 HD13 ' O ' ' A' ' 181' ' ' MET . 20.9 mm -141.17 143.08 29.51 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 124.501 1.126 . . . . 0.0 109.321 179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.666 ' HG2' ' HB2' ' A' ' 186' ' ' TYR . 18.2 Cg_endo -75.04 136.96 21.01 Favored 'Trans proline' 0 C--N 1.359 1.109 0 O-C-N 124.546 1.814 . . . . 0.0 110.989 -179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.826 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 71.6 t -75.23 -31.32 1.08 Allowed Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 124.49 1.119 . . . . 0.0 109.337 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.826 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -4.21 15.06 Favored 'Trans proline' 0 C--N 1.361 1.194 0 O-C-N 124.527 1.804 . . . . 0.0 111.001 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.666 ' HB2' ' HG2' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -101.65 -45.26 5.31 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.501 1.126 . . . . 0.0 111.003 -179.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.674 HG12 ' HB2' ' A' ' 139' ' ' ALA . 34.9 m -86.39 174.16 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 O-C-N 124.563 1.165 . . . . 0.0 109.383 179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.539 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 5.7 tt0 -132.35 173.8 10.9 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.569 1.168 . . . . 0.0 110.31 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.56 103.64 15.74 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 124.487 1.117 . . . . 0.0 109.277 179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.439 ' O ' ' N ' ' A' ' 134' ' ' CYS . 88.8 t80 -77.03 107.93 9.73 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.425 1.078 . . . . 0.0 111.017 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.997 0 O-C-N 124.546 1.154 . . . . 0.0 111.034 -179.961 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p . . . . . 0 N--CA 1.452 -0.336 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . -134.79 -57.5 0.07 OUTLIER Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.461 1.1 . . . . 0.0 110.999 -179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -92.64 -179.95 5.32 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.509 0.77 . . . . 0.0 111.046 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.651 HG22 ' O ' ' A' ' 159' ' ' LEU . 28.4 m -118.8 170.85 7.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.482 1.114 . . . . 0.0 109.258 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 11.8 mtm105 -145.85 136.08 23.84 Favored 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.489 1.118 . . . . 0.0 110.287 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.94 124.23 32.91 Favored 'General case' 0 C--N 1.324 -0.51 0 O-C-N 124.524 1.14 . . . . 0.0 109.294 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.554 HD21 ' HG2' ' A' ' 188' ' ' GLU . 0.6 OUTLIER -108.31 46.52 0.95 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.544 1.153 . . . . 0.0 109.254 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.586 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 11.2 m-85 -171.87 119.88 0.44 Allowed 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.538 1.149 . . . . 0.0 111.016 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -65.72 136.92 56.88 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.489 1.118 . . . . 0.0 109.344 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.463 ' HB2' ' CE1' ' A' ' 153' ' ' PHE . 10.5 t80 -151.25 100.25 2.74 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.436 1.085 . . . . 0.0 110.938 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.424 ' O ' ' C ' ' A' ' 145' ' ' GLY . 32.8 t-20 -70.08 -71.12 0.25 Allowed 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.509 1.13 . . . . 0.0 109.308 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 144' ' ' ASN . . . 35.8 -154.07 0.01 OUTLIER Glycine 0 CA--C 1.53 1.013 0 O-C-N 124.506 1.129 . . . . 0.0 111.008 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 172.57 39.16 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.495 0.762 . . . . 0.0 109.294 179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 150' ' ' ASP . 0.8 OUTLIER -91.4 101.59 14.27 Favored 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.506 1.129 . . . . 0.0 109.315 179.982 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -38.35 -39.15 0.42 Allowed 'General case' 0 C--N 1.325 -0.493 0 O-C-N 124.549 1.155 . . . . 0.0 110.262 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -42.15 -40.33 2.3 Favored 'General case' 0 C--N 1.324 -0.507 0 O-C-N 124.552 1.158 . . . . 0.0 110.286 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 147' ' ' ASP . 0.1 OUTLIER -137.72 142.2 41.02 Favored 'General case' 0 C--N 1.324 -0.516 0 O-C-N 124.506 1.129 . . . . 0.0 109.341 -179.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 152' ' ' PRO . 0.0 OUTLIER -78.12 145.01 68.34 Favored Pre-proline 0 C--N 1.325 -0.47 0 O-C-N 124.519 1.137 . . . . 0.0 109.304 179.967 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.1 Cg_endo -75.03 -179.6 5.15 Favored 'Trans proline' 0 C--N 1.36 1.16 0 O-C-N 124.488 1.783 . . . . 0.0 110.923 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' A' ' 143' ' ' PHE . 3.3 p90 -175.68 173.07 2.45 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 124.433 1.083 . . . . 0.0 110.997 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 157' ' ' ASP . 3.6 pttt -120.76 171.28 8.72 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.581 1.176 . . . . 0.0 109.299 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.84 116.73 5.08 Favored 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.476 1.11 . . . . 0.0 109.28 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 77.53 41.62 19.88 Favored Glycine 0 CA--C 1.53 1.019 0 O-C-N 124.519 1.137 . . . . 0.0 110.949 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 154' ' ' LYS . 9.7 t0 -86.72 159.13 19.26 Favored 'General case' 0 C--N 1.324 -0.511 0 O-C-N 124.521 0.777 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.423 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 0.5 OUTLIER -103.43 140.25 22.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 O-C-N 124.562 1.164 . . . . 0.0 109.334 179.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.886 HD23 ' HA ' ' A' ' 174' ' ' ASP . 17.5 mt -148.34 117.95 7.03 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.547 1.155 . . . . 0.0 109.339 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.607 ' O ' ' HA ' ' A' ' 172' ' ' ALA . 0.0 OUTLIER -87.14 137.62 32.19 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.586 1.179 . . . . 0.0 110.275 -179.953 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.45 HD11 ' HE3' ' A' ' 170' ' ' TRP . 0.3 OUTLIER -85.2 126.5 40.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 O-C-N 124.554 1.159 . . . . 0.0 109.363 179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 15.5 ttt-85 -122.63 -52.68 1.91 Allowed 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.599 1.187 . . . . 0.0 110.253 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -127.69 143.01 51.18 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 124.5 1.125 . . . . 0.0 109.285 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.54 ' HG3' ' CE2' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -139.53 59.82 15.03 Favored Pre-proline 0 C--N 1.326 -0.45 0 O-C-N 124.544 1.153 . . . . 0.0 109.285 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.511 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.5 Cg_endo -74.91 -55.37 0.08 OUTLIER 'Trans proline' 0 C--N 1.36 1.157 0 O-C-N 124.47 1.774 . . . . 0.0 111.053 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 -72.82 -178.45 2.73 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.497 1.123 . . . . 0.0 110.407 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 19.2 tt0 -110.3 136.52 49.35 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 124.5 1.125 . . . . 0.0 110.23 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.961 ' O ' HG13 ' A' ' 184' ' ' VAL . 2.2 mt-30 78.65 -51.9 0.47 Allowed 'General case' 0 C--N 1.325 -0.462 0 O-C-N 124.422 1.076 . . . . 0.0 110.305 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -98.97 117.35 33.28 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.548 1.155 . . . . 0.0 108.024 -179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.775 ' CE2' HG11 ' A' ' 184' ' ' VAL . 15.2 m0 -120.04 159.06 25.51 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.507 1.129 . . . . 0.0 107.989 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.484 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 2.1 t30 -85.51 108.45 17.93 Favored 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.546 1.154 . . . . 0.0 109.229 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -118.72 147.98 43.27 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 124.512 1.132 . . . . 0.0 109.331 179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.428 ' HG3' ' CG ' ' A' ' 179' ' ' ARG . 20.1 tt0 -95.26 105.96 17.95 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.414 1.071 . . . . 0.0 110.256 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.886 ' HA ' HD23 ' A' ' 159' ' ' LEU . 23.3 t0 -53.35 171.27 0.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.55 1.157 . . . . 0.0 109.362 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -77.55 29.89 0.15 Allowed 'General case' 0 C--N 1.325 -0.487 0 O-C-N 124.604 1.19 . . . . 0.0 109.964 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.496 ' H ' ' C ' ' A' ' 174' ' ' ASP . 46.1 mt-10 -135.66 -5.58 2.22 Favored 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.489 1.118 . . . . 0.0 110.351 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.92 64.2 Favored Glycine 0 CA--C 1.53 0.998 0 O-C-N 124.44 1.087 . . . . 0.0 110.998 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -77.55 110.86 12.7 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.487 0.757 . . . . 0.0 109.248 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.428 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 32.2 mtt85 -95.48 117.15 29.86 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 124.443 1.09 . . . . 0.0 110.29 179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.484 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.2 -174.67 23.04 Favored Glycine 0 CA--C 1.53 1.028 0 O-C-N 124.561 1.163 . . . . 0.0 111.03 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.476 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -84.89 130.71 34.61 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.558 0.799 . . . . 0.0 111.002 -179.976 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.648 ' C ' HD12 ' A' ' 182' ' ' ILE . 2.0 pp -125.78 148.95 64.13 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.565 1.166 . . . . 0.0 109.272 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.83 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.1 Cg_endo -75.01 133.16 16.23 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.506 1.793 . . . . 0.0 111.028 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.961 HG13 ' O ' ' A' ' 168' ' ' GLN . 27.7 m -76.92 -28.3 0.65 Allowed Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.503 1.127 . . . . 0.0 109.328 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.859 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.4 Cg_endo -74.9 -47.54 0.2 Allowed 'Trans proline' 0 C--N 1.36 1.15 0 O-C-N 124.474 1.776 . . . . 0.0 111.025 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.586 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.1 OUTLIER -65.5 -35.97 82.46 Favored 'General case' 0 C--N 1.324 -0.525 0 O-C-N 124.559 1.162 . . . . 0.0 110.968 -179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.83 HG22 ' O ' ' A' ' 183' ' ' PRO . 14.0 m -87.68 177.51 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 O-C-N 124.437 1.085 . . . . 0.0 109.326 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.59 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 0.3 OUTLIER -141.75 169.85 16.82 Favored 'General case' 0 C--N 1.326 -0.454 0 O-C-N 124.509 1.131 . . . . 0.0 110.412 179.924 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.58 93.49 9.44 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.546 1.154 . . . . 0.0 109.332 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 191' ' ' GLY . 20.4 t80 -72.03 132.9 44.89 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.56 1.163 . . . . 0.0 110.956 -179.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.506 ' C ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.53 1.02 0 O-C-N 124.46 1.1 . . . . 0.0 111.004 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.453 -0.309 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.455 ' N ' ' HA3' ' A' ' 191' ' ' GLY . . . 120.86 -42.45 1.71 Allowed Glycine 0 CA--C 1.53 1.007 0 O-C-N 124.522 1.139 . . . . 0.0 110.993 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.571 ' CD1' ' HB3' ' A' ' 160' ' ' ARG . 1.6 m-85 -86.11 163.82 17.65 Favored 'General case' 0 C--N 1.326 -0.456 0 O-C-N 124.481 0.754 . . . . 0.0 111.038 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 5.4 m -109.22 176.06 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 O-C-N 124.438 1.087 . . . . 0.0 109.341 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.471 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -141.51 129.17 21.53 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.504 1.127 . . . . 0.0 110.333 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.545 ' CA ' HG12 ' A' ' 187' ' ' VAL . . . -85.56 123.81 31.4 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 124.462 1.101 . . . . 0.0 109.24 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -105.07 31.62 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.45 1.094 . . . . 0.0 109.315 179.958 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.617 ' CB ' ' CE2' ' A' ' 186' ' ' TYR . 20.8 m-85 -163.42 125.15 2.45 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.493 1.121 . . . . 0.0 110.926 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -69.28 144.69 53.53 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.463 1.102 . . . . 0.0 109.299 179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 152' ' ' PRO . 0.5 OUTLIER -85.47 176.42 8.26 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 124.496 1.123 . . . . 0.0 110.999 179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 4.5 p30 -174.31 77.48 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.502 1.126 . . . . 0.0 109.289 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.41 ' C ' ' OD1' ' A' ' 146' ' ' ASN . . . 59.44 147.41 0.01 OUTLIER Glycine 0 CA--C 1.531 1.059 0 O-C-N 124.552 1.157 . . . . 0.0 110.981 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.41 ' OD1' ' C ' ' A' ' 145' ' ' GLY . 2.4 p-10 173.9 -53.97 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.513 0.772 . . . . 0.0 109.247 -179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.12 119.26 0.6 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.558 1.161 . . . . 0.0 109.231 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -42.21 -48.96 4.97 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.507 1.129 . . . . 0.0 110.288 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -40.71 -48.46 2.98 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.522 1.139 . . . . 0.0 110.267 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.616 ' OD1' ' CE3' ' A' ' 169' ' ' TRP . 0.3 OUTLIER -61.23 154.93 22.18 Favored 'General case' 0 C--N 1.326 -0.426 0 O-C-N 124.495 1.122 . . . . 0.0 109.274 -179.946 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.76 HD21 ' HG3' ' A' ' 178' ' ' LYS . 12.9 tp -100.38 136.32 20.03 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.533 1.146 . . . . 0.0 109.297 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.01 155.0 42.84 Favored 'Trans proline' 0 C--N 1.36 1.154 0 O-C-N 124.461 1.769 . . . . 0.0 110.954 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.479 ' CD2' ' O ' ' A' ' 151' ' ' LEU . 9.4 p90 -168.1 170.15 10.55 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.502 1.126 . . . . 0.0 111.007 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.74 157.64 21.97 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.471 1.107 . . . . 0.0 109.336 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . . . . . . . . . 1.1 tmpt? -51.88 127.19 20.33 Favored 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.495 1.122 . . . . 0.0 109.297 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.493 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 78.82 34.9 33.04 Favored Glycine 0 CA--C 1.53 1.009 0 O-C-N 124.55 1.156 . . . . 0.0 111.035 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -87.56 164.34 16.15 Favored 'General case' 0 C--N 1.325 -0.485 0 O-C-N 124.531 0.783 . . . . 0.0 109.266 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.473 ' C ' ' HG ' ' A' ' 159' ' ' LEU . 20.1 mt -118.18 131.54 70.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 O-C-N 124.56 1.163 . . . . 0.0 109.297 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.898 HD23 ' HA ' ' A' ' 174' ' ' ASP . 2.6 mt -145.33 135.05 23.47 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.494 1.121 . . . . 0.0 109.281 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.571 ' HB3' ' CD1' ' A' ' 136' ' ' TYR . 5.8 ptm180 -96.97 151.92 19.22 Favored 'General case' 0 C--N 1.326 -0.455 0 O-C-N 124.488 1.118 . . . . 0.0 110.3 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.442 HG21 ' CE ' ' A' ' 164' ' ' LYS . 93.5 mt -85.0 126.23 40.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 O-C-N 124.526 1.141 . . . . 0.0 109.288 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.04 -52.99 2.75 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.487 1.117 . . . . 0.0 110.307 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.455 ' C ' ' HD3' ' A' ' 165' ' ' PRO . 1.4 m-20 -145.4 140.02 27.35 Favored 'General case' 0 C--N 1.325 -0.491 0 O-C-N 124.496 1.122 . . . . 0.0 109.28 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 2.4 mtpt -128.51 66.51 74.25 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.543 1.152 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 163' ' ' ASP . 18.5 Cg_endo -74.99 15.36 0.74 Allowed 'Trans proline' 0 C--N 1.36 1.155 0 O-C-N 124.511 1.795 . . . . 0.0 111.043 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.447 ' H ' ' C ' ' A' ' 164' ' ' LYS . 49.4 mm-40 -144.21 178.9 7.57 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.504 1.128 . . . . 0.0 110.273 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 27.7 mm-40 -116.57 45.12 1.87 Allowed 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.453 1.096 . . . . 0.0 110.3 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.478 ' HB3' ' CD1' ' A' ' 169' ' ' TRP . 0.0 OUTLIER -172.81 -65.72 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.494 1.121 . . . . 0.0 110.214 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.616 ' CE3' ' OD1' ' A' ' 150' ' ' ASP . 3.3 m95 -100.97 125.8 47.58 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 108.007 -1.109 . . . . 0.0 108.007 -179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.622 ' CZ3' HG21 ' A' ' 184' ' ' VAL . 14.1 m0 -123.86 160.64 27.0 Favored 'General case' 0 C--N 1.325 -0.466 0 O-C-N 124.523 1.139 . . . . 0.0 107.95 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 1.7 m120 -85.74 99.78 11.57 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.505 1.128 . . . . 0.0 109.229 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.52 ' HA ' ' O ' ' A' ' 160' ' ' ARG . . . -102.7 151.32 22.52 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.117 . . . . 0.0 109.25 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.47 ' O ' ' CG ' ' A' ' 160' ' ' ARG . 7.6 tt0 -108.77 116.17 31.47 Favored 'General case' 0 C--N 1.326 -0.441 0 O-C-N 124.469 1.105 . . . . 0.0 110.342 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.898 ' HA ' HD23 ' A' ' 159' ' ' LEU . 39.2 t0 -65.93 177.9 1.22 Allowed 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.508 1.13 . . . . 0.0 109.261 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -83.34 30.53 0.47 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.589 1.181 . . . . 0.0 110.003 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.403 ' H ' ' C ' ' A' ' 174' ' ' ASP . 3.3 mm-40 -128.3 -9.3 5.25 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.539 1.149 . . . . 0.0 110.257 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.91 -2.31 61.76 Favored Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.515 1.134 . . . . 0.0 110.998 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . 0.76 ' HG3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.71 120.37 25.03 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.489 0.758 . . . . 0.0 109.32 -179.964 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.431 ' CG ' ' HG3' ' A' ' 173' ' ' GLU . 15.5 mtt180 -105.12 121.42 43.78 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.48 1.112 . . . . 0.0 110.276 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.41 -178.51 27.15 Favored Glycine 0 CA--C 1.53 0.986 0 O-C-N 124.47 1.106 . . . . 0.0 110.987 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.429 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mmm -82.59 138.62 34.17 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.464 0.744 . . . . 0.0 111.034 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.443 HD12 HD13 ' A' ' 159' ' ' LEU . 0.0 OUTLIER -142.99 145.27 32.45 Favored Pre-proline 0 C--N 1.324 -0.509 0 O-C-N 124.486 1.116 . . . . 0.0 109.344 -179.987 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.754 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.4 Cg_endo -75.04 136.82 20.82 Favored 'Trans proline' 0 C--N 1.36 1.171 0 O-C-N 124.471 1.774 . . . . 0.0 111.013 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.839 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 86.9 t -79.06 -30.88 0.68 Allowed Pre-proline 0 C--N 1.325 -0.486 0 O-C-N 124.468 1.105 . . . . 0.0 109.281 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.839 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.5 Cg_endo -74.91 -19.58 17.92 Favored 'Trans proline' 0 C--N 1.36 1.18 0 O-C-N 124.462 1.769 . . . . 0.0 111.065 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.645 ' CB ' ' HG2' ' A' ' 183' ' ' PRO . 0.4 OUTLIER -95.91 10.14 38.27 Favored 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.479 1.112 . . . . 0.0 110.976 -179.978 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.754 HG22 ' O ' ' A' ' 183' ' ' PRO . 4.7 m -136.67 -179.83 3.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 O-C-N 124.524 1.14 . . . . 0.0 109.33 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.599 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 20.7 pt-20 -140.14 165.01 28.51 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.501 1.125 . . . . 0.0 110.274 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 1.4 mppt? -88.08 106.3 18.06 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.475 1.109 . . . . 0.0 109.258 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.462 ' O ' ' O ' ' A' ' 191' ' ' GLY . 28.2 t80 -123.13 -67.1 0.97 Allowed 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.562 1.164 . . . . 0.0 111.024 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 190' ' ' TYR . . . . . . . . 0 CA--C 1.529 0.957 0 O-C-N 124.536 1.148 . . . . 0.0 111.03 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 6.6 t . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.615 ' O ' ' CD1' ' A' ' 136' ' ' TYR . . . -136.99 66.73 0.54 Allowed Glycine 0 CA--C 1.53 0.991 0 O-C-N 124.562 1.164 . . . . 0.0 111.031 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.615 ' CD1' ' O ' ' A' ' 135' ' ' GLY . 13.5 m-85 -145.75 160.54 41.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.449 0.735 . . . . 0.0 110.997 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.568 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 16.3 m -139.03 171.12 15.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 O-C-N 124.54 1.15 . . . . 0.0 109.296 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.515 ' O ' ' HA ' ' A' ' 187' ' ' VAL . 0.0 OUTLIER -138.19 131.82 30.91 Favored 'General case' 0 C--N 1.325 -0.497 0 O-C-N 124.465 1.103 . . . . 0.0 110.282 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.486 ' HB3' ' HB3' ' A' ' 157' ' ' ASP . . . -86.83 127.79 35.03 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.504 1.128 . . . . 0.0 109.299 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.403 HD21 ' HB3' ' A' ' 188' ' ' GLU . 0.0 OUTLIER -119.77 50.3 1.28 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.534 1.147 . . . . 0.0 109.3 179.975 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.577 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 0.0 OUTLIER -178.23 133.17 0.15 Allowed 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.493 1.12 . . . . 0.0 111.047 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -69.82 133.44 47.41 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 124.559 1.162 . . . . 0.0 109.301 -179.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.491 ' CD2' ' HB2' ' A' ' 152' ' ' PRO . 1.7 p90 -69.12 164.01 23.5 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 124.46 1.1 . . . . 0.0 111.03 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . . . . . . . . . 18.7 t30 -103.43 -74.78 0.63 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.489 1.118 . . . . 0.0 109.277 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.435 ' O ' ' CB ' ' A' ' 146' ' ' ASN . . . -155.6 128.72 2.33 Favored Glycine 0 CA--C 1.53 1.006 0 O-C-N 124.566 1.166 . . . . 0.0 110.961 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . 0.437 ' O ' ' O ' ' A' ' 150' ' ' ASP . 8.3 m-20 160.76 51.59 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 124.476 0.751 . . . . 0.0 109.32 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 149' ' ' GLU . 0.2 OUTLIER -78.66 158.29 28.42 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.471 1.107 . . . . 0.0 109.323 -179.965 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 147' ' ' ASP . 9.4 mm-40 66.69 -58.23 0.38 Allowed 'General case' 0 C--N 1.325 -0.496 0 O-C-N 124.521 1.138 . . . . 0.0 110.344 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . 0.506 ' N ' ' O ' ' A' ' 147' ' ' ASP . 1.2 pt-20 -66.17 -34.29 77.71 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.501 1.125 . . . . 0.0 110.251 179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.632 ' OD2' ' CE3' ' A' ' 169' ' ' TRP . 4.5 t70 -150.39 92.74 1.9 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.512 1.132 . . . . 0.0 109.267 -179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.468 HD21 ' HB2' ' A' ' 174' ' ' ASP . 0.6 OUTLIER -39.61 110.39 0.62 Allowed Pre-proline 0 C--N 1.325 -0.46 0 O-C-N 124.501 1.126 . . . . 0.0 109.339 179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.491 ' HB2' ' CD2' ' A' ' 143' ' ' PHE . 18.2 Cg_endo -75.0 -170.47 0.78 Allowed 'Trans proline' 0 C--N 1.36 1.141 0 O-C-N 124.484 1.781 . . . . 0.0 111.034 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.464 ' CE1' ' HB1' ' A' ' 139' ' ' ALA . 3.0 p90 -169.22 -177.1 2.76 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 124.507 1.129 . . . . 0.0 110.99 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.16 162.42 17.06 Favored 'General case' 0 C--N 1.325 -0.464 0 O-C-N 124.449 1.093 . . . . 0.0 109.296 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.444 ' HG2' ' N ' ' A' ' 141' ' ' PHE . 0.0 OUTLIER -56.18 134.56 53.08 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.491 1.119 . . . . 0.0 109.304 179.991 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 69.14 36.02 79.12 Favored Glycine 0 CA--C 1.53 0.97 0 O-C-N 124.545 1.153 . . . . 0.0 111.034 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . 0.486 ' HB3' ' HB3' ' A' ' 139' ' ' ALA . 12.1 t70 -90.04 163.49 14.88 Favored 'General case' 0 C--N 1.324 -0.537 0 O-C-N 124.474 0.749 . . . . 0.0 109.249 -179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 159' ' ' LEU . 10.1 mt -111.95 140.09 33.23 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.503 1.127 . . . . 0.0 109.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.722 HD23 ' HA ' ' A' ' 174' ' ' ASP . 15.6 mt -148.02 123.38 10.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.474 1.109 . . . . 0.0 109.333 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.578 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 6.1 ttt85 -88.91 148.98 23.54 Favored 'General case' 0 C--N 1.325 -0.492 0 O-C-N 124.471 1.107 . . . . 0.0 110.253 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.542 HG21 ' HE3' ' A' ' 164' ' ' LYS . 18.5 mm -85.18 130.75 35.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 O-C-N 124.539 1.15 . . . . 0.0 109.316 179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 25.4 ttt180 -120.54 -59.3 1.77 Allowed 'General case' 0 C--N 1.325 -0.495 0 O-C-N 124.518 1.136 . . . . 0.0 110.329 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.509 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 16.6 m-20 -144.04 149.71 37.08 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.45 1.094 . . . . 0.0 109.249 179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.588 ' HB3' ' CD1' ' A' ' 170' ' ' TRP . 0.0 OUTLIER -134.43 58.95 33.3 Favored Pre-proline 0 C--N 1.327 -0.407 0 O-C-N 124.543 1.152 . . . . 0.0 109.304 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.517 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.6 Cg_endo -74.96 5.8 3.75 Favored 'Trans proline' 0 C--N 1.36 1.159 0 O-C-N 124.442 1.759 . . . . 0.0 111.023 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.481 ' O ' ' NE1' ' A' ' 170' ' ' TRP . 2.7 mt-10 -134.33 -176.96 4.38 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.499 1.124 . . . . 0.0 110.333 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' O ' ' CB ' ' A' ' 168' ' ' GLN . 0.9 OUTLIER -115.04 134.99 54.7 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.549 1.156 . . . . 0.0 110.285 -179.939 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.756 ' O ' HG23 ' A' ' 184' ' ' VAL . 0.0 OUTLIER 81.39 -54.54 0.28 Allowed 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.538 1.149 . . . . 0.0 110.327 -179.982 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.632 ' CE3' ' OD2' ' A' ' 150' ' ' ASP . 43.6 m95 -104.93 128.34 53.15 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.519 1.137 . . . . 0.0 107.973 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.588 ' CD1' ' HB3' ' A' ' 164' ' ' LYS . 22.8 m0 -131.18 166.17 21.71 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 124.495 1.122 . . . . 0.0 108.03 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.475 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 0.8 OUTLIER -87.73 111.17 21.05 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 124.472 1.108 . . . . 0.0 109.359 -179.976 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.578 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -117.24 149.65 40.06 Favored 'General case' 0 C--N 1.326 -0.45 0 O-C-N 124.464 1.102 . . . . 0.0 109.343 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -95.94 108.57 20.97 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 124.529 1.143 . . . . 0.0 110.284 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.722 ' HA ' HD23 ' A' ' 159' ' ' LEU . 6.0 t70 -56.14 171.36 0.27 Allowed 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.496 1.122 . . . . 0.0 109.237 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 79.9 p -81.65 27.31 0.45 Allowed 'General case' 0 C--N 1.326 -0.423 0 O-C-N 124.473 1.108 . . . . 0.0 109.977 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 174' ' ' ASP . 1.6 mt-10 -133.89 -3.75 2.85 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.545 1.153 . . . . 0.0 110.326 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.68 -3.09 62.78 Favored Glycine 0 CA--C 1.53 1.027 0 O-C-N 124.565 1.165 . . . . 0.0 110.967 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 3.5 ttmm -80.88 112.07 17.93 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.494 0.761 . . . . 0.0 109.239 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -98.48 119.21 36.79 Favored 'General case' 0 C--N 1.325 -0.489 0 O-C-N 124.494 1.121 . . . . 0.0 110.303 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -151.84 -171.92 20.09 Favored Glycine 0 CA--C 1.53 0.995 0 O-C-N 124.513 1.133 . . . . 0.0 111.023 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.502 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 4.1 mtt -85.92 139.82 30.89 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.504 0.767 . . . . 0.0 111.011 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.618 ' O ' HD13 ' A' ' 182' ' ' ILE . 0.0 OUTLIER -139.05 150.07 63.66 Favored Pre-proline 0 C--N 1.326 -0.438 0 O-C-N 124.491 1.119 . . . . 0.0 109.292 179.988 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.793 ' O ' HG22 ' A' ' 187' ' ' VAL . 18.5 Cg_endo -74.92 139.72 24.85 Favored 'Trans proline' 0 C--N 1.36 1.168 0 O-C-N 124.538 1.81 . . . . 0.0 111.026 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.829 ' N ' ' CD ' ' A' ' 185' ' ' PRO . 47.1 t -83.1 -30.51 0.49 Allowed Pre-proline 0 C--N 1.326 -0.417 0 O-C-N 124.357 1.036 . . . . 0.0 109.299 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.829 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.2 Cg_endo -75.02 -48.65 0.17 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 O-C-N 124.504 1.792 . . . . 0.0 110.992 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.577 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.5 OUTLIER -60.87 -36.42 79.13 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.52 1.137 . . . . 0.0 110.996 179.971 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.793 HG22 ' O ' ' A' ' 183' ' ' PRO . 12.8 m -90.65 179.62 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 O-C-N 124.577 1.173 . . . . 0.0 109.272 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.568 ' O ' ' HA ' ' A' ' 137' ' ' VAL . 14.4 pt-20 -134.82 166.41 23.04 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 124.486 1.116 . . . . 0.0 110.272 179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.44 117.33 26.15 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 124.506 1.129 . . . . 0.0 109.284 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.401 ' HB3' ' NH1' ' A' ' 138' ' ' ARG . 0.3 OUTLIER -157.9 82.54 0.87 Allowed 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.584 1.177 . . . . 0.0 111.055 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 1.024 0 O-C-N 124.613 1.195 . . . . 0.0 110.968 179.99 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.442 ' O ' ' O ' ' A' ' 136' ' ' TYR . 94.7 m . . . . . 0 N--CA 1.452 -0.339 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 134' ' ' CYS . . . 35.15 -108.47 0.05 OUTLIER Glycine 0 CA--C 1.529 0.95 0 O-C-N 124.559 1.162 . . . . 0.0 111.001 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' TYR . . . . . 0.442 ' O ' ' O ' ' A' ' 134' ' ' CYS . 33.7 p90 -91.93 178.9 5.76 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.486 0.756 . . . . 0.0 110.978 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 188' ' ' GLU . 12.2 m -118.24 174.03 4.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 O-C-N 124.49 1.118 . . . . 0.0 109.287 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.499 ' HD3' ' CD1' ' A' ' 158' ' ' ILE . 0.3 OUTLIER -141.94 135.08 29.05 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 124.435 1.085 . . . . 0.0 110.284 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . 0.548 ' O ' ' N ' ' A' ' 156' ' ' GLY . . . -86.8 117.3 25.45 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 124.551 1.157 . . . . 0.0 109.246 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.617 HD11 ' HB3' ' A' ' 188' ' ' GLU . 0.3 OUTLIER -104.15 36.94 2.2 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.541 1.15 . . . . 0.0 109.264 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' PHE . . . . . 0.611 ' HB3' ' CE2' ' A' ' 186' ' ' TYR . 17.3 m-85 -159.94 120.19 2.98 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 124.455 1.097 . . . . 0.0 110.983 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -78.29 121.87 24.99 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 124.526 1.141 . . . . 0.0 109.29 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PHE . . . . . 0.542 ' CE2' ' HA3' ' A' ' 145' ' ' GLY . 18.2 t80 -96.19 175.4 6.46 Favored 'General case' 0 C--N 1.324 -0.502 0 O-C-N 124.48 1.113 . . . . 0.0 111.04 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASN . . . . . 0.401 ' O ' ' O ' ' A' ' 145' ' ' GLY . 2.8 p30 -117.27 -50.62 2.55 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 124.485 1.116 . . . . 0.0 109.237 -179.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.542 ' HA3' ' CE2' ' A' ' 143' ' ' PHE . . . -45.97 173.48 0.01 OUTLIER Glycine 0 CA--C 1.531 1.04 0 O-C-N 124.472 1.108 . . . . 0.0 110.989 179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 174.2 68.11 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.482 0 O-C-N 124.562 0.801 . . . . 0.0 109.33 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -71.92 157.35 38.01 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 124.541 1.151 . . . . 0.0 109.291 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -79.78 42.26 0.53 Allowed 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.425 1.078 . . . . 0.0 110.261 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -142.99 -41.84 0.31 Allowed 'General case' 0 C--N 1.324 -0.515 0 O-C-N 124.479 1.112 . . . . 0.0 110.331 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASP . . . . . 0.411 ' OD2' ' O ' ' A' ' 181' ' ' MET . 0.2 OUTLIER -111.47 151.58 28.42 Favored 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.443 1.089 . . . . 0.0 109.301 179.984 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' OD2' ' A' ' 174' ' ' ASP . 0.1 OUTLIER -85.25 144.16 40.49 Favored Pre-proline 0 C--N 1.325 -0.462 0 O-C-N 124.493 1.121 . . . . 0.0 109.263 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 151' ' ' LEU . 18.5 Cg_endo -74.91 174.28 13.02 Favored 'Trans proline' 0 C--N 1.36 1.152 0 O-C-N 124.525 1.802 . . . . 0.0 111.033 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.591 ' CZ ' ' HD3' ' A' ' 183' ' ' PRO . 0.2 OUTLIER -139.99 173.76 11.2 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 124.469 1.106 . . . . 0.0 110.977 179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LYS . . . . . . . . . . . . . 5.4 mmmt -135.87 169.17 18.0 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.5 1.125 . . . . 0.0 109.267 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LYS . . . . . 0.504 ' O ' ' CE ' ' A' ' 155' ' ' LYS . 0.0 OUTLIER -75.53 55.9 0.85 Allowed 'General case' 0 C--N 1.325 -0.494 0 O-C-N 124.584 1.177 . . . . 0.0 109.311 179.955 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLY . . . . . 0.548 ' N ' ' O ' ' A' ' 139' ' ' ALA . . . 133.2 49.57 0.09 OUTLIER Glycine 0 CA--C 1.529 0.959 0 O-C-N 124.541 1.151 . . . . 0.0 111.04 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -99.03 167.65 10.59 Favored 'General case' 0 C--N 1.325 -0.47 0 O-C-N 124.457 0.739 . . . . 0.0 109.346 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ILE . . . . . 0.499 ' CD1' ' HD3' ' A' ' 138' ' ' ARG . 0.5 OUTLIER -107.75 142.53 20.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 O-C-N 124.531 1.144 . . . . 0.0 109.265 -179.96 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.979 HD13 HD12 ' A' ' 182' ' ' ILE . 10.0 mt -148.87 120.17 7.84 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 124.505 1.128 . . . . 0.0 109.333 179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.596 ' O ' ' HB1' ' A' ' 172' ' ' ALA . 13.2 ttt180 -88.38 152.18 22.09 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 124.553 1.158 . . . . 0.0 110.273 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.416 ' N ' ' CG ' ' A' ' 160' ' ' ARG . 21.0 mm -87.86 124.06 40.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 O-C-N 124.465 1.103 . . . . 0.0 109.294 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 14.3 tpt180 -112.51 -59.15 2.05 Favored 'General case' 0 C--N 1.325 -0.468 0 O-C-N 124.51 1.131 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.461 ' C ' ' HG3' ' A' ' 164' ' ' LYS . 2.6 m-20 -149.91 156.71 42.23 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 124.478 1.111 . . . . 0.0 109.327 -179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' LYS . . . . . 0.522 ' HG2' ' CG ' ' A' ' 170' ' ' TRP . 4.4 mttt -133.6 60.47 47.11 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 124.504 1.127 . . . . 0.0 109.318 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' PRO . . . . . 0.49 ' HD3' ' N ' ' A' ' 164' ' ' LYS . 18.2 Cg_endo -75.04 13.31 1.05 Allowed 'Trans proline' 0 C--N 1.36 1.144 0 O-C-N 124.493 1.786 . . . . 0.0 111.065 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 164' ' ' LYS . 32.7 mp0 -147.32 -174.68 4.58 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 124.507 1.129 . . . . 0.0 110.338 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.602 ' O ' ' HB2' ' A' ' 168' ' ' GLN . 2.1 mp0 -114.93 134.22 55.34 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 124.577 1.173 . . . . 0.0 110.298 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLN . . . . . 0.967 ' O ' HG13 ' A' ' 184' ' ' VAL . 70.3 mt-30 78.51 -51.91 0.48 Allowed 'General case' 0 C--N 1.325 -0.465 0 O-C-N 124.487 1.117 . . . . 0.0 110.344 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TRP . . . . . 0.436 ' HB3' ' CG ' ' A' ' 181' ' ' MET . 9.6 m95 -102.56 119.53 38.98 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 184' ' ' VAL . 8.6 m0 -125.44 163.62 22.25 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.972 -1.122 . . . . 0.0 107.972 -179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ASN . . . . . 0.514 ' HA ' ' O ' ' A' ' 180' ' ' GLY . 16.5 m120 -86.9 107.06 18.19 Favored 'General case' 0 C--N 1.325 -0.458 0 O-C-N 124.488 1.117 . . . . 0.0 109.297 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.596 ' HB1' ' O ' ' A' ' 160' ' ' ARG . . . -112.44 148.82 33.58 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 124.56 1.162 . . . . 0.0 109.347 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.424 ' CB ' ' HG2' ' A' ' 179' ' ' ARG . 25.7 tt0 -92.92 103.06 15.42 Favored 'General case' 0 C--N 1.324 -0.506 0 O-C-N 124.435 1.085 . . . . 0.0 110.304 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.749 ' OD2' HD21 ' A' ' 151' ' ' LEU . 7.6 t70 -49.63 170.74 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.56 0 O-C-N 124.476 1.11 . . . . 0.0 109.334 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' SER . . . . . . . . . . . . . 80.1 p -80.16 27.95 0.31 Allowed 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.539 1.149 . . . . 0.0 110.007 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLU . . . . . 0.453 ' H ' ' C ' ' A' ' 174' ' ' ASP . 23.7 mt-10 -137.03 -2.64 2.06 Favored 'General case' 0 C--N 1.325 -0.475 0 O-C-N 124.492 1.12 . . . . 0.0 110.271 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' GLY . . . . . . . . . . . . . . . 96.33 -3.86 64.18 Favored Glycine 0 CA--C 1.529 0.943 0 O-C-N 124.554 1.159 . . . . 0.0 110.993 -179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' LYS . . . . . . . . . . . . . 5.3 mmtp -78.01 105.08 8.98 Favored 'General case' 0 C--N 1.325 -0.478 0 O-C-N 124.505 0.768 . . . . 0.0 109.29 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ARG . . . . . 0.424 ' HG2' ' CB ' ' A' ' 173' ' ' GLU . 59.2 mtm180 -93.36 116.88 29.42 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.465 1.103 . . . . 0.0 110.346 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.514 ' O ' ' HA ' ' A' ' 171' ' ' ASN . . . -152.03 -175.25 23.51 Favored Glycine 0 CA--C 1.53 1.017 0 O-C-N 124.477 1.111 . . . . 0.0 110.939 -179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' MET . . . . . 0.455 ' HA ' ' O ' ' A' ' 170' ' ' TRP . 0.4 OUTLIER -82.93 133.37 35.12 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 124.451 0.736 . . . . 0.0 111.032 179.936 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ILE . . . . . 0.979 HD12 HD13 ' A' ' 159' ' ' LEU . 5.5 pt -135.03 150.93 74.42 Favored Pre-proline 0 C--N 1.324 -0.524 0 O-C-N 124.52 1.137 . . . . 0.0 109.313 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.591 ' HD3' ' CZ ' ' A' ' 153' ' ' PHE . 18.4 Cg_endo -75.05 139.51 24.23 Favored 'Trans proline' 0 C--N 1.361 1.197 0 O-C-N 124.468 1.773 . . . . 0.0 110.97 179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' VAL . . . . . 0.967 HG13 ' O ' ' A' ' 168' ' ' GLN . 31.6 m -81.09 -28.75 0.49 Allowed Pre-proline 0 C--N 1.326 -0.446 0 O-C-N 124.61 1.194 . . . . 0.0 109.328 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.85 ' CD ' ' N ' ' A' ' 184' ' ' VAL . 18.3 Cg_endo -75.02 -35.12 3.31 Favored 'Trans proline' 0 C--N 1.359 1.12 0 O-C-N 124.556 1.819 . . . . 0.0 110.984 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.611 ' CE2' ' HB3' ' A' ' 141' ' ' PHE . 0.2 OUTLIER -86.06 26.48 1.01 Allowed 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.472 1.107 . . . . 0.0 111.048 179.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 138' ' ' ARG . 15.8 m -148.34 179.6 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 124.524 1.14 . . . . 0.0 109.219 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLU . . . . . 0.617 ' HB3' HD11 ' A' ' 140' ' ' LEU . 2.0 pp20? -142.79 161.57 37.74 Favored 'General case' 0 C--N 1.326 -0.452 0 O-C-N 124.57 1.169 . . . . 0.0 110.279 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 6.9 mtmt -88.76 123.65 33.38 Favored 'General case' 0 C--N 1.326 -0.44 0 O-C-N 124.493 1.121 . . . . 0.0 109.321 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' TYR . . . . . 0.592 ' CD1' ' OE2' ' A' ' 188' ' ' GLU . 0.2 OUTLIER -132.26 114.0 13.91 Favored 'General case' 0 C--N 1.324 -0.532 0 O-C-N 124.504 1.127 . . . . 0.0 110.998 179.964 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.419 ' O ' ' N ' ' A' ' 135' ' ' GLY . . . . . . . . 0 CA--C 1.531 1.048 0 O-C-N 124.512 1.132 . . . . 0.0 110.918 179.936 . . . . . . . . 1 1 . 1 stop_ save_